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ABSTRACT 
 
The development of new catalytic reactions, particularly synthetically efficient 
cascade processes for the facile preparation of important molecular architectures, which 
otherwise are difficult to access via traditional methods, is of considerable significance. 
Toward this end, my Ph.D. work focuses on developing new organocatalytic reactions 
and their applications in organic syntheses.  
A novel direct organocatalytic stereoselective α-arylation methodology has been 
discovered. The cross-coupling-like products are assembled using simple enals and 
various brominated aromatic systems, such as p-bromophenols, bromonaphthols and 3-
bromoindoles. The products have been applied in the concise photo-syntheses of [α]-
annulated carbazoles. Moreover, an unexpected reaction has been identified with 
aliphatic enals, and fully developed into a new [3+3] formal cycloaddition cascade 
reaction, and serves as a powerful approach to polysubstituted arenes from simple enals 
in a highly regio- and chemo-selective fashion. 
The Diels-Alder reaction of acetylenic aldehydes has been realized for “one-pot” 
synthesis of polysubstituted salicylaldehyde frameworks that were constructed via an 
unprecedented aminocatalytic Diels-Alder-retro-Diels-Alder cascade from simple 
alkynals and 2-pyrones. Furthermore, the use of N-protected 3-hydroxy-2-pyridines as 
dienes leads to catalytic enantioselective Diels-Alder process without subsequent retro-
Diels-Alder reaction. A chiral C2 symmetric organocatalyst is found as an effective 
promoter for the activation and stereo-control of various substituted alkynals. 
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Chapter 1 
Introduction 
 
1.1. Cascade Reaction 
Chemical knowledge and technology have advanced to the stage that, given a 
sufficient amount of time, money, manpower and chemical resource, it is possible to 
synthesize almost any desired organic substance.  Among the main challenges that 
remain to be addressed in modern organic synthesis are the improvement of synthetic 
efficiency, the avoidance of toxic reagents, and the reduction of waste and hazardous 
byproducts. General solutions to these problems will become increasingly important as 
chemists and society strive to develop effective and responsible synthetic methodologies 
that can contribute to sustaining our precious and limited resources. One effective way to 
surmount these challenges is to uncover and utilize novel cascade strategies.1, 2 
Cascade (or domino, or tandem) reaction is a sequence of chemical 
transformations, in which several bond forming steps take place in a single operation. In 
the process, only a single reaction solvent, workup procedure, and purification step is 
required to produce a product that would otherwise be derived from a tedious multi-step 
synthetic sequence. The starting materials are rationally designed to, or serendipitously 
happened to undergo an initial reaction step, which produce a reactive intermediate that 
becomes the substrate for the consecutive step, whose product again acts as the substrate 
for the successive step, and so on, until a product stable enough to the reaction conditions 
is received. The overall sequential transformations occur under the same reaction 
 2 
conditions, without introducing additional reagents or catalysts. Besides those obvious 
advantages in elevation of synthetic efficiency, the methodology of cascade also 
significantly broadens our spectra of organic reactions and strategies by granting the 
utilization of synthetically reactive intermediates that would be difficult to construct and 
not feasible to isolate.1, 2, 3 
 
Scheme 1.1. Robinson’s synthesis of tropinone and its proposed mechanism 
 
 
Historically, cascade strategies have already been used by organic chemists since 
the inception of total synthesis. Robinson’s one-pot synthesis of tropinone (Scheme 1.1) 
 3 
back as early as 1917 is considered as the seminal work in the realm of cascade reaction.4 
Tropinone is produced after the decarboxylation of compound 7, which is synthesized 
using succinaldehyde 1, methylamine, and acetonedicarboxylic acid 2 in water at room 
temperature. Such a cascade process is initiated from the condensation of methylamine 
and succinaldehyde to form a Schiff base 3. The reactive intermediate species 4 is 
generated via intramolecular addition of imine moiety to aldehyde moiety. The following 
intermolecular Mannich reaction between 4 and starting material 2 yields compound 5. 
After condensation, the second reactive intermediate species 6 is formed, and it 
spontaneously transforms to bicyclic product 7 via intramolecular Mannich reaction. 
Using simple compounds as starting materials, under mild and green one-pot reaction 
conditions, the cascade reaction demonstrates a great synthetic efficiency with the overall 
yield of more than 90% after optimization of reaction conditions.  
Because of their unique features, cascade processes often serve as the basis for 
highly efficient synthetic strategies for the construction of complex molecular 
architectures from simple starting materials. Consequently, these reactions have been the 
subject of intense research in recent years, as evidenced by the number of reviews that 
have appeared.5, 6, 7 However, the current status of cascade reactions is limited, 
particularly catalytic asymmetric versions. Therefore, it is clear that new investigations in 
this field are required in order to develop more atom-economic, cost effective catalytic 
enantioselective versions of cascade reactions.8, 9 
 In biological aspects, small molecule modulation of protein gene products 
(chemical genetics) is an extremely powerful tool for studying biological systems and 
drug discovery. In order to find a selective small molecule modulator of any protein 
 4 
function, a structurally diverse compound collection is required. Historically, nature has 
provided many of these pharmaceutically active small molecules. Unfortunately, there are 
disadvantages with screening natural product extracts; for example, the need for active 
component(s) identification, limited supply, and formidable analog synthesis. As a result, 
the quick and successful identification of new and highly specific small-molecule probes 
remains an important challenge in the fields of chemical biology and medicinal chemistry. 
The bottleneck is the lack of efficient synthetic strategies to quickly construct structurally 
diverse small molecules and explore chemical space. The number of drug-like molecules 
possible in chemical space has been estimated to be 1030-10200. Therefore, clearly it is 
impossible to synthesize every drug-like molecule and chemists must be selective. These 
problems have led to an alternative strategy of synthesizing structurally diverse small 
molecules directly and efficiently, which is known as diversity oriented synthesis (DOS). 
A significant approach of DOS is to develop new powerful cascade reactions to assemble 
compound libraries of biologically significant frameworks. 10, 11, 12 
 
1.2. Organocatalysis 
In modern organic chemistry, atom economy and selectivity (chemo-, regio-, 
stereo-) are the two major criteria for the discovery and development of a practical 
synthetic methodology.13, 14 Catalysis is undoubtedly the main vehicle for such 
exploration, since the use of catalyst could significantly reduce reaction time, decrease 
reaction temperature, improve selectivity, optimize reaction route or increase product 
yield.15 Although it has been discovered and utilized since the infancy of organic 
 5 
chemistry, the concept of organocatalysis was just brought up at the beginning of the 21st 
century. The catalysis using small organic molecules exclusively, in which an inorganic 
element is not participated in the catalytic cycle, is generally considered as 
organocatalysis. Together with biocatalysis and metal catalysis, organocatalysis becomes 
a dynamic research area of modern asymmetric catalysis.16 Compared with metal 
catalysts and biomolecule based catalysts, typical organocatalysts, such as proline 
derivatives and thioureas, have tremendous advantages such as stable in air and water, 
readily available from biological materials, easy to prepare from inexpensive chemicals, 
simple to apply in various synthetic methodologies, accessible of both enantiomers, and 
non-toxic.17   
The organocatalysts can be classified into two categories based on the way it 
interacts with substrate. The covalent catalyst forms covalent bond with substrate, while 
the non-covalent catalyst does not form such tight interaction.17, 18 Each category contains 
various catalysis modes. Some modes render the substrate more electronic deficient, 
which is labile for the attacking of nucleophile. And other modes make the substrate 
more electronic rich, which is labile for electrophilic attacking. 
 One of the covalent catalysts is enamine catalyst. In this catalysis mode, the 
electrophilic substitution reactions of the α-position of carbonyl compounds are catalyzed 
by primary or secondary amine via enamine intermediate. L-Proline is a representative 
catalyst for enamine catalysis. After the secondary amine is associated with aldehyde 
substrate, α-proton of the aldehyde is extracted to form nucleophilic enamine species.  
Meanwhile, a reactant electrophile is delivered by the carboxylic moiety of L-proline, and 
is aligned for electrophilic attacking (Scheme 1.2). Enamine catalysis is a fruitful field of 
 6 
research and becomes a powerful methodology for asymmetric synthesis. Under the 
catalysis of an increasing amount of aminocatalysts, almost all types of ketones and 
aldehydes can be used as nucleophiles together various electrophiles with a broad 
spectra.19 
 
Scheme 1.2. Catalysis modes of covalent catalysts 
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 Although the earliest recorded example of an iminium catalyzed reaction is the 
Knoevenagel condensation mediated by primary or secondary amines in 1894, the 
concept of LUMO-lowering iminium organocatalysis is not brought up until the turn of 
the century. MacMillan and co-workers were the first to introduce the iminium catalysis 
concept to describe the catalytic strategy similar to metal cation Lewis acids.20 Generally 
speaking, α, β-unsaturated aldehyde or ketone is activated by secondary or primary amine 
via iminium intermediate for further nucleophilic attacking or cycloaddition processes, 
and McMillan’s imidazolidinone catalyst family and protected diarylprolinol catalyst 
series are typical iminium activation promoters (Scheme 1.2).21 
The concept of SOMO catalysis was introduced by McMillan and coworkers in 
2007.22, 23 The singly occupied molecular orbital (SOMO) is a reactive radical cation 
species with three π-electrons, which is generated from one-electron oxidation of an 
electron-rich enamine intermediate. The electrophilicity of the SOMO intermediate 
makes it vulnerable to the attack of weakly nucleophilic carbon-based nucleophiles, 
which also has a nick name of “SOMOphiles” (Scheme 1.2). Although SOMO catalysis 
has just come into being, this novel aminocatalysis mode has already produced several 
applicable examples in asymmetric synthesis.24, 25 
N-Heterocyclic carbenes (NHCs) have been extensively used as excellent ligands 
in metal catalysis, and impressively demonstrated in organic synthesis. In last decades, 
NHC catalysis has gradually became a hot research area in organocatalysis. Based on 
Breslow’s mechanism, stable NHC or in situ generated NHC associates with aldehyde 
substrate to form an electrophilic intermediate species, which is known as Breslow 
intermediate.26 The nucleophilic carbonyl carbon is changed to an electrophilic carbon 
 8 
with the help of NHC catalyst, and such a reversion of electronic property is usually 
named as umpolung, and the NHC catalysis is usually considered as umpolung 
catalysis.27 
Although, conceptually as well as practically, covalent catalysis has brought deep 
and revolutionary impact in the realm of organic chemistry, without non-covalent 
catalysis, it still cannot depict the big picture of the organocatalysis. As in non-covalent 
catalysis, only non-bonding weak interactions take place between catalyst and substrate 
during the catalytic process. 
Small-molecule chiral hydrogen-bond donors have been used as non-covalent 
catalysts in the frontier research field of enantioselective synthesis. Inspired by the 
function of enzymes in biocatalysis, organic chemists have found that small organic 
molecules bearing hydrogen-bond donor moiety and complementary functional 
frameworks were able to catalyze C-C and C-heteroatom bond formation reaction with 
extensive substrate scope. Chiral thioureas and cinchona alkaloids are typical H-bonding 
catalysts. In the case of thioureas, two hydrogen bond donating sites are able to pinch the 
carbonyl oxygen tightly, and the activated substrate is readily available for the 
nucleophilic attack (Scheme 1.3). Since the proton on the catalyst is not deprotonated, the 
H-bonding catalyst is usually considered as neutral Brønsted acid catalyst. 
  Strong  Brønsted acid is the other branch of Brønsted acid catalyst besides neutral 
one, and spectacular achievement has been made in this area. As we known, the proton is 
the smallest Lewis acid. The general strategy for strong Brønsted acid catalysis is to 
mimic the process of metal-based Lewis acid catalysis. Since Lewis-acids have already  
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Scheme 1.3. Catalysis modes of non-covalent catalysts 
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been widely used as catalysts for C-C bond-forming reactions, strong Brønsted acids are 
also capable of such employment. Furthermore, in contrast to the Lewis acids, strong 
Brønsted acids possess various merits of organocatalysts, such as stable in oxygen and 
environmental friendliness. As a benchmark reaction, BINOL derived chiral phosphoric 
acid, a typical strong Brønsted acid, is able to activate carbonyl compound for 
nucleophilic attack (Scheme 1.3). The deprotonated phosphate anion and protonated 
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carbonyl oxonium cation forms a contact ion pair, which is a crucial intermediate stage 
for activation and asymmetric control. The phosphate will be re-protonated after the 
catalytic cycle.29 
 Phase transfer catalysis (PTC), a class of highly useful and active catalysts based 
on quaternary ammonium salts, belongs to Lewis acid organocatalysis. Different from 
strong Brønsted acid catalyst, the activation and stereo-control species of PTC is the 
chiral quaternary ammonium cation. The deprotonated substrate anion and the catalyst 
cation also generate a contact ion pair, and the activated substrate is ready for 
electrophilic bombardment.30 
 Besides abovementioned classification method based on catalytic activation 
modes, there is another method. Benjamin List firstly described that most but not all the 
organocatalysts could be classified as Lewis bases and acids, and Brønsted bases and 
acids.31 Generally speaking, in the Lewis model, a Lewis acid is an electron acceptor, and 
Lewis base is an electron donor. And in the Lowry-Brønsted model, a Brønsted acid is a 
proton donor, and a Brønsted base is a proton acceptor or abstractor. The two acid-base 
theories can be reconciled by recognizing that the proton is a unique and the smallest 
Lewis acid that is also the agent responsible for the Brønsted acidity. As for 
organocatalysis, both enamine catalysis and iminium catalysis fall into the category of 
Lewis base catalysis. Since only one electron transfers from a nucleophilic radical to an 
electrophilic radical species in the process of SOMO catalysis, the SOMO catalysis is 
generally considered as a special kind of Lewis base catalysis. Similarly, the N-
heterocyclic carbene catalysis also belongs to Lewis base catalysis. And the phase 
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transfer catalysis is a kind of Lewis acid catalysis. Both hydrogen-bonding catalysis and 
strong Brønsted acid catalysis are Brønsted acid catalysis.31 
 Furthermore, based on the advance of organocatalysis, bifunctional or 
multifunctional organocatalysts are rationally designed and applied in synthetic chemistry. 
Multiple catalytic moieties possessing different catalysis modes are integrated in one 
single catalyst. And such multifunctional catalysts are also considered as cooperative 
catalysts mimicking enzyme’s cooperative catalysis.32 However, in most of the cases, 
multifunctional organocatalysts are designed to cope with special scaffolds or functional 
groups of substrates, and they usually lacks the generality and the ability of catalyzing 
wide range of one-pot cascade reaction sequences. 
 
1.3. Organocatalytic Cascade Reaction 
 To achieve atom economy and efficiency in the current status of organic 
chemistry, multicomponent cascade reactions have been utilized for the efficient and 
stereoselective construction of complex molecules from easily accessible simple 
precursors in a one-pot fashion. Inheriting the unprecedented advantages of 
organocatalysis, the organocatalytic cascade reactions have quickly become a mighty 
instrument to achieving high molecular complexity. In the organocatalytic cascade 
process, the combination of various activation catalytic modes provides unexampled 
opportunity of strategic design of innovative cascade sequences to afford an unobtainable 
structural topology as well as a high level of stereocontrol.33, 34 
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 Thanks to pioneer endeavors of various organic chemists, a number of review 
articles have been published in the research area of organocatalytic cascade reactions.33-36 
Based on their summary, the aminocatalysts are considered as a widely used catalyst for 
cascade process than other organocatalysts. The aminocatalysts could have up to three 
activation modes, while others only have one (Scheme 1.2 and Scheme 1.3). Moreover, 
the number of combination of activation modes using the same aminocatalyst could be 
double-cascade, triple-cascade, and even the impressive quadruple-cascades.37, 38 
Professor Gong and coworkers had discovered an asymmetric organocatalytic 
four-component quadruple cascade reaction (Scheme 1.4). The oxo-Michael-Michael-
Michael-aldol condensation process is catalyzed by a single diphenylprolinol silyl ether 
aminocatalyst with two equiv. acrolein 1, simple alcohol 2 and nitroalkene 3 as reactants. 
The cascade reaction affords highly functionalized trisubstituted cyclohexene 
carbaldehyde 8 with excellent diastereoselectivity and enantioselectivity. In the first step 
of the quadruple cascade process, the aminocatalyst associates with acrolein to form an 
activated iminium intermediate species 4, which can readily undergo nucleophilic attack 
from alcohol 2. The directly formed oxo-Michael adduct 5 is an enamine activated 
intermediate. In the second step, the activated Michael donor reacts with olefin Michael 
acceptor 3 to form Michael adduct 6. Due to electronic withdrawing effect of nitro group, 
the α-carbon demonstrates nucleophilicity, which renders the nitro compound 6 a good 
Michael donor. In the third step, another equiv. of iminium activated acrolein 4 reacts 
with intermediate 6 to form a Michael adduct 7, which is an enamine activated 
intermediate. In the last step, intramolecular aldol condensation reaction happens, and the 
cyclohexene product is formed after dissociation of the aminocatalyst. The iminium-
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enamine-iminium-enamine cascade reaction enables the consecutive formation of four 
new bonds stereoselectively and provides an atom economic access to the functionalized 
cyclohexene in good yield. And in the quadruple-cascades process, only a single catalyst, 
one solvent condition and one purification operation are used in a one-pot fashion.37 
 
Scheme 1.4. Organocatalytic quadruple cascade reaction and its mechanism 
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Based on the extensive study of various organocatalysts and their applications in 
the discovery of novel methodologies, the diarylprolinol silyl ether system is selected as a 
general organocatalyst. In the development of organic chemistry, the discovery of general 
catalysts is a longstanding goal in the pursuit of new catalytic systems, which should be 
capable of mediating a large quantity of stereoselective reactions, through various 
isolated or consecutive activation modes, with a wide scope of substrate tolerance and 
high stereoselectivity. The diarylprolinol silyl ether derivatives are capable of promoting 
various enamine- and iminium-ion- mediated processes, and this renders the catalytic 
system ideal for the sequential addition of nucleophiles and electrophiles in a cascade 
manner, leading access to products bearing multiple stereocetners. 
 
1.4. Summary of Dissertation Research 
The discovery and development of novel organocatalytic cascade methodologies 
has become one of the important strategies for modern organic chemists. In the following 
chapters, I will detail my efforts towards a stepwise fulfillment of such duty. Chapter 2 
describes the direct organocatalytic stereoselective α-arylation methodology. In chapter 3, 
strategies of stereoselective achieving both E- and Z- arylation products are scrutinized. 
Chapter 4 focuses on the concise synthesis of [α]-annulated carbazoles using the 
stereoselective arylation method. In chapter 5, the organocatalytic regioselective 
synthesis of poly-substituted arenes is depicted. Chapter 6 summarizes the pyrrolidine-
catalyzed Diels-Alder-retro-Diels-Alder cascade reactions of alkynals with functionalized 
2-pyrones. In chapter 7, the asymmetric Diels-Alder reaction of alkynals using a C2-
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symmetric organocatalyst is elaborated.  
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Chapter 2 
Direct Stereoselective α-Arylation of Unmodified Enals with p-
Bromophenols using an Organocatalytic Cross-Coupling-Like Reaction 
 
2.1. Introduction 
Cross-coupling reactions have revolutionized chemical synthesis and, arguably, 
have become one of the most powerful tools for carbon – carbon bond formation.1-6 The 
successful achievement of Csp2-Csp2 coupling (Suzuki-Miyaura, etc.), Csp2-Csp1 
coupling (Sonogashira, etc.), and Csp3-Csp2 coupling (C-H activation) renders the cross-
coupling methodology a cornerstone in organic synthesis.7-11 
In recent years, the scope of cross-coupling reactions has moved beyond 
traditional processes by enabling direct arylation reactions of aromatic C-H bonds. 
Although great strides have been made in the development of efficient methods for 
coupling and direct arylation reactions, the strategies devised to date rely on transition-
metal-assisted approaches for which new transition metal complexes and ligands have 
been developed. Moreover, owing to the general inertness of C-H bonds, harsh reaction 
conditions (for example, strong base used and at high temperature) are generally required 
to promote transition-metal-catalyzed direct crossing couplings and difficulties associated 
with the control of chemo-, regio- and stereoselectivity are often problematic. In another 
perspective, despite tremendous efforts made in creating various environmentally benign 
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alternatives, the toxicity originated from transition metals was still an Achilles’ heel, 
especially in the realm of medicinal chemistry. 12-20 
 
2.2. Organocatalytic Approaches to Functionalized Enals via a Cross-coupling Like 
Reaction 
The pioneering work on respective enamine and iminium catalysis by List and 
Barbas and MacMillan serve as the conceptual basis for the field of organocatalysis.21-25 
A large number of unprecedented and typically stereoselective organic transformations, 
which are complementary to transition-metal catalysed processes, have been devised 
using this chemistry. The success of aminocatalysis can perhaps be attributed to the 
involvement of unique activation modes that enable stereoselective reactions to proceed 
under mild conditions and with a broad functional compatibility and operational 
simplicity. Although the main focus in this area will continue to be the design of highly 
efficient catalysts that promote existing reactions with greater turnover numbers, 
expansion of the scope of aminocatalysis to include new reactions is an important yet 
challenging aim. To our knowledge, the exploration of organocatalysis in the arena of 
cross-coupling reactions has not been described previously. 26, 27 
Interest in functionalized α, β -unsaturated aldehydes has grown significantly in 
recent years because of the results of their broad utility in cosmetic28, 29, pharmaceutical30-
35 and agrochemical36-39 industries. Moreover, enals are arguably the most widely used 
substrates in current organocatalytic reactions21-25. Therefore, efficient methods for the 
generation of structurally diverse α, β-unsaturated aldehydes with high levels of E/Z 
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stereoselectivity (especially E-selective synthesis of α-substituted enals) are highly 
desirable (Scheme 2.1). Although cross-aldol condensation reactions of two different 
aldehydes afford facile access to these targets, intrinsic problems associated with poor 
E/Z stereoselectivity, in which formation of thermodynamically more stable Z isomers 
are favored, and production of complex product mixtures render this process 
impracticable. State-of-the-art approaches to these targets use Pd(0)-catalysed cross-
coupling protocols, including Suzuki-Miyaura reaction of potassium aryl trifluoroborates 
with alkenyl bromides (Scheme 2.1.a)40 and the reaction of benzyl bromides with 
diazoesters (Scheme 2.1.b)41. 
 
Scheme 2.1. Approaches to selective (E)-α-arylation/alkylation of enals and acrylates  
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In recent years, we have carried out investigations leading to the development of 
new organocatalysed reactions and, in particular, those that involve efficient and 
stereoselective cascade processes.42 These atom-economical processes serve as powerful 
approaches to transform readily available chemicals in one-pot operations to useful 
building blocks for organic synthesis. This effort has recently resulted in the discovery of 
an organocatalytic, enantioselective Michael-alkylation cascade sequence in which chiral 
propanes are generated from enals and bromomalonates (Scheme 2.1.c).43, 44 In this study, 
an unexpected side reaction was uncovered that produces stereoselectively (E)-α-
substituted malonate enals. The results from ensuing mechanistic studies revealed that 
this product is formed through a catalytic Michael-alkylation sequence that gives rise to a 
cyclopropane intermediate, which then undergoes a stereo-specific ring-opening via an 
enamine-initiated retro-Michael reaction. Stimulated by these findings, we question 
whether this chemistry could serve as the foundation of a new transformation involving a 
Friedel-Craft s alkylation-ring opening cascade (Scheme 2.1.d). If successful, this process 
would give products derived by direct connection of the α-carbon of an enal with an aryl-
ring carbon. To our knowledge, no transformation of this type exists for direct coupling 
of unmodified enals with arenes. 
 
2.3. Substrate Design 
A consideration of the proposed Friedel-Crafts alkylation-ring opening pathway 
led to the conclusion that the aromatic substrates that participate as Michael donors in the 
process must be electron rich so that the initial electrophilic aromatic substitution step 
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can occur efficiently. Although organocatalytic Michael addition reactions of electron-
rich aromatic compounds to α, β-unsaturated aldehydes has been intensively studied, to 
our knowledge no precedent exists for bond formation at ipso-positions, which is an 
essential component of the new α-arylation reaction.45, 46  
In typical transition-metal-catalysed cross-coupling reactions, the halo-substituent 
not only polarizes the C-X bond for oxidative insertion of the transition metal, it also 
functions as a leaving group in the reductive elimination step. In the new ‘cross-coupling 
like’ process, the aromatic ipso-halogen functions in a similar manner in that it serves as 
a leaving group in the ensuing alkylation step. More importantly, it functions as an 
appropriate pool to balance both steric and electronic effects that govern the initial 
Michael addition process. On the basis of these considerations, we reasoned that bromine 
would serve optimally in both capacities in that its steric hindrance would be 
compensated by its electron-donating ability as well as its softness, which would favor 
conjugated addition. Accordingly, p-bromophenol was selected as the substrate in our 
exploratory investigations of the new process. 
 
2.4. Optimization of Reaction Conditions 
A model cross-coupling-like reaction at room temperature between p-
bromophenol (1a) and trans-p-nitro-cinnamaldehyde (2a) in the presence of Na2CO3 and 
an aminocatalyst was explored in our initial effort (Table 2.1). The cinnamaldehyde with 
the electronic withdrawing group was selected because of its high electrophilicity after 
activated by aminocatalyst. Indeed, the reaction occurs to give the desired product 3a, but 
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in only a moderate yield before further optimization. The E-isomer was observed 
predominantly as the product, and the structure of compound 3a was determined by X-
ray crystal structural analysis (Figure 2.1).  
 
Table 2.1. Catalyst screening for amine-catalysed direct α-arylation reaction of trans-p-
nitro-cinnamaldehyde 2a with p-bromophenol 1aa 
 
entry catalyst time (days) yield (%)b E/Zc 
1 I 4 41 >30:1 
2 II 6 0 ndd 
3 III 4 19 >30:1 
4 IV 4 <5 ndd 
5 V 6 0 ndd 
6 VI 8 15 >30:1 
7 VII 8 11 >30:1 
aReaction conditions: unless specified, a mixture of 1a (0.2 mmol), 2a (0.1 mmol),  
designated catalyst (20 % mol, or 0.02 mmol) and Na2CO3 additive (0.4 mmol) in 
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chloroform (1.0 mL, 0.1 M)  was stirred for a specified time period at room temperature. 
bIsolated yields. cDetermined by 1H NMR. dNot determined. 
 
Figure 2.1. Single X-ray crystal structure of 3a at probability ellipsoids of 20% 
 
 
 
A survey of various aminocatalysts was carried out first using the initial model 
reaction conditions (Table 2.1). The diphenylprolinol TMS ether I was found to generate 
a good yield of 41% with decent E/Z stereoselectivity (entry 1). McMillan’s 2nd 
generation catalyst II did not show any catalysis under the reaction conditions, and 
starting materials were recovered (entry 2). The Barbas catalyst III could only provide a 
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yield of 19% (entry 3). When simple L-proline IV was used as the aminocatalyst, only 
trace amount of desired product was received (entry 4). Surprisingly, compared with the 
TMS protected prolinol catalyst I, the naked diphenylprolinol catalyst V had no catalytic 
effect (entry 5). Simple secondary amines, such as pyrrolidine VI and piperidine VII, 
demonstrated decreased catalytic abilities. When they were used, the reaction could only 
drive to a completion after 8 days, and the isolated yield was also as low as 15% and 11% 
respectively (entries 6 and 7). As a result, diphenylprolinol TMS ether I was considered 
as an optimal aminocatalyst. 
 
Table 2.2. Solvent screening for amine-catalysed direct α-arylation reaction of trans-p-
nitro-cinnamaldehyde 2a with p-bromophenol 1aa 
 
entry solvent time (days) yield (%)b E/Zc 
1 toluene 4 34 >30:1 
2 Et2O 4 0 ndd 
3 THF 4 0 ndd 
4 MeCN 5 12 >30:1 
5 DMF 5 4 >30:1 
6 DMSO 5 5 >30:1 
7 MeOH 4 10 >30:1 
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8 acetone 5 0 ndd 
9 CHCl3 4 41 >30:1 
aReaction conditions: unless specified, see footnote a and Experimental section. bIsolated 
yields. cDetermined by 1H NMR. dNot determined. 
 
Ensuing studies showed that the efficiency of formation of the desired cross-
coupling-like product was highly solvent dependent (Table 2.2). Toluene is considered as 
a good alternative, but its efficiency is not as effective as chloroform (entry 1). 
Additionally, comparing with chloroform, toluene provided poorer solvation environment 
for the polar reactants and product. In contrast to chloroform (entry 9), reactions taking 
place in other solvents, such as acetonitrile (entry 4), dimethylformamide (entry 5), 
dimethylsulfoxide (entry 6) and methanol (entry 7), occur with low yields even when 
prolonged reaction times are used. Furthermore, when diethyl ether (entry 2), 
tetrahedrofuran (entry 3) or acetone (entry 9) was used as solvent, the desired 
transformation was staggered without product formation. As a result, chloroform was 
chosen as an optimal solvent. 
Further optimizations of reaction conditions as well as experimental procedure 
were carried out (Table 2.3). Elevating the temperature of the reaction in chloroform to 
60°C shortens the reaction time significantly without affecting the yield (entry 2). 
Probing basic additives lead to the conclusion that sodium carbonate is optimal. The 
weaker base, sodium acetate, could be used to mediate reaction, but with lower efficiency 
(entry 1). Stronger bases, such as potassium carbonate and cesium carbonate, 
significantly deteriorated the transformation (entries 3 and 4). An increase in the amount 
 27 
of 1a from 2.0 to 4.0 or 8.0 equiv. results in an improvement of the reaction yield (entries 
5 and 6). These results suggest that addition of 2a via a syringe pump over a long period 
of time would improve yields. The proposal was supported by the observation that the 
efficiency of the process was enhanced (85% yield, entry 8) when slow addition of 2.0 
equiv. of 2a was used. If a reversed experimental method, syringing 1a in to a mixture of 
2a, was used, decreasing of efficiency was observed (13% yield, entry 7). Prolongation of 
the addition time of 2a would also lead to the reduction of yield (entries 12 and 13). As 
we known, reducing the catalyst loading resulted in slower transformation due to slow 
catalyst turnover, and thus longer reaction time would compensate the loss of efficiency, 
which was generally observed in covalent-bond-mediated aminocatalysis. However, in 
our cases, under the reaction conditions at relatively high temperature (60 °C comparing 
with room temperature), although longer reaction time could completely consume the 
starting materials, the reaction become more complicated with unidentified by-products 
formed and therefore even lower reaction yields are obtained. As seen, when 10 and 5 
mol % catalyst loadings were used, it takes respectively 2 days and 3 days for complete 
conversion. However, only 39 and 12% yields of desired product 3a are obtained, 
respectively (entries 10 and 11). In conclusion, the slowly syringing of enal 2a into the 
mixture of p-bromophenol and catalytic system in an elevated temperature of 60 °C over 
the period of 7 hours was considered as the optimal reaction conditions for the cross-
coupling-like α-arylation process. 
 
 
 28 
Table 2.3. Optimization of experimental procedure for amine-catalysed direct α-arylation 
reaction of trans-p-nitro-cinnamaldehyde 2a with p-bromophenol 1aa 
 
entry 
1a:1b 
(ratio) 
Cat. x 
(mol%)
exp.  
methoda 
additive 
(4 equiv.)
time  
(days)
yield  
(%)b 
E/Zc 
1 2:1 20 A NaOAc 3 20 >30:1
2 2:1 20 A Na2CO3 1 43 >30:1
3 2:1 20 A K2CO3 1 <5 ndd 
4 2:1 20 A Cs2CO3 1 0 ndd 
5 4:1 20 A Na2CO3 1 58 >30:1
6 8:1 20 A Na2CO3 1 70 >30:1
7 2:1 20 B Na2CO3 1 13 >30:1
8 2:1 20 C Na2CO3 1 85 >30:1
9 3:2 20 C Na2CO3 1 72 >30:1
10 2:1 10 C Na2CO3 2 39 >30:1
11 2:1 5 C Na2CO3 3 12 >30:1
12 2:1 20 D Na2CO3 1 57 >30:1
13 2:1 20 E Na2CO3 1 11 >30:1
aReaction conditions: 1a (corresponding amount based on the table above), 2a (0.1 
mmol), catalyst I (20  mol%, or 0.02 mmol) and additive (0.4 mmol) were combined 
according to following methods: (A) starting materials were mixed together at the same 
time in a fashion of one-pot; (B) a solution of 1a in chloroform (1 mL) was syringed 
slowly into the mixture of 2a and other materials in chloroform (1 mL) in the time span 
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of 7 hours; (C) a solution of 2a in chloroform (1 mL) was syringed slowly into the 
mixture of 1a and other materials in chloroform (1 mL) in the time span of 7 hours; (D) a 
solution of 2a in chloroform (1 mL) was syringed slowly into the mixture of 1a and other 
materials in chloroform (1 mL) in the time span of 15 hours; (E) a solution of 2a in 
chloroform (1 mL) was syringed slowly into the mixture of 1a and other materials in 
chloroform (1 mL) in the time span of 22 hours. bIsolated yields. cDetermined by 1H 
NMR. d Not determined. 
 
2.5. Expansion of Substrate Scopes 
The scope of the α-arylation reactions of p-bromophenols with enals was probed 
using the optimized conditions described above. As the results in Table 2.4 shown, the 
diphenylprolinol TMS ether I catalysed “cross-coupling-like” reaction displayed broad 
substrate compatibility. Reactions of a variety of structurally diverse cinnamaldehydes, in 
which the aromatic ring bears electron-withdrawing, -neutral and -donating substituents, 
with p-bromophenol 1a as a Michael donor, were explored (entries 1-17). These 
transformations took place smoothly to give products 3 in moderate to excellent yields 
(46-99 %). The general conclusion drawn from the results of this effort was that steric 
effect on reactivity and stereoselectivity were more pronounced than that of electronic 
effects. For example, relatively lower yields and poorer E/Z ratios attended reactions of 
cinnamaldehydes containing ortho- and meta- versus para- aromatic substituents (entries 
6-8 and 12-13 versus entries 1-5 and 9-11). The steric effect also reflected in the reaction 
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of even more hindered β, β-disubstituted enals (for example, trans-3-phenyl-but-2-enal): 
no reaction took place at all. 
 
Table 2.4. Scope of amine-catalysed direct α-arylation reaction of p-bromophenols with 
enalsa 
 
entry R Y time (h) 3 yield (%)b E/Zc 
1 4-NO2C6H4 H 24 3a 85 >30:1 
2 4-FC6H4 H 22 3b 92 >30:1 
3 4-ClC6H4 H 21 3c 95 >30:1 
4 4-BrC6H4 H 13 3d 96 >30:1 
5 4-CNC6H4 H 22 3e 86 10:1 
6 3-FC6H4 H 44 3f 62 15:1 
7 2-FC6H4 H 17 3g 77 20:1 
8 2-ClC6H4 H 24 3h 69 7:1 
9 Ph H 19 3i 99 >30:1 
10 4-MeOC6H4 H 45 3j 99 >30:1 
11 4-MeC6H4 H 48 3k 99 >30:1 
12 2-MeOC6H4 H 60 3l 52 19:1 
13 2-MeC6H4 H 60 3m 50 20:1 
14 2-Furanyl H 36 3n 46 24:1 
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15 2-Naphthyl H 15 3o 84 >30:1 
16 1-Naphthyl H 48 3p 68 8:1 
17 Me H 72 3q 0 ndd 
18 Ph 2-MeO 96 3r 99 >30:1 
19 Ph 2,6-Me2 120 3s 86 >30:1 
20 Ph 3-Me 168 3t 91 >30:1 
21 Ph 2-F 120 3u 79 >30:1 
22 Ph 2-Cl 120 3v 62 21:1 
23 Ph 3-Cl 168 3w 62 >30:1 
aReaction conditions: a solution of 2 (0.1 mmol) in chloroform (1mL) was syringed 
slowly into the mixture of 1 (0.2 mmol), catalyst I (20 mol%, 0.02 mmol) and Na2CO3 
(0.4 mmol) in chloroform (1 mL) in the time span of 7 hours. bIsolated yields. 
cDetermined by 1H NMR. dNot determined. 
 
Moreover, in general, reactions of electron-withdrawing-substituted 
cinnamaldehydes yielded products in relatively higher yields and E/Z selectivities. In 
addition, the process could be extended to heterocyclic and conjugated arenes (entries 14-
16). Finally, the result demonstrated that an aliphatic enal could not provide the desired 
product (entry 17). Nevertheless, interestingly, an unexpected 4-methylbenzaldehyde 
product was obtained in 64% yield. The product was presumably through a [3+3] process, 
which would be elaborated in Chapter 5. 
The effects of varying the substitution pattern (for example, at positions 2, 3 and 6) 
of the p-bromophenol reactants were also investigated (Table 2, entries 18-23). The 
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results shown that p-bromophenol substituents had only a limited influence on yields and 
stereoselectivities. In general, good to high yields (62-99%) and high E/Z selectivities 
were observed in all cases. As they were expected, electronic donating groups were found 
to facilitate the process (entries 18-20 versus 21-23), whereas the effect of sterics was 
limited. Finally, we also find that reactions of substrates, in which the phenol -OH group 
was changed to -OMe, -NH2, -NHMe, -NMe2 and -SH, did not take place (data not 
shown in the Table 2.4). 
 
2.6. Investigation of Mechanism  
Cross-coupling reactions are typically performed by using transition-metal 
catalysis. Only recently did Sun47 and Lei48 independently describe elegant 
organocatalysed cross-coupling reactions of aryl iodides/bromides with arenes using 1, 
10-phenanthroline and N, N’-dimethylethane-1, 2-diamine as respective catalysts in the 
presence of t-BuOK. It is believed that these processes take place through radical 
pathways.47-52 The strategic basis of the new coupling reactions described above are 
completely different from those reported by Sun, Lei and others.49-52 The proposed 
mechanism of the amine I catalysed α-arylation reactions of enals ( Figure 2.2 ) involves 
the intermediacy of iminium ion 4, derived from the reaction of enal 2 with catalyst I 
followed by a Friedel-Crafts (or Michael addition) reaction with, for example, 4-
bromophenol 1a. This step is the key to success of the overall process, as it must not only 
take place smoothly to initiate subsequent steps but, more importantly, it must occur 
regioselectively at a highly crowded para-phenol position. Therefore, the facility of the 
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electrophilic aromatic substitution step requires the presence of an appropriately small 
halogen, like Br, with a weaker C-X versus C-C bond and an electron-donating or weak-
withdrawing capacity. 
 
Figure 2.2. A proposed reaction mechanism for α-arylation reactions of enals with 4-
bromophenol 
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Table 2.5. The effects of leaving groups X on the fate of the arylation reactionsa 
OH
X
OH
O
O
N
H OTMS
Ph
Ph
Cat. I, 20 mol%
Na2CO3, 60°C
CHCl3
NO2
NO2
O
O
X2a
1
3a
5  
entry X C-X (kcal mol-1)e time (days) yield (%)b E/Zc 
1 H 96-99 2 0 ndd 
2 OAc 85-91 3 0 ndd 
3 Cl 79 4 <5 ndd 
4 Br 66 1 85 >30:1 
5 I 52 3 59 >30:1 
aReaction conditions: unless specified, see footnote a and Experimental section. bIsolated 
yields. cDetermined by 1H NMR. dNot determined. eC-C bond energy: 83-85 kcal mol-1. 
 
Importantly, as mentioned above, to the best of our knowledge, no precedent 
exists for an organocatalysed Friedel-Crafts reaction of a benzene derivative leading to 
ipso-substitution, a process that is energetically costly as it initially involves de-
aromatization of the benzene ring and generation of a highly congested quaternary carbon 
centre. Moreover, an intramolecular alkylation reaction could compete with retro-
Michael addition (Friedel-Crafts). Notably, owing to the relatively weak C-Br (bond 
energy: 66 kcal mol-1) versus C-C bond (BDE of 83-85 kcal mol-1), C-Br bond cleavage 
in alkylation process is more favorable than the retro-Michael reaction.53 To verify this 
conclusion, studies were carried out with different arene-leaving groups using the same 
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reaction conditions (Table 2.5). As the results indicate, when the C-X bond energies (for 
example, C-H and C-O, entries 1 and 2) are larger than that of the C-C bond, retro-
Michael addition is dominant and it results in no product formation. When C-X bond 
energies (for example, C-Br and C-I, entries 4 and 5) are smaller than that of the C-C 
bond, intramolecular cyclopropanation occurs and leads to a subsequent cascade that 
delivers product 3a. 
 
Figure 2.3. Preparation of the stable p-acetoxy quinol 9 and catalyst I catalyzed retro-
Michael addition reaction of 9 
 
 
It is expected that reaction with chloro-arenes will not take place (Table 2.5, entry 
3) as the C-Cl bond energy is close to that of the C-C bond, and the stronger electron-
withdrawing ability of Cl would deactivate the aromatic system for the Friedel-Crafts 
reaction. In this effort, we have also prepared the stable p-acetoxy quinol 9 (Figure 2.3). 
Treatment of 9 in the presence of catalyst I gives 4-acetyloxy phenol 10 and trans-
cinnamaldehyde 11. This finding indicates that retro-Michel (retro-Friedel-Crafts) 
reaction via breaking of the weaker C-C bond rather than the stronger C-O bond prevails 
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in this process. Taken together, the results described above not only provide support for 
the proposed reaction mechanism involving a Friedel-Crafts-initiated alkylation-ring-
opening cascade process but also can be used to explain why brominated arenes are 
critical for the success of the organocatalytic α-arylation reactions of enals. The 
mechanistic pathway outlined in Figure 2.2 also explains why at least 2 equiv of Na2CO3 
are important for the process. The base is required for the activation of the phenol for the 
initial Friedel-Crafts reaction (step 2). Furthermore, in step 4, it facilitates formation of 
enamine 7 for subsequent ring opening. The enamine-retro-Michael sequence has been 
demonstrated in our early studies of organocatalysed cyclopropanation reaction. As 
observed earlier, treatment of the cyclopropane products with catalyst I in the presence of 
base (NaOAc) leads to ring opening to give enal products. The cross-coupling-like 
reaction is proposed to follow a similar pathway. The Michael adduct 5 proceeds an 
intramolecular alkylation through a favorable enol-exo-3-exo-tert attack to produce the 
strained spiro-cyclopropane intermediate 6, which spontaneously undergoes formation of 
enamine 7, followed by stereoselective retro-Michael reaction (ring opening) to give final 
product 3 with E-configuration. Unlike the earlier cyclopropanation reaction, in the 
current process, isolation of the highly active intermediate cyclopropane aldehyde, 
derived from 6, and species 5 and 7 is not possible. Interestingly, in situ 1H NMR studies 
lead to the detection of resonance associated with the quinols 5-7 (Figure 2.4) at 6.24-
6.40, 6.50-6.58 and 6.61-6.68 p.p.m. Finally, the formation of major products 3 with (E) 
stereo-configuration is consistent with the geometry of starting material trans-α, β-
unsaturated aldehydes due to the essential orbital alignment for selective ring opening. 
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Figure 2.4. Monitoring quinol formation by 1H NMR 
 
 
2.7. Summary 
In conclusion, in the effort described above, we have developed an unprecedented 
organocatalytic method for direct, stereoselective α-arylation of simple unfunctionalized 
α, β-unsaturated aldehydes. A novel iminium-initiated Michael-alkylation-enamine-ring-
opening cascade process has been demonstrated by using mechanistic studies. The amine 
catalysed α -arylation reactions, which occur under mild conditions, display a broad 
substrate scope for the 4-bromophenols and α, β-unsaturated aldehyde reactants. Notably, 
synthetically challenging E-cross-coupling products are generated in good to high yields 
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and with good to excellent levels of stereoselectivity. The conceptually novel cross-
coupling strategy can also be viewed as a stereoselective C-H functionalization process 
using an organocatalyst and, as such, adds a new process to the emerging field of 
organocatalysis. Finally, the unique transformation holds significant potential for 
applications to a broad spectrum of novel organic reactions, a proposal that will guide our 
further efforts in this area. 
 
2.8. Experimental Section 
General Information: 
All commercially available reagents were used without further purification. The 
progress of the reactions was monitored by analytical thin-layer chromatography (TLC) 
on Whatman silica gel plates with fluorescence F254 indicator. And Merck 60 silica gel 
was used for chromatography. 1H (300 MHz) and 13C (75 MHz) NMR spectra were 
recorded on a Bruker Avance 300. 1H (500 MHz) and 13C (125 MHz) NMR spectra were 
recorded on a Bruker Avance 500. When deuteriorated chloroform (CDCl3) was used to 
dissolve sample, tetramethylsilane (TMS) was used as an internal reference. Data for 1H 
are reported as follows: chemical shift (ppm), and multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet).  Data for 13C NMR are reported as ppm.   
 
 
 
 39 
Procedure for (E)-α, β-diarylacrylaldehydes (Table 2.4):  
To a mixture of a substituted p-bromophenol (1a, 35 mg, 0.2 mmol), catalyst I (7 
mg, 0.02 mmol) and sodium carbonate (42 mg, 0.4 mmol) in 0.5 ml of chloroform at 
60°C was added a solution of a α, β -unsaturated aldehyde (2, 0.1 mmol) in chloroform (1 
ml) slowly via a syringe pump over 7 h. After the aldehyde was totally consumed 
(determined by TLC analysis), the vial was cooled to room temperature. The solvent was 
evaporated and the residue was purified by column chromatography, eluting with a 
mixture of ethyl acetate and hexane. The compound is characterized by 1H and 13C NMR 
and high-resolution mass spectrometry (HRMS) with > 95 % purity-based 1H NMR. 
 
 
(E)-2-(4-hydroxyphenyl)-3-(4-nitrophenyl)acrylaldehyde (3a). The title compound 
was prepared according to the typical procedure, as described above in 85 % yield. 
Melting point (MP) 186-187°C; 1H NMR (Acetone-d6, 500 MHz): δ = 9.83 (s, 1H), 8.67 
(br, 1H), 8.14 (d, J = 8.5 Hz, 2H), 7.65 (s, 1H), 7.55 (d, J = 8.5 Hz, 2H), 7.03 (d, J = 8.5 
Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.2, 158.6, 
148.4, 146.3, 145.1, 142.1, 131.8, 131.6, 124.0, 116.3; HRMS (ESI) calcd. for 
C15H11NO4: m/z 292.0586 ([M + Na]+), found 292.0583. 
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(E)-3-(4-fluorophenyl)-2-(4-hydroxyphenyl)acrylaldehyde (3b). The title compound 
was prepared according to the typical procedure, as described above in 92 % yield. 1H 
NMR (Acetone-d6, 500 MHz): δ = 9.73 (s, 1H), 8.62 (br, 1H), 7.51 (s, 1H), 7.37 (m, 2H), 
7.06 (t, J = 9.0 Hz, 2H), 7.00 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H); 13C NMR 
(Acetone -d6, 125 MHz): δ = 194.2, 164.8, 162.8, 158.1, 148.4, 142.4, 133.4, 133.3, 
131.9, 131.4, 124.9, 116.2, 116.1, 115.9; HRMS (ESI) calcd. for C15H11FO2: m/z 
265.0641 ([M + Na]+), found 265.0640. 
 
 
(E)-3-(4-chlorophenyl)-2-(4-hydroxyphenyl)acrylaldehyde (3c). The title compound 
was prepared according to the typical procedure, as described above in 95 % yield. 1H 
NMR (Acetone-d6, 500 MHz): δ = 9.75 (s, 1H), 8.64 (br, 1H), 7.50 (s, 1H), 7.32 (s, 4H), 
7.00 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 9.0 Hz, 2H); 13C NMR (Acetone -d6, 125 MHz): δ = 
194.2, 158.2, 148.0, 143.1, 135.6, 134.3, 132.6, 131.4, 129.2, 124.7, 116.2; HRMS (ESI) 
calcd. for C15H11ClO2: m/z 281.0345 ([M + Na]+), found 281.0339. 
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(E)-3-(4-bromophenyl)-2-(4-hydroxyphenyl)acrylaldehyde (3d). The title compound 
was prepared according to the typical procedure, as described above in 96 % yield. MP 
185-186°C; 1H NMR (Acetone-d6, 500 MHz): δ = 9.75 (s, 1H), 8.65 (br, 1H), 7.47 (m, 
3H), 7.24 (d, J = 8.5 Hz, 2H), 7.00 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 8.5 Hz, 2H); 13C 
NMR (Acetone -d6, 125 MHz): δ = 194.2, 158.3, 148.1, 143.2, 134.7, 132.8, 131.4, 124.7, 
124.1, 116.3; HRMS (ESI) calcd. for C15H11BrO2: m/z 324.9840 ([M + Na]+), found 
324.9833. 
 
 
(E)-4-(2-(4-hydroxyphenyl)-3-oxoprop-1-enyl)benzonitrile (3e). The title compound 
was prepared according to the typical procedure, as described above in 86 % yield. MP 
160-162°C;  1H NMR (Acetone-d6, 500 MHz): δ = 9.80 (s, 1H), 8.64 (br, 1H), 7.69 (d, J 
= 8.5 Hz, 2H), 7.58 (s, 1H), 7.48 (d, J = 8.0 Hz, 2H), 7.01 (d, J = 8.5 Hz, 2H), 6.87 (d, J 
= 8.5 Hz, 2H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.2, 158.5, 146.9, 144.7, 140.1, 
132.8, 131.5, 128.7, 124.2, 118.8, 116.3, 115.8, 113.1; HRMS (ESI) calcd. for 
C16H11NO2: m/z 272.0687 ([M + Na]+), found 272.0681. 
 42 
 
 
(E)-3-(3-fluorophenyl)-2-(4-hydroxyphenyl)acrylaldehyde (3f). The title compound 
was prepared according to the typical procedure, as described above in 62 % yield. 1H 
NMR (Acetone-d6, 500 MHz): δ = 9.77 (s, 1H), 8.60 (br, 1H), 7.53 (s, 1H), 7.34 (m, 1H), 
7.18 (d, J = 8.0 Hz, 1H), 7.10 (m, 1H), 7.01 (m, 3H), 6.89 (d, J = 8.5 Hz, 2H); 13C NMR 
(Acetone -d6, 125 MHz): δ = 194.3, 158.4, 147.9, 143.7, 137.9, 131.4, 131.1, 131.0, 
127.4, 124.7, 117.2, 117.1, 117.0, 116.3; HRMS (ESI) calcd. for C15H11FO2: m/z 
265.0641 ([M + Na]+), found 265.0636. 
 
 
(E)-3-(2-fluorophenyl)-2-(4-hydroxyphenyl)acrylaldehyde (3g). The title compound 
was prepared according to the typical procedure, as described above in 77 % yield. MP 
165-166°C; 1H NMR (Acetone-d6, 500 MHz): δ = 9.83 (s, 1H), 8.56 (br, 1H), 7.62 (s, 
1H), 7.37 (m, 1H), 7.19 (m, 1H), 7.02 (m, 4H), 6.85 (d, J = 8.5 Hz, 2H); 13C NMR 
(Acetone -d6, 125 MHz): δ = 194.2, 158.3, 144.0, 140.5, 140.4, 132.5, 132.4, 131.5, 
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131.0, 124.6, 116.5, 116.3, 116.1; HRMS (ESI) calcd. for C15H11FO2: m/z 265.0641 ([M 
+ Na]+), found 265.0642. 
 
 
(E)-3-(2-chlorophenyl)-2-(4-hydroxyphenyl)acrylaldehyde (3h). The title compound 
was prepared according to the typical procedure, as described above in 69 % yield.  1H 
NMR (Acetone-d6, 500 MHz): δ = 9.87 (s, 1H), 8.58 (br, 1H), 7.68 (s, 1H), 7.50 (d, J = 
8.0 Hz, 1H), 7.31 (m, 1H), 7.06 (m, 2H), 6.98 (d, J = 9.0 Hz, 2H), 6.80 (d, J = 8.5 Hz, 
2H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.2, 158.2, 145.0, 144.0, 134.9, 134.1, 
131.7, 131.6, 131.3, 130.3, 127.2, 124.0, 115.9; HRMS (ESI) calcd. for C15H11ClO2: m/z 
281.0345 ([M + Na]+), found 281.0337. 
 
 
(E)-2-(4-hydroxyphenyl)-3-phenylacrylaldehyde (3i). The title compound was 
prepared according to the typical procedure, as described above in 99 % yield. MP 152-
153°C; 1H NMR (Acetone-d6, 500 MHz): δ = 9.72 (s, 1H), 8.55 (br, 1H), 7.47 (s, 1H), 
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7.25 (m, 5H), 6.97 (d, J= 8.5 Hz, 2H), 6.84 (d, J = 8.5 Hz, 2H); 13C NMR (Acetone -d6, 
125 MHz): δ = 194.3, 158.0, 149.8, 142.6, 135.4, 131.4, 131.1, 130.4, 129.0, 125.1, 116.1; 
HRMS (ESI) calcd. for C15H12O2: m/z 247.0735 ([M + Na]+), found 247.0733. 
 
 
(E)-2-(4-hydroxyphenyl)-3-(4-methoxyphenyl)acrylaldehyde (3j). The title compound 
was prepared according to the typical procedure, as described above in 99 % yield. MP 
180-181°C; 1H NMR (Acetone-d6, 500 MHz): δ = 9.68 (s, 1H), 8.57 (br, 1H), 7.43 (s, 
1H), 7.27 (d, J = 9.0 Hz, 2H), 7.00 (d, J = 8.5 Hz, 2H), 6.88 (d, J = 8.5 Hz, 2H), 6.83 (d, 
J = 9.0 Hz, 2H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.1, 161.9, 157.9, 149.9, 140.7, 
133.1, 131.4, 127.9, 125.6, 116.2, 114.5, 55.5; HRMS (ESI) calcd. for C15H12O2: m/z 
277.0841 ([M + Na]+), found 277.0838. 
 
 
(E)-2-(4-hydroxyphenyl)-3-p-tolylacrylaldehyde (3k). The title compound was 
prepared according to the typical procedure, as described above in 99 % yield. MP 188-
190°C; 1H NMR (Acetone-d6, 500 MHz): δ = 9.72 (s 1H), 8.56 (br, 1H), 7.46 (s, 1H), 
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7.20 (d, J = 8.5 Hz, 2H), 7.09 (d, J = 8.0 Hz, 2H), 7.00 (d, J = 8.5 Hz, 2H), 6.87 (d, J = 
8.5 Hz, 2H), 2.28 (s, 3H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.3, 158.0, 150.0, 
141.9, 140.9, 132.6, 131.4, 131.2, 129.7, 125.4, 116.1, 21.1; HRMS (ESI) calcd. for 
C16H14O2: m/z 261.0891 ([M + Na]+), found 261.0888. 
 
 
(E)-2-(4-hydroxyphenyl)-3-(2-methoxyphenyl)acrylaldehyde (3l). The title compound 
was prepared according to the typical procedure, as described above in 52 % yield. MP 
173-174°C;  1H NMR (Acetone-d6, 500 MHz): δ = 9.76 (s, 1H), 8.47 (br, 1H), 7.74 (s, 
1H), 7.30 (t, J = 7.8 Hz, 1H), 7.06 (d, J = 8.0 Hz, 1H), 7.00 (d, J = 8.5 Hz, 2H), 6.97 (d, J 
= 7.5 Hz, 1H), 6.82 (d, J = 8.5 Hz, 2H), 6.68 (t, J = 7.5 Hz, 1H), 3.91 (s, 3H); 13C NMR 
(Acetone -d6, 125 MHz): δ = 194.3, 159.0, 158.0, 144.5, 142.1, 132.1, 131.6, 130.8, 
125.4, 124.1, 120.6, 116.0, 111.9, 56.0; HRMS (ESI) calcd. for C16H14O3: m/z 277.0841 
([M + Na]+), found 277.0835. 
 
OH
O
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(E)-2-(4-hydroxyphenyl)-3-o-tolylacrylaldehyde (3m). The title compound was 
prepared according to the typical procedure, as described above in 50 % yield. MP 161-
162°C;  1H NMR (Acetone-d6, 500 MHz): δ = 9.83 (s, 1H), 8.45 (br, 1H), 7.69 (s, 1H), 
7.19 (d, J = 5.0 Hz, 1H), 7.17 (m, 1H), 6.95 (m. 4H), 6.76 (d, J = 8.5 Hz, 2H), 2.40 (s, 
3H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.5, 158.0, 148.5, 143.1, 138.3, 134.9, 
131.9, 131.0, 130.0, 129.8, 126.1, 124.8, 115.8, 19.9; HRMS (ESI) calcd. for C16H14O2: 
m/z 261.0891 ([M + Na]+), found 261.0889. 
 
 
(E)-3-(furan-2-yl)-2-(4-hydroxyphenyl)acrylaldehyde (3n). The title compound was 
prepared according to the typical procedure, as described above in 46 % yield.  1H NMR 
(Acetone-d6, 500 MHz): δ = 9.68 (s, 1H), 8.55 (br, 1H), 7.68 (s, 1H), 7.36 (s, 1H), 7.06 (d, 
J = 8.0 Hz, 2H), 6.90 (d, J = 8.5 Hz, 2H), 6.50 (d, J = 2.0 Hz, 1H), 6.34 (d, J = 3.5 Hz, 
1H); 13C NMR (Acetone -d6, 125 MHz): δ = 193.2, 158.2, 151.8, 146.3, 139.5, 135.9, 
131.3, 130.8, 125.3, 116.6, 116.0, 113.4; HRMS (ESI) calcd. for C13H10O3: m/z 237.0528 
([M + Na]+), found 237.0525. 
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(E)-2-(4-hydroxyphenyl)-3-(naphthalen-2-yl)acrylaldehyde (3o). The title compound 
was prepared according to the typical procedure, as described above in 84 % yield. MP 
151-152°C; 1H NMR (Acetone-d6, 500 MHz): δ = 9.81 (s, 1H), 8.62 (br, 1H), 7.98 (s, 
1H), 7.84 (d, J = 7.5 Hz, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.69 (m, 2H), 7.51 (m, 2H), 7.27 
(d, J = 8.5 Hz, 1H), 7.06 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 8.5 Hz, 2H); 13C NMR (Acetone 
-d6, 125 MHz): δ = 194.3, 158.2, 149.7, 142.7, 134.4, 133.8, 133.2, 132.3, 131.6, 129.2, 
128.3, 128.2, 128.1, 127.2, 127.1, 125.1, 116.1; HRMS (ESI) calcd. for C19H14O2: m/z 
297.0891 ([M + Na]+), found 297.0890. 
 
 
(E)-2-(4-hydroxyphenyl)-3-(naphthalen-1-yl)acrylaldehyde (3p). The title compound 
was prepared according to the typical procedure, as described above in 68 % yield. 1H 
NMR (Acetone-d6, 500 MHz): δ = 10.00 (s, 1H), 8.45 (br, 1H), 8.25 (d, J = 8.5 Hz, 1H), 
8.20 (s, 1H), 7.95 (d, J = 7.5 Hz, 1H), 7.87 (d, J = 8.0 Hz, 1H), 7.58 (m, 2H), 7.30 (t, J = 
7.8 Hz, 1H), 7.22 (d, J = 7.5 Hz, 1H), 6.97 (d, J = 8.5 Hz, 2H), 6.72 (d, J = 8.5 Hz, 2H); 
13C NMR (Acetone -d6, 125 MHz): δ = 194.5, 157.9, 147.6,144.3, 134.4, 132.9, 132.4, 
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131.9, 130.9, 130.1, 129.4, 128.5, 127.5, 127.0, 125.8, 124.7, 115.8; HRMS (ESI) calcd. 
for C19H14O2: m/z 297.0891 ([M + Na]+), found 297.0884. 
 
 
(E)-2-(4-hydroxy-3-methoxyphenyl)-3-phenylacrylaldehyde (3r). The title compound 
was prepared according to the typical procedure, as described above in 99 % yield.  1H 
NMR (Acetone-d6, 500 MHz): δ = 9.75 (s, 1H), 7.79 (br, 1H), 7.51 (s, 1H), 7.31 (m, 5H), 
6.86 (d, J = 8.0 Hz, 1H), 6.75 (s, 1H), 6.63 (d, J = 8.0 Hz, 1H); 13C NMR (Acetone -d6, 
125 MHz): δ = 194.3, 149.7, 148.3, 147.4, 142.7, 135.4, 131.2, 130.5, 129.1, 125.5, 123.1, 
116.0, 113.6, 56.1; HRMS (ESI) calcd. for C16H14O3: m/z 277.0841 ([M + Na]+), found 
277.0837. 
 
 
(E)-2-(4-hydroxy-3,5-dimethylphenyl)-3-phenylacrylaldehyde (3s). The title 
compound was prepared according to the typical procedure, as described above in 86 % 
yield. MP 148-149°C; 1H NMR (Acetone-d6, 500 MHz): δ = 9.74 (s, 1H), 7.47 (s, 2H), 
7.30 (m, 5H), 6.75 (s, 2H), 2.20 (s, 6H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.5, 
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153.9, 149.5, 142.9, 135.5, 131.2, 130.5, 129.9, 129.0, 125.3, 124.9, 16.4; HRMS (ESI) 
calcd. for C17H16O2: m/z 275.1048 ([M + Na]+), found 275.1046. 
 
 
(E)-2-(4-hydroxy-2-methylphenyl)-3-phenylacrylaldehyde (3t). The title compound 
was prepared according to the typical procedure, as described above in 91 % yield. 1H 
NMR (Acetone-d6, 500 MHz): δ = 9.77 (s, 1H), 8.40 (br, 1H), 7.29 (m, 6H), 6.80 (d, 2H), 
6.72 (m, 1H), 1.95 (s, 3H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.4, 158.1, 150.6, 
142.8, 138.2, 135.6, 131.0, 130.8, 129.3, 125.6, 117.7, 114.0, 19.6; HRMS (ESI) calcd. 
for C16H14O2: m/z 261.0891 ([M + Na]+), found 261.0891. 
 
 
(E)-2-(3-fluoro-4-hydroxyphenyl)-3-phenylacrylaldehyde (3u). The title compound 
was prepared according to the typical procedure, as described above in 79 % yield. 1H 
NMR (Acetone-d6, 500 MHz): δ = 9.74 (s, 1H), 8.88 (br, 1H), 7.57 (s, 1H), 7.31 (m, 5H), 
7.02 (t, J = 8.8 Hz, 1H), 6.94 (d, J = 12 Hz, 1H), 6.81 (d, J = 8.0 Hz, 1H); 13C NMR 
(Acetone -d6, 125 MHz): δ = 193.9, 153.0, 151.1, 150.4, 145.5, 145.4, 141.4, 135.1, 
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131.1, 130.7, 129.1, 126.6, 126.0X2, 118.6, 118.0, 117.8; HRMS (ESI) calcd. for 
C15H11FO2: m/z 265.0641 ([M + Na]+), found 265.0635. 
 
 
(E)-2-(3-chloro-4-hydroxyphenyl)-3-phenylacrylaldehyde (3v). The title compound 
was prepared according to the typical procedure, as described above in 62 % yield. 1H 
NMR (Acetone-d6, 500 MHz): δ = 9.75 (s, 1H), 9.05 (br, 1H), 7.58 (s, 1H), 7.32 (m, 6H), 
7.18 (s, 1H), 7.04 (d, J = 8.5 Hz, 1H), 6.95 (d, J = 8.0 Hz, 1H); 13C NMR (Acetone -d6, 
125 MHz): δ = 194.0, 153.6, 150.6, 141.2, 135.1, 131.6, 131.2, 130.8, 130.1, 129.2, 126.7, 
121.0, 117.6; HRMS (ESI) calcd. for C15H11ClO2: m/z 281.0345 ([M + Na]+), found 
281.0344. 
 
 
(E)-2-(2-chloro-4-hydroxyphenyl)-3-phenylacrylaldehyde (3w). The title compound 
was prepared according to the typical procedure, as described above in 62 % yield. 1H 
NMR (Acetone-d6, 500 MHz): δ = 9.76 (s, 1H), 7.72 (s, 1H), 7.33 (m, 6H), 7.02 (d, J = 
2.5 Hz, 1H), 6.98 (d, J = 8.0 Hz, 1H), 6.87 (dd, J = 8.0, 2.5 Hz, 1H); 13C NMR (Acetone -
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d6, 125 MHz): δ = 193.4, 159.1, 151.1, 140.6, 135.2, 134.2, 132.6, 131.0, 129.4, 125.0, 
117.1, 115.6; HRMS (ESI) calcd. for C15H11ClO2: m/z 281.0345 ([M + Na]+), found 
281.0342. 
 
O Ph
OH  
3-(4-Hydroxyphenyl)-3-phenylpropanal (8). The title compound was synthesized 
according to a known procedure.55 1H NMR (CDCl3, 500 MHz): δ = 9.73 (s, 1H), 7.37-
7.18 (m, 5H), 7.09 (d, J = 9.0 Hz, 2H), 6.75 (d, J = 9.0 Hz, 2H), 4.62 (br, 1H), 4.56 (t, J = 
8.0 Hz, 1H), 3.13 (dd, J = 8.0 2.0 Hz, 2H). 
 
O
O
OO
 
4-Oxo-1-(3-oxo-1-phenylpropyl)cyclohexa-2,5-dienyl acetate (9). The title compound 
was synthesized according to a known procedure.56 (Diacetoxyiodo)benzene (0.5 mmol) 
was added to a solution of 3-(4-hydroxyphenyl)-3-phenylpropanal  (0.5 mmol) in glacial 
AcOH (2mL) at 0°C. After starting material was totally consumed, the reaction was 
concentrated and purified by flash chromatography. 1H NMR (CDCl3, 500 MHz): δ = 
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9.60 (s, 1H), 7.30-7.18 (m, 5H), 6.73 (m, 2H), 6.31 (d, J = 10.0 Hz, 1H), 6.24 (d, J = 10.0 
Hz, 1H), 3.81 (m, 1H), 2.95 (m, 2H), 2.10 (s, 3H). 
 
1H NMR study of the formation of quinols: 
Trans-p-nitro-cinnamaldehyde (2a, 18 mg, 0.1 mmol) and 4-bromophenol (1a, 26 
mg, 0.15 mmol) and catalyst (0.02 mmol) were dissolved in 0.8 ml of CDCl3 and the 
reaction mixture was transferred into a NMR tube. A small magnetic stir bar was used to 
stir the mixture, and it was removed before 1H NMR measurement. The reaction mixture 
was monitored with designated period of time (2, 8, and 10, 49 h, and 3 days). 
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Chapter 3 
Direct Stereoselective α-Arylation of Simple Enals with 
Bromonaphthols using an Organocatalytic Cross-Coupling-Like 
Approach 
 
3.1. Introduction to Functionalized Naphthol Frameworks 
The bicyclic privileged structural frameworks of naphthols exist ubiquitously in 
natural products possessing a wide spectrum of important biological activities such as 
antibacterial, anticancer, antiviral, mutagenicity, antiproliferative, antitumor, etc.1-8 Both 
metal or Lewis acid mediated methodologies9-12 and organocatalytic strategies13-18 have 
been developed for the construction of various functionalized naphthol containing 
frameworks.  
As a class of electronic rich bicyclic arenes, naphthols are readily participating in 
the Friedel-Crafts reaction enantioselectively as well as regioselectively. Erker and 
coworkers reported the first Lewis acid catalyzed enantioselective Friedel-Crafts reaction 
of 1-naphthols and ethyl pyruvates as early as in 1990.9 Recently, Jørgensen and 
coworkers demonstrated the first organocatalytic asymmetric Friedel-Crafts amination of 
2-naphthols to generate atropisomers13,14, and Chen and coworkers also reported the 
enantioselective Friedel-Crafts alkylation/cascade reaction of naphthols and nitroolefins 
catalyzed by thiourea-tertiary amine based bifunctional organocatalyst15. Discovery of 
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novel methodologies towards versatile functionalized naphthols is a rewarding task in the 
circumstance of modern organic synthesis. 
 
3.2. Substrate Design 
Recently we reported an unprecedented organocatalytic cross-coupling-like 
strategy for the direct α-arylation of unmodified α, β-unsaturated aldehydes with 4-
bromophenols (Scheme 3.1, equation a).19 The synthetically challenging E-α,β-
diarylacrylaldehydes were obtained via a novel iminium initiated Michael-alkylation-
enamine-ring opening cascade process. Besides 4-bromophenols, we also probe 2-
bromophenol for the reaction. No reaction occurs and only starting materials are 
recovered. Furthermore, when 2, 4-dibromophenol was used as Michael donor, an 
exclusive regioselectivity favoring para-phenol position over ortho-position was also 
discovered (Scheme 3.1, equation b). In the 2, 4-dibromophenol, both para and ortho 
positions are potential Michael donation sites. However, after it is submitted to optimized 
reaction conditions, α-arylation only happens at para-position of the phenol (with 69% 
yield).  
The observation of high regioselectivity could be directly led to a seemingly 
convenient conclusion that ortho-bromophenol is less reactive than para-bromophenol. It 
is believed that 2-bromophenol framework is more crowded than 4-bromophenol for the 
cross-coupling process, and such an effect becomes significant in the initial Michael 
addition reaction, which is steric sensitive, as results of the generation of a highly 
crowded quaternary carbon center and requires high energy for dearomatization.19 In 
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order to overcome such an energy barrier, we proposed that 1-bromo-2-naphthol, which 
is considered as an reactive analogue of 2-bromophenol, should be a good candidate 
sufficing the investigation of the ortho-bromophenol framework in direct α-arylation 
methodology. 
 
Scheme 3.1. Cross-coupling-like strategy for the direct α-arylation of unmodified α, β-
unsaturated aldehydes with 4-bromophenols 
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3.3. Optimization of Reaction Conditions 
A model reaction at 600C using trans-p-nitrocinnamaldehyde and 1-bromo-2-
naphthol in the presence of sodium acetate and diphenylprolinol TMS ether catalyst was 
set up according to a typical α-arylation reaction condition we previously developed 
(Table 3.1). After initial screening of various solvents and solvents combination, 
acetonitrile was found to be the optimal solvent which provided maximum yield of 56% 
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after 3 days reaction under 600C (Table 3.1, entry 8). It was found that the organic 
solvents with high polarity usually provided higher yield (entries 5-8 and entries 1-3). 
Although water was more polarized than acetonitrile, after mixing the water with 
acetonitrile in different volume ratios, the reaction accomplished much faster but the 
yield decreased significantly (data not shown here).  
 
Table 3.1. Reaction conditions optimization of amine-catalyzed direct α-arylation 
reaction of trans-p-nitrocinnamaldehyde with 1-bromo-2-naphthola 
 
entry solvent additive time(days) yield(%)b E/Zc 
1 CHCl3 NaOAc 3 <5 ndd 
2 THF NaOAc 3 <5 ndd 
3 Toluene NaOAc 3 <5 ndd 
4 DMF NaOAc 3 13 >30:1 
5 MeOH NaOAc 3 39 >30:1 
6 EtOH NaOAc 3 41 >30:1 
7 Acetone NaOAc 3 50 >30:1 
8 MeCN NaOAc 3 56 >30:1 
9 MeCN K2CO3 3 <5 ndd 
10 MeCN Na2CO3 3 22 >30:1 
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11 MeCN NaHCO3 3 24 >30:1 
12 MeCN LiOAc 2 32 >30:1 
13 MeCN LiOAc 3 61 >30:1 
14 MeCN LiOAc-2H2O 3 68 >30:1 
aUnless stated otherwise, the reaction was carried out with trans-p-nitrocinnamaldehyde 
(0.2 mmol), 1-bromo-2-naphthol (0.4 mmol), additive (0.8 mmol) and aminocatalyst 
(0.04 mmol) in solvent (1 mL) for a specified time. bIsolated yield. cDetermined by 1H 
NMR. dNot determined. 
 
It was also know that the inorganic salts gave significant influence towards the 
overall yield of the model reaction. After submitting various salts into the reaction 
mixtures, lithium acetate double hydrate provides a better yield of 68% (Table 3.1, entry 
14). The optimal reaction conditions were not established, until series of temperature and 
time control studies were carried out (data not shown here). Based on our previously 
experience, the slow addition of a limiting reagent into an exceeding reagent usually give 
higher yield. However, when 1-bromo-2-naphthol was used as Michael donor, such a 
slow syringing technique provided a lower overall yield. As a result, one pot reaction 
condition is considered as a better experimental method than slow syringing in this 
specific reaction process. 
As expected, the E-isomer was observed predominantly as the product, and the 
structure of compound 3a was determined by X-ray crystal structural analysis (Figure 
3.1).  
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Figure 3.1. Single X-ray crystal structure of 3a at probability ellipsoids of 20% 
 
 
 
3.4. Expansion of Substrate Scopes 
After reaction condition was optimized, the substrate scope was expanded 
accordingly (Table 3.2). Generally speaking, the scope of the direct α-arylation of enals 
with 1-bromo-2-naphthols follows the same trend of the scope of p-bromophenols as well 
as 3-bromoindoles. Most of the products give excellent E/Z ratio of more than 30:1 
(entries except 3, 13 and 15). In some of the cases, poor overall yields of the E-isomer 
were obtained (entries 5 and 12). Enal substrates with electronic withdrawing groups 
generated relative higher yields than those with electronic donating groups (entries 1, 3, 4, 
and 8 comparing with entries 13 and 14). If compared with substrates bearing the same 
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substitutes on para-position of phenyl ring, ortho-substitutes usually brought down the 
yields because of large steric hindrance (entries 1 and 2; entries 4 and 5; entries 6 and 7). 
The reason of the relatively low yields comparing with the results of α-arylation of p-
bromophenols is that the E-isomeric products could easily undergo reversed-aldol-
condensation process.  
Further on, various brominated naphthol derivatives were submitted to the same 
optimized reaction conditions (Table 3.2, entries 15-18). As described in our previous 
report, if the brominated aromatic system contains a strong electron withdrawing 
substituent, it usually demonstrated decreased reactivity. This experimental rule was also 
useful for the brominated naphthol systems. The electron deficient property of the 
quinoline ring rendered the 5-bromo-6-hydroxyquinoline inert to the cross-coupling like 
reaction (data not shown here). If a weak electron withdrawing group was integrated to 
the 1-bromo-2-naphthol skeleton, expected product could be obtained with decent yields. 
As demonstrated, when bromo- substituent was attached at 3, 6, or 7-position of the 1-
bromo-2-naphthol ring, the cross-coupling like C-C bond formation happened exclusively 
at 2-position with good regioselectivity as well as stereoselectivity (entries 15, 16 and 17). 
When a carboxylic ester group was attached to the naphthol framework, expected α-
arylation product was also obtained with 41% yield (entry 18). Comparing with 1-bromo-
2-naphthol, the 2-bromo-1-naphthol demonstrated decreased reactivity and provided only 
a trace amount of desired product. As one of its close derivative, 3-bromo-4-
hydroxycoumarine also generated similar negative results (data not shown in the table). 
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Table 3.2. Substrates scope of amine-catalyzed direct α-arylation reactions of 1-bromo-2-
naphthols with enalsa 
OH
O Ar
O Ar
N
H OTMS
Ph
Ph
20 mol%
LiOAc• equiv.
MeCN, 60°C
Br
OH
3
45
8
R
H
R
1 2 3  
entry Ar R time(day) 3 yield(%)b E/Zc 
1 4-NO2C6H4 H 3 3a 68 > 30 : 1
2 2-NO2C6H4 H 3 3b 34 > 30 : 1
3 4-CNC6H4 H 3 3c 57 7 : 1 
4 4-CF3C6H4 H 3 3d 73 > 30 : 1
5 2-CF3C6H4 H 3 3e 13 > 30 : 1
6 4-FC6H4 H 3 3f 46 > 30 : 1
7 2-FC6H4 H 3 3h 43 > 30 : 1
8 4-ClC6H4 H 3 3i 65 > 30 : 1
9 4-BrC6H4 H 3 3j 42 > 30 : 1
10 Ph H 4 3k 51 > 30 : 1
11 2-Naphthyl H 3 3l 45 > 30 : 1
12 2-Furanyl H 3 3m 12 > 30 : 1
13 4-MeOC6H4 H 5 3n 31 6 : 1 
14 2-MeOC6H4 H 4 3o 33 > 30 : 1
15 4-NO2C6H4 3-Br 4 3p 49 14:1 
16 4-NO2C6H4 6-Br 4 3q 56 > 30 : 1
17 4-NO2C6H4 7-Br 4 3r 62 > 30 : 1
18 4-NO2C6H4 3-COOMe 6 3s 41 > 30 : 1
 65 
aUnless stated otherwise, the reaction was carried out with enals (0.2 mmol), 1-bromo-2-
naphthols (0.4 mmol), lithium acetate dihydrate (0.8 mmol) and diphenyl prolinol TMS 
ether catalyst  (0.04 mmol) in acetonitrile (1 mL) for a specified time. bIsolated yield. 
cDetermined by 1H NMR of crude reaction mixture. 
 
3.5. Amine Integrated Three-Component Reaction 
As demonstrated in our previous work and also in the above mentioned results, 
diphenylprolinol TMS ether, was found as an optimal organocatalyst for the direct α-
arylation of enals with various brominated aromatic systems. Due to the large steric 
hindrance brought by the TMS protecting group, E-isomeric product was received almost 
exclusively in most of cases. Surprisingly, in the extensive exploration of the cross-
coupling-like reactions of enals and bromonaphthols, when secondary amines with 
smaller steric hindrance were used, the amine-integrated Z-isometric three-component 
products were obtained for instead. Compared with abovementioned direct α-arylation 
process, the three component reaction demonstrated much higher efficiency, and the 
reaction was usually driven to a completion within hours at room temperature (Table 3). 
Various secondary amines, enals and bromonaphthols were submitted to the 
three-component reaction conditions (Table 3.3). Cyclic secondary amines, such as 
piperidine and pyrrolidine, usually generate three-component adducts with decent yields 
and excellent Z/E ratio within 2 hours at room temperature (entries 1 and 2). The Z-
isomer was observed predominantly as the product, and the structure of compound 4a 
was determined by X-ray crystal structural analysis (data not shown here). Acyclic  
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Table 3.3. Three component reactions of 1-bromo-2-naphthols and enals with 
stoichiometric amount of aminesa 
 
entry Ar R, X amine time (h) 4 yield (%)b Z/Ec
1 4-NO2C6H4 H, CH piperidine 2 4a 91 >30:1
2 4-NO2C6H4 H, CH pyrrolidine 1 4b 99 >30:1
3 4-NO2C6H4 H, CH diethylamine 36 4c 88 >30:1
4 Ph H, CH pyrrolidine 2 4d 60 >30:1
5 2-NO2C6H4 H, CH pyrrolidine 4 4e 48 >30:1
6 4-CF3C6H4 H, CH pyrrolidine 2 4f 94 >30:1
7 4-ClC6H4 H, CH pyrrolidine 2 4h 95 >30:1
8 4-CNC6H4 H, CH pyrrolidine 2 4i 82 6 : 1 
9 4-MeOC6H4 H, CH pyrrolidine 4 4j 16 4 : 1 
10 COOEt H, CH pyrrolidine 4 4k 59 5 : 1 
11 4-NO2C6H4 H, N pyrrolidine 48 4l 72 >30:1
12 4-NO2C6H4 3-Br, CH pyrrolidine 2 4m 82 >30:1
13 4-NO2C6H4 6-Br, CH pyrrolidine 2 4n 80 >30:1
14 4-NO2C6H4 7-Br, CH pyrrolidine 2 4o 87 >30:1
15 4-NO2C6H4 3-COOMe, CH pyrrolidine 6 4p 85 >30:1
aUnless stated otherwise, the reaction was carried out with enals (0.2 mmol), 1-bromo-2-
naphthols (0.2 mmol), potassium carbonate (0.8 mmol) and amines (0.24 mmol) in 
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chloroform (1 mL) for a specified time. bIsolated yield. cDetermined by 1H NMR of crude 
reaction mixture. 
 
secondary amines that possess larger special hindrance than cyclic one, usually prolong 
reaction time, decrease yields (entry 3). As a result, pyrrolidine was chosen as an 
effective amine component during the following substrate scope expansion.  
Structurally modified cinnamaldehydes with electron-withdrawing, electron-
neutral, and weak electron-donating substituents bearing on the phenyl ring usually 
provide 3-component products with decent yield and good Z/E selectivity (entries 4-9). 
While in the case of cinnamaldehyde bearing methoxide group on phenyl ring, the 
profound effect of the cleavage of amine moiety from the 3-component product was 
observed (Table 3, entry 9; Scheme 3.2). As a result, the three component product 4j was 
collected with the yield of only 16% (entry 9), and the two component α-arylation 
product 5a was gathered with 69% yield in favor of Z-isomer. The intramolecular 
hemiacetal 5a exhibited weak fluorescence because of hyper-conjugation of aromatic 
systems. 
Due to high efficiency of the 3-component reaction process, substrates that were 
inert to E-selective α-arylation pathway, such as aliphatic enal or electron-deficient 
brominated naphthols, could participated in the Z-selective 3-component pathway 
smoothly. The (E)-methyl 4-oxobut-2-enoate, which is an aliphatic enal without γ-proton, 
could take part in the three-component α-arylation reaction effectively (entry 10). 
Moreover, electronic deficient aromatic system, such as 5-bromo-6-hydroxyquinoline, 
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was also feasible for the direct α-arylation process, and the decent yield of 72% was 
obtained after an elevated reaction time of two days in room temperature (entry 11). 
Other substituted 1-bromo-2-naphthols were also able to generate desired product 
smoothly within hours (entries 12-15). 
 
Scheme 3.2. The α-arylation reaction of trans-p-methoxy-cinnamaldehyde  with 1-
bromo-2-naphthol 
 
 
Similarly, although they were left intact during the bulky diphenylprolinol TMS 
ether catalyzed α-arylation reaction, 2-bromo-1-naphthol and its derivatives could be 
implanted in the 3-component reaction in excellent efficiency. Mediated by pyrrolidine, 
enal and 2-bromo-1-naphthol provide desired three-component product with 97% yield 
and preference of E-isomer (Scheme 3.3, equation a). The 3-bromo-4-hydroxycoumarine, 
which has similar structural framework, could also participate in the α-arylation process 
with excellent stereoselectivity (Scheme 3.2, equation b).  
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Scheme 3.3. Three-component α-arylation reaction of enals with 2-bromo-1-naphthol and  
3-bromo-4-hydroxycoumarine 
 
 
Interestingly, α-arylation E-isomeric product 3a can be quantitatively converted to 
its Z-isomeric three-component-reaction analog 4a using stoichiometric amount of 
secondary amine, such as piperidine, under room temperature within hours (Scheme 3.4). 
The releasing of the steric hindrance in E-isomeric two-component α-arylation product, 
such as 3a, is considered as a driving force for the E to Z conversion. Such a 
transformation mechanism was believed to follow the retro-Aldol condensation (from 3a 
to 6 and 7) tandem Aldol condensation (from 6 and 7 to 4a) cascade processes. 
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Scheme 3.4. Conversion from the E-isomer 3a to the three-component Z-isomer 4a using 
piperidine 
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3.6. Summary 
In conclusion, both E- and Z- functionalized naphthol frameworks can be 
stereoselectively constructed by carefully selection of secondary amine mediator used in 
the direct α-arylation reactions. Catalyzed by bulky diphenylprolinol TMS ether, a cross-
coupling-like reaction of α, β-unsaturated aldehydes and 1-bromo-2-naphthols was 
described, and (E)-α,β-diarylacrylaldehydes were obtained in moderate to good yields 
and excellent E/Z ratios. Additionally, stoichiometric amount of cyclic secondary amines 
could mediate the reaction in the generation of Z-isomeric three-component product with 
higher efficiency. 
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3.7. Experimental Section 
General Information: 
All commercially available reagents were used without further purification. The 
progress of the reactions was monitored by analytical thin-layer chromatography (TLC) 
on Whatman silica gel plates with fluorescence F254 indicator. And Merck 60 silica gel 
was used for chromatography. 1H (300 MHz) and 13C (75 MHz) NMR spectra were 
recorded on a Bruker Avance 300. 1H (500 MHz) and 13C (125 MHz) NMR spectra were 
recorded on a Bruker Avance 500. When deuteriorated chloroform (CDCl3) was used to 
dissolve sample, tetramethylsilane (TMS) was used as an internal reference. Data for 1H 
are reported as follows: chemical shift (ppm), and multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet).  Data for 13C NMR are reported as ppm.   
 
Procedure for the mono-bromination of various substituted naphthols 
To a mixture of substituted naphthol (1 mmol) and ammonium acetate (10 mol %) 
in MeCN (5mL), NBS (1.05 mmol) was added in one portion. The reaction mixture was 
stirred at room temperature until the naphthol was totally consumed (determined by TLC 
analysis). The solvent was evaporated, and the residue was purified by column 
chromatography, eluting with a mixture of ethyl acetate and hexane. 
 
OH
Br
Br
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1,3-Dibromonaphthalen-2-ol. 1H NMR (CDCl3, 500 MHz): δ = 7.97 (d, J = 7.5 Hz, 1H), 
7.94 (s, 1H), 7.61 (d, J = 7.5 Hz, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.37 (t, J = 7.5 Hz, 1H), 
6.21 (s, 1H); 13C NMR (CDCl3, 125 MHz): δ = 147.2, 131.8, 131.6, 129.8, 128.2, 127.4, 
125.8, 125.2, 110.8, 106.5. 
 
OH
Br
Br
 
1,6-Dibromonaphthalen-2-ol. 1H NMR (CDCl3, 500 MHz): δ = 7.89 (d, J = 1.8 Hz, 1H), 
7.85 (d, J = 9.0 Hz, 1H), 7.58 (m, 2H), 7.24 (d, J = 9.0 Hz, 1H). 
 
OHBr
Br
 
1,7-Dibromonaphthalen-2-ol. 1H NMR (CDCl3, 500 MHz): δ = 8.17 (s, 1H), 7.67 (d, J 
= 9.0 Hz, 1H), 7.60 (d, J = 9.0 Hz, 1H), 7.45 (d, J = 1.8 Hz, 1H), 7.42 (d, J = 1.8 Hz, 
1H), 7.23 (d, J = 9.0 Hz, 1H), 5.94 (s, 1H); 13C NMR (CDCl3, 125 MHz): δ = 151.7, 
133.8, 130.1, 129., 128.4, 127.9, 122.8, 117.9, 105.2. 
 
OH
O
O
Br
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Methyl 4-bromo-3-hydroxy-2-naphthoate. 1H NMR (CDCl3, 500 MHz): δ = 11.24 (s, 
1H), 8.44 (s, 1H), 8.14 (d, J = 8.0 Hz, 1H), 7.78 (d, J = 8.0 Hz, 1H), 7.63 (t, J = 8.0 Hz, 
1H), 7.38 (t, J = 8.0 Hz, 1H), 4.02 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 170.2, 
153.4, 136.4, 132.2, 130.8, 130.0, 127.7, 126.1, 124.9, 114.4, 107.3, 53.3. 
 
Typical procedure for the synthesis of (E)-α-(2-hydroxynaphthalen-1-yl)-β-
Arylacrylaldehyde 
To the mixture containing 0.2 mmol of α,β-unsaturated aldehyde, 0.4 mmol of 1-
bromo-2-naphthol, 20 % mol of diphenylprolinol TMS ether as catalyst, and 0.8 mmol of 
lithium acetate dehydrate, 1mL acetonitrile was added in one portion. The reaction 
mixture was heated at 600C until the aldehyde was totally consumed (determined by TLC 
analysis). The solvent was evaporated after the reaction was cooled to room temperature. 
The residue was purified by column chromatography, eluting with a mixture of ethyl 
acetate and hexane. 
 
 
(E)-2-(2-hydroxynaphthalen-1-yl)-3-(4-nitrophenyl)acrylaldehyde (3a). 1H NMR 
(Acetone-d6, 500 MHz): δ = 9.98 (s, 1H), 8.76 (s, 1H), 8.13 (s, 1H), 8.02 (d, J = 8.5 Hz, 
2H), 7.87 (m, 2H), 7.52 (d, J = 8.5 Hz, 2H), 7.42 (d, J = 8.0, 1H), 7.30 (m, 3H); 13C NMR 
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(DMSO-d6, 125 MHz): δ = 194.5, 152.6, 148.8, 147.6, 140.9, 139.9, 132.0, 130.5, 130.1, 
128.3, 127.9, 126.8, 123.6, 123.0, 122.9, 118.3, 112.2. 
 
 
(E)-2-(2-hydroxynaphthalen-1-yl)-3-(2-nitrophenyl)acrylaldehyde (3b). 1H NMR 
(Acetone-d6, 500 MHz): δ = 10.05 (s, 1H), 8.70 (s, 1H), 8.39 (s, 1H), 8.05 (dd, J = 8.0, 
1.2 Hz, 1H), 7.74 (t, J = 8.3 Hz, 2H), 7.53 (d, J = 8.4 Hz, 1H), 7.42 (td, J = 7.7, 1.5 Hz, 
1H), 7.33 (td, J = 7.5, 1.2 Hz, 1H), 7.25 (m, 4H); 13C NMR (Acetone -d6, 125 MHz): δ = 
193.5, 153.8, 148.5, 148.2, 140.2, 133.9, 133.7, 131.8, 130.7, 130.6, 129.3, 128.9, 127.3, 
125.1, 124.1, 123.7, 118.4, 113.6. 
 
 
(E)-4-(2-(2-hydroxynaphthalen-1-yl)-3-oxoprop-1-enyl)benzonitrile (3c). 1H NMR 
(Acetone-d6, 500 MHz): δ = 9.96 (s, 1H), 8.61 (br, 1H), 8.05 (s, 1H), 7.87 (m, 2H), 7.56 
(d, J = 8.5 Hz, 2H), 7.43 (m, 3H), 7.28 (m, 3H); 13C NMR (Acetone -d6, 125 MHz): δ = 
194.0, 153.0, 149.5, 140.4, 140.0, 133.2, 132.8, 131.0, 129.5, 129.1, 128.6, 127.5, 124.1, 
123.9, 118.8, 118.6, 113.8, 113.5. 
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(E)-2-(2-hydroxynaphthalen-1-yl)-3-(4-(trifluoromethyl)phenyl)acrylaldehyde (3d). 
1H NMR (Acetone-d6, 500 MHz): δ = 9.98 (s, 1H), 8.58 (br, 1H), 8.07 (s, 1H), 7.89 (d, J 
= 8.5 Hz, 1H), 7.85 (d, J = 7.5 Hz, 1H), 7.48 (m, 5H), 7.29 (m, 3H); 13C NMR (Acetone -
d6, 125 MHz): δ = 194.1, 152.9, 149.9, 139.9, 139.4, 133.2, 131.3, 131.0, 130.9, 129.5, 
129.0, 127.4, 125.9, 125.7, 124.1, 123.8, 118.8, 114.0. 
 
 
(E)-2-(2-hydroxynaphthalen-1-yl)-3-(2-(trifluoromethyl)phenyl)acrylaldehyde (3e). 
1H NMR (Acetone-d6, 500 MHz): δ = 10.02 (s, 1H), 8.73 (s, 1H), 8.24 (s, 1H), 7.77 (m, 
3H), 7.39 (m, 2H), 7.24 (m, 5H); 13C NMR (Acetone -d6, 125 MHz): δ = 192.8, 152.8, 
145.7, 140.3, 133.2, 132.5, 131.6, 130.0, 129.5, 128.4, 128.1, 127.5, 126.4, 125.7X2, 
123.2, 122.8, 117.6, 112.9. 
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(E)-3-(4-fluorophenyl)-2-(2-hydroxynaphthalen-1-yl)acrylaldehyde (3f). 1H NMR 
(Acetone-d6, 500 MHz): δ = 9.91 (s, 1H), 8.44 (br, 1H), 7.98 (s, 1H), 7.87 (d, J = 9.0 Hz, 
1H), 7.84 (d, J = 7.5 Hz, 1H), 7.43 (d, J = 7.5 Hz, 1H), 7.28 (m, 5H), 6.95 (t, J = 9.0 Hz, 
2H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.1, 165.2, 163.2, 153.0, 151.0, 137.4, 
133.3, 133.2, 133.1, 132.2, 130.7, 129.6, 129.0, 127.3, 124.3, 123.8, 118.9, 116.3, 116.1, 
114.4. 
 
O
F
OH
 
(E)-3-(2-fluorophenyl)-2-(2-hydroxynaphthalen-1-yl)acrylaldehyde (3h). 1H NMR 
(Acetone-d6, 500 MHz): δ = 9.99 (s, 1H), 8.55 (br, 1H), 8.17 (s, 1H), 7.86 (d, J = 9.0 Hz, 
1H), 7.84 (d, J = 7.5 Hz, 1H), 7.44 (d, J = 8.0 Hz, 1H), 7.28 (m, 4H), 7.17 (t, J = 9.5 Hz, 
1H), 6.93 (t, J = 7.8 Hz, 1H), 6.74 (t, J = 7.5 Hz, 1H); 13C NMR (Acetone -d6, 125 MHz): 
δ = 194.1, 160.7, 153.1, 142.5, 139.3, 133.4, 133.0, 132.9, 130.8, 129.8, 129.5, 129.1, 
127.4, 125.0, 124.2, 123.8, 123.6, 123.4, 118.9, 116.3, 116.1, 114.3. 
 
 
(E)-3-(4-chlorophenyl)-2-(2-hydroxynaphthalen-1-yl)acrylaldehyde (3i). 1H NMR 
(Acetone-d6, 500 MHz): δ = 9.92 (s, 1H), 8.48 (br, 1H), 7.97 (s, 1H), 7.85 (m, 2H), 7.42 
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(m, 1H), 7.25 (m, 7H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.0, 152.9, 150.6, 138.3, 
136.1, 134.5, 133.3, 132.2, 130.7, 129.5, 129.3, 129.0, 127.4, 124.2, 123.8, 118.9, 114.3. 
 
 
(E)-3-(4-bromophenyl)-2-(2-hydroxynaphthalen-1-yl)acrylaldehyde (3j). 1H NMR 
(Acetone-d6, 500 MHz): δ = 9.92 (s, 1H), 8.47 (br, 1H), 7.96 (s, 1H), 7.85 (m, 2H), 7.42 
(m, 1H), 7.38 (d, J = 15 Hz, 2H), 7.29 (m, 3H), 7.20 (d, J = 15 Hz, 2H); 13C NMR 
(Acetone -d6, 125 MHz): δ = 194.1, 152.9, 150.7, 138.4, 134.8, 133.3, 132.4, 132.3, 
130.8, 129.5, 129.0, 127.4, 124.6, 124.2, 123.8, 118.9, 114.3. 
 
 
(E)-2-(2-hydroxynaphthalen-1-yl)-3-phenylacrylaldehyde (3k). 1H NMR (Acetone-d6, 
500 MHz): δ = 9.93 (s, 1H), 8.39 (br, 1H), 7.98 (s, 1H), 7.85 (m, 2H), 7.44 (m, 1H), 7.27 
(m, 6H), 7.15 (m, 2H); 13C NMR (Acetone -d6, 125 MHz): δ = 194.2, 152.9, 152.5, 137.6, 
135.6, 133.4, 130.9, 130.5, 129.5, 129.2, 128.9, 127.2, 124.3, 123.7, 118.9, 114.7. 
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(E)-2-(2-hydroxynaphthalen-1-yl)-3-(naphthalen-2-yl)acrylaldehyde (3l). 1H NMR 
(Acetone-d6, 500 MHz): δ = 10.00 (s, 1H), 8.50 (br, 1H), 8.15 (s, 1H), 7.97 (s, 1H), 7.91 
(d, J = 9.0 Hz, 1H), 7.86 (d, J = 9.5 Hz, 1H), 7.74 (d, J = 7.5 Hz, 1H), 7.68 (d, J = 8.0 Hz, 
1H), 7.54 (d, J = 8.5 Hz, 1H), 7.46 (m, 3H), 7.31 (d, J = 9.0 Hz, 1H), 7.26 (m, 2H), 7.19 
(d, J = 8.5 Hz, 1H), ; 13C NMR (Acetone -d6, 125 MHz): δ = 194.2, 153.0, 152.3, 137.8, 
134.6, 133.7, 133.5 133.3, 132.4, 130.6, 129.5, 129.2, 128.9, 128.6, 127.2, 126.5, 124.3, 
123.7, 118.9, 114.8. 
 
 
(E)-3-(furan-2-yl)-2-(2-hydroxynaphthalen-1-yl)acrylaldehyde (3m). 1H NMR 
(Acetone-d6, 500 MHz): δ = 9.88 (s, 1H), 8.33 (br, 1H), 7.85 (m, 3H), 7.62 (s, 1H), 
7.43(d, J = 14 Hz, 2H), 7.29 (m, 2H), 6.34 (s, 1H), 5.85 (d, J = 5.5 Hz, 1H); 13C NMR 
(Acetone -d6, 125 MHz): δ = 192.9, 152.8, 151.9, 146.5, 138.5, 134.7, 133.4, 130.6, 
129.6, 128.9, 127.2, 124.3, 123.7, 119.0, 116.3, 114.6, 113.6. 
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(E)-2-(2-hydroxynaphthalen-1-yl)-3-(4-methoxyphenyl)acrylaldehyde (3m). 1H NMR 
(Acetone-d6, 500 MHz): δ = 9.86 (s, 1H), 8.29 (s, 1H), 7.87 (m, 3H), 7.44 (m, 1H), 7.28 
(m, 3H), 7.20 (d, J = 15 Hz, 2H), 6.72 (d, J = 15 Hz, 2H), 3.72 (s, 3H); 13C NMR 
(Acetone -d6, 125 MHz): δ = 194.0, 162.3, 152.8, 152.5, 135.1, 134.4, 133.0, 130.4, 
129.6, 129.0, 128.2, 127.2, 124.5, 123.7, 119.0, 115.0, 114.7, 55.5. 
 
 
(E)-2-(2-hydroxynaphthalen-1-yl)-3-(2-methoxyphenyl)acrylaldehyde (3o). 1H NMR 
(Acetone-d6, 500 MHz): δ = 9.92 (s, 1H), 8.41 (br, 1H), 8.33 (s, 1H), 7.82 (t, J = 9.0 Hz, 
2H), 7.43 (t, J = 9.0 Hz, 2H), 7.43 (d, J = 8.0 Hz, 1H), 7.25 (m, 4H), 7.01 (d, J = 8.5 Hz, 
1H), 6.89 (d, J = 8.0 Hz, 1H), 6.45 (t, J = 7.8 Hz, 1H), 3.95 (s, 3H); 13C NMR (Acetone -
d6, 125 MHz): δ = 194.1, 158.8, 152.9, 146.1, 137.0, 133.4, 132.5, 130.3, 129.5, 129.4, 
128.8, 127.0, 124.3, 124.1, 123.5, 120.7, 118.8, 115.0, 111.7, 56.0. 
 
 
(E)-2-(3-bromo-2-hydroxynaphthalen-1-yl)-3-(4-nitrophenyl)acrylaldehyde (3p). 1H 
NMR (Acetone-d6, 500 MHz): δ = 9.93 (s, 1H), 8.30 (s, 1H), 8.19 (s, 1H), 8.04 (d, J = 8.7 
 80 
Hz, 2H), 7.86 (m, 1H), 7.49 (d, J = 8.7 Hz, 2H), 7.43 (m, 1H), 7.36 (m, 2H); 13C NMR 
(CDCl3, 125 MHz): δ = 149.7, 149.4, 148.9, 141.4, 139.9, 133.5, 132.2, 131.5, 130.3, 
128.3, 128.1, 125.2, 124.4, 124.3, 116.1, 113.5. 
 
 
(E)-2-(6-bromo-2-hydroxynaphthalen-1-yl)-3-(4-nitrophenyl)acrylaldehyde (3q). 1H 
NMR (Acetone-d6, 500 MHz): δ = 9.98 (s, 1H), 8.84 (s, 1H), 8.14 (s, 1H), 8.06 (s, 1H), 
8.03 (d, J = 9.0 Hz, 2H), 7.89 (d, J = 9.0 Hz, 1H), 7.50 (d, J = 9.0 Hz, 2H), 7.35 (m, 3H); 
13C NMR (CDCl3, 125 MHz): δ = 193.9, 153.6, 149.4, 148.8, 141.7, 140.3, 131.9, 131.3, 
131.0, 130.7, 130.4, 130.3, 126.4, 124.2, 120.1, 117.0, 114.0. 
 
O
NO2OH
Br
 
(E)-2-(7-bromo-2-hydroxynaphthalen-1-yl)-3-(4-nitrophenyl)acrylaldehyde (3r). 1H 
NMR (Acetone-d6, 500 MHz): δ = 10.02 (s, 1H), 8.92 (s, 1H), 8.18 (s, 1H), 8.07 (d, J = 
8.7 Hz, 2H), 7.94 (d, J = 9.0 Hz, 1H), 7.83 (d, J = 9.0 Hz, 1H), 7.63 (s, 1H), 7.55 (d, J = 
8.7 Hz, 2H), 7.41 (dd, J = 8.7 1.8 Hz, 1H), 7.35 (d, J = 9.0 Hz, 1H); 13C NMR (CDCl3, 
125 MHz): δ = 194.0, 154.1, 149.7, 148.9, 141.7, 140.1, 134.7, 131.4, 131.2, 127.9, 127.1, 
126.1, 124.2, 121.6, 119.5, 113.1. 
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(E)-methyl 3-hydroxy-4-(1-(4-nitrophenyl)-3-oxoprop-1-en-2-yl)-2-naphthoate (3s). 
1H NMR (Acetone-d6, 500 MHz): δ = 10.77 (s, 1H), 10.02 (s, 1H), 8.72 (s, 1H), 8.20 (s, 
1H), 8.03 (m 3H), 7.53 (d, J = 9.0 Hz, 2H), 7.48 (m, 2H), 7.39 (m, 1H)4.07 (s, 3H); 13C 
NMR (CDCl3, 125 MHz): δ = 193.7, 171.0, 154.4, 149.4, 148.8, 141.7, 140.1, 136.0, 
134.1, 131.3, 130.9, 130.7, 127.9, 125.1, 124.2, 124.1, 115.7, 114.8, 53.3. 
 
Typical procedure for the three-component reaction 
To the mixture containing 0.2 mmol of α,β-unsaturated aldehyde, 0.2 mmol of 1-
bromo-2-naphthol, 0.24 mmol of secondary amine, and 0.8 mmol of potassium carbonate, 
1mL chloroform was added in one portion. The reaction mixture was stirred at room 
temperature until the aldehyde was totally consumed (determined by TLC analysis). The 
solvent was evaporated and the residue was purified by column chromatography, eluting 
with a mixture of ethyl acetate and hexane. 
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(Z)-1-(1-(4-nitrobenzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-yl)piperidine (4a). 
1H NMR (CDCl3, 500 MHz): δ = 8.35 (d, J = 8.5 Hz, 1H), 8.23 (d, J = 8.5 Hz, 2H), 7.95 
(d, J = 8.5 Hz, 2H), 7.86 (d, J = 8.0 Hz, 1H), 7.79 (d, J = 9.0 Hz, 1H), 7.62 (t, J = 7.5 Hz, 
1H), 7.55 (s, 1H), 7.40 (t, J = 7.5 Hz, 1H), 7.14 (d, J = 8.5 Hz, 1H), 5.92 (s, 1H), 2.90 (m, 
2H), 1.45 (m, 8H); 13C NMR (CDCl3, 125 MHz): δ = 162.1, 146.1, 144.5, 142.9, 133.8, 
130.4, 130.1, 130.0, 129.1, 128.5, 123.8, 122.4, 122.3, 116.7, 112.6, 101.4, 26.2, 24.5. 
 
 
(Z)-1-(1-(4-nitrobenzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-yl)pyrrolidine (4b). 
1H NMR (CDCl3, 500 MHz): δ = 8.35 (d, J = 8.5 Hz, 1H), 8.22 (d, J = 8.5 Hz, 2H), 7.87 
(m, 3H), 7.79 (d, J = 9.0 Hz, 1H), 7.62 (t, J = 7.8 Hz, 1H), 7.51 (s, 1H), 7.40 (t, J = 7.3 
Hz, 1H), 7.14 (d, J = 9.0 Hz, 1H), 6.22 (s, 1H), 2.95 (m, 2H), 2.82 (s, 2H), 1.76 (s, 4H); 
13C NMR (CDCl3, 125 MHz): δ = 162.5, 146.1, 144.5, 143.4, 133.8, 130.1, 129.5, 128.5, 
123.9, 123.8, 122.3, 121.6, 116.1, 112.5, 96.9, 46.3, 24.6. 
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(Z)-N,N-diethyl-1-(4-nitrobenzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-amine 
(4c). 1H NMR (CDCl3, 500 MHz): δ = 8.37 (d, J = 8.5 Hz, 1H), 8.21 (d, J = 8.5 Hz, 2H), 
7.92 (d, J = 8.5 Hz, 2H), 7.86 (d, J = 8.5 Hz, 1H), 7.79 (d, J = 8.5 Hz, 1H), 7.62 (t, J = 
7.5 Hz, 1H), 7.54 (s, 1H), (t, J = 7.5 Hz, 1H), 7.11 (d, J = 8.5 Hz, 1H), 6.20 (s, 1H), 2.88 
(m, 4H), 1.07 (m, 6H); 13C NMR (CDCl3, 125 MHz): δ = 162.2, 146.1, 144.5, 143.2, 
133.8, 130.3, 130.2, 130.0, 129.3, 129.5, 123.7, 122.3, 122.0, 116.8, 112.9, 100.1, 30.0, 
13.5. 
 
 
(Z)-1-(1-benzylidene-1,2-dihydronaphtho[2,1-b]furan-2-yl)pyrrolidine (4d). 1H NMR 
(CDCl3, 500 MHz): δ = 8.39 (d, J = 8.5 Hz, 1H), 7.84 (d, J = 8.0 Hz, 1H), 7.50 (m, 3H), 
7.58 (t, J = 7.5 Hz, 1H), 7.50 (s, 1H), 7.38 (m, 3H), 7.27 (m, 1H), 7.13 (d, J = 8.5 Hz, 
1H), 6.23 (s, 1H), 2.97 (m, 2H), 2.83 (m, 2H), 1.75 (m, 4H) ; 13C NMR (CDCl3, 125 
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MHz): δ = 161.1, 138.7, 137.9, 132.0, 130.0, 129.9, 129.4, 128.6, 127.9, 127.1, 124.5, 
123.3, 122.5, 116.8, 112.3, 96.9, 46.2, 24.5. 
 
O
N
O2N
 
(Z)-1-(1-(2-nitrobenzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-yl)pyrrolidine (4e). 
1H NMR (CDCl3, 500 MHz): δ = 8.33 (d, J = 8.5 Hz, 1H), 8.02 (d, J = 8.0 Hz, 1H), 7.80 
(m, 4H), 7.59 (m, 2H), 7.39 (m, 2H), 7.10 (d, J = 9.0 Hz, 1H), 6.15 (s, 1H), 2.78 (m, 2H), 
2.53 (m, 2H), 1.55 (m, 4H); 13C NMR (CDCl3, 125 MHz): δ = 162.5, 148.7, 141.1, 133.9, 
133.2, 132.8, 131.0, 129.9, 129.8, 128.4, 127.7, 124.6, 123.6, 122.5, 118.6, 115.8, 112.6, 
97.5, 46.2, 24.5. 
 
O
N
CF3
 
(Z)-1-(1-(4-(trifluoromethyl)benzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-
yl)pyrrolidine (4f). 1H NMR (CDCl3, 500 MHz): δ = 8.34 (d, J = 8.5 Hz, 1H), 7.82 (m, 
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3H), 7.73 (d, J = 8.5 Hz, 1H), 7.59 (m, 3H), 7.47 (s, 1H), 7.35 (t, J = 7.5 Hz, 1H), 7.11 (d, 
J = 8.5 Hz, 1H), 6.16 (s, 1H), 2.93 (m, 2H), 2.79 (m, 2H), 1.72 (m, 4H); 13C NMR 
(CDCl3, 125 MHz): δ = 161.8, 141.3, 132.9, 130.1, 130.0, 129.8, 129.5, 128.8, 128.3, 
128.2, 126.5, 125.4, 124.3, 123.5, 122.9, 122.6, 122.4, 116.3, 112.4, 96.8, 46.2, 24.5. 
 
O
N
Cl
 
(Z)-1-(1-(4-chlorobenzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-yl)pyrrolidine 
(4h). 1H NMR (CDCl3, 500 MHz): δ = 8.34 (d, J = 8.7 Hz, 1H), 7.82 (d, J = 8.0 Hz, 1H), 
7.70 (m, 3H), 7.56 (t, J = 7.5 Hz, 1H), 7.44 (s, 1H), 7.34 (m, 3H), 7.11 (d, J = 8.7 Hz, 
1H), 6.15 (s, 1H), 2.94 (m, 2H), 2.79 (m, 2H), 1.73 (m, 4H) ; 13C NMR (CDCl3, 125 
MHz): δ = 161.4, 139.3, 136.4, 132.9, 132.3, 131.0, 130.0, 129.9, 129.4, 128.7, 127.9, 
123.4, 123.0, 122.4, 116.5, 112.3, 96.7, 46.2, 24.5. 
 
O
N
CN
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(Z)-4-((2-(pyrrolidin-1-yl)naphtho[2,1-b]furan-1(2H)-ylidene)methyl)benzonitrile 
(4i). 1H NMR (CDCl3, 500 MHz): δ = 8.36 (d, J = 8.5 Hz, 1H), 7.83 (m, 4H), 7.63 (m, 
3H), 7.47 (d, J = 1.5 Hz, 1H), 7.41 (t, J = 7.5 Hz, 1H), 7.16 (d, J = 8.7 Hz, 1H), 6.21 (s, 
1H), 2.98 (m, 2H), 2.82 (m, 2H), 1.77 (m, 4H); 13C NMR (CDCl3, 125 MHz): δ = 162.2, 
142.5, 142.4, 133.4, 132.7, 132.2, 130.0, 129.4, 128.3, 123.7, 122.3, 122.1, 119.5, 116.1, 
112.4, 109.8, 96.846.3, 24.5. 
 
O
N
OMe
 
(Z)-1-(1-(4-methoxybenzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-yl)pyrrolidine 
(4j). 1H NMR (CDCl3, 500 MHz): δ = 8.38 (d, J = 8.4 Hz, 1H), 7.82 (d, J = 8.0 Hz, 1H), 
7.73 (m, 3H), 7.56 (t, J = 7.5 Hz, 1H), 7.45 (s, 1H), 7.36 (m, 1H), 7.25 (s, 1h), 7.11 (d, J 
= 8.4 Hz, 1H), 6.93 (d, J = 8.0 Hz, 2H), 6.19 (s, 1H), 3.85 (s, 3H), 2.97 (m, 2H), 2.83 (m, 
2H), 1.75 (m, 4H); 13C NMR (CDCl3, 125 MHz): δ = 160.7, 159.0, 136.5, 131.5, 131.3, 
130.8, 130.0, 129.9, 129.4, 127.7, 124.2, 123.2, 122.6, 117.1, 114.1, 112.3, 96.9, 55.6, 
46.2, 24.6. 
 
 87 
O
EtOOC
N
 
(Z)-ethyl 2-(2-(pyrrolidin-1-yl)naphtho[2,1-b]furan-1(2H)-ylidene)acetate (4k). 1H 
NMR (CDCl3, 500 MHz): δ = 8.16 (d, J = 8.4 Hz, 1H), 7.81 (m, 2H), 7.57 (t, J = 7.4 Hz, 
1H), 7.36 (t, J = 7.4 Hz, 1H), 7.11 (d, J = 9.0 Hz, 1H), 6.83 (s, 1H), 6.68 (s, 1H), 4.25 (q, 
J = 7.0 Hz, 2H), 2.84 (m, 4H), 1.72 (m, 4H), 1.35 (t, J = 7.0 Hz, 3H); 13C NMR (CDCl3, 
125 MHz): δ = 166.9, 164.8, 154.0, 135.8, 130.0, 129.8, 128.8, 123.9, 122.4, 114.2, 112.8, 
110.6, 98.5, 60.3, 46.8, 24.6, 14.6. 
 
 
(Z)-1-(4-nitrobenzylidene)-2-(pyrrolidin-1-yl)-1,2-dihydrofuro[3,2-f]quinoline (4l). 
1H NMR (CDCl3, 500 MHz): δ = 8.81 (s, 1H), 8.67 (d, J = 8.5 Hz, 1H), 8.22 (d, J = 7.5 
Hz, 2H), 8.05 (d, J = 8.5 Hz, 1H), 7.86 (d, J = 7.5 Hz, 2H), 7.49 (m, 1H), 7.41 (s, 1H), 
7.35 (d, J = 8.5 Hz, 1H), 6.28 (s, 1H), 2.95 (m, 2H), 2.82 (m, 2H), 1.76 (m, 4H); 13C 
NMR (CDCl3, 125 MHz): δ = 162.2, 147.7, 146.3, 145.4, 143.8, 142.6, 134.8, 130.1, 
124.8, 123.8, 122.5, 115.9, 97.7, 46.3, 24.6. 
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O
NO2
N
Br  
(Z)-1-(4-bromo-1-(4-nitrobenzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-
yl)pyrrolidine (4m). 1H NMR (CDCl3, 500 MHz): δ = 8;.29 (d, J = 8.5 Hz, 1H), 8.20 (d, 
J =8.0 Hz, 2H), 7.97 (s, 1H), 7.84 ( d, J =8.0 Hz, 2H), 7.75 (d, J =8.5 Hz, 1H), 7.60 (t, J 
=7.5 Hz, 1H), 7.49 (s, 1H), 7.40 (d, J = 7.5 Hz, 1H), 6.26 (s, 1H), 2.96 (m, 2H), 2.80 (m, 
2H), 1.76 (m, 4H); 13C NMR (CDCl3, 125 MHz): δ = 158.8, 146.4, 143.8, 142.8, 134.8, 
130.9, 130.2, 129.2, 128.5, 128.4, 124.5, 123.9, 123.2, 122.3, 117.5, 105.8, 97.7, 46.4, 
24.5. 
 
O
NO2
N
Br  
(Z)-1-(7-bromo-1-(4-nitrobenzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-
yl)pyrrolidine (4n). 1H NMR (CDCl3, 500 MHz): δ = 8.22 (m, 3H), 8.00 (d, J = 2.0 Hz, 
1H), 7.87 (d, J = 9.0 Hz, 2H), 7.69 (m, 2H), 7.44 (d, J =2.0 Hz, 1H), 7.15 (d, J = 9.0 Hz, 
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1H), 6.22 (s, 1H), 2.93 (m, 2H), 2.80 (m, 2H), 1.76 (m, 4H); 13C NMR (CDCl3, 125 
MHz): δ = 162.6, 146.3, 144.2, 142.8, 132.6, 132.0, 131.5, 131.4, 130.2, 127.9, 124.0, 
123.9, 122.2, 117.2, 116.4, 113.7, 97.2, 46.3, 24.6. 
 
O
NO2
N
Br
 
(Z)-1-(8-bromo-1-(4-nitrobenzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-
yl)pyrrolidine (4o). 1H NMR (CDCl3, 500 MHz): δ = 8.44 (s, 1H), 8.21 (d, J = 8.7 Hz, 
2H), 7.87 (d, J = 8.7 Hz, 2H), 7.72 (m, 2H), 7.45 (dd, J = 8.7 1.8 Hz, 1H), 7.39 (d, J = 1.8 
Hz, 1H), 7.12 (d, J = 8.7 Hz, 1H), 6.19 (s, 1H), 2.94 (m, 2H), 2.78 (m, 2H), 1.75 (m, 4H); 
13C NMR (CDCl3, 125 MHz): δ = 163.0, 146.3, 144.1, 142.5, 133.5, 131.5, 130.5, 130.2, 
128.4, 127.1, 124.7, 123.8, 123.3, 121.9, 115.4, 112.9, 97.2, 46.3, 24.6. 
 
O
NO2
N
COOMe  
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(Z)-methyl-1-(4-nitrobenzylidene)-2-(pyrrolidin-1-yl)-1,2-dihydronaphtho[2,1-
b]furan-4-carboxylate (4p). 1H NMR (CDCl3, 500 MHz): δ = 8.48 (s, 1H), 8.35 (d, J = 
8.7 Hz, 1H), 8.23 (d, J = 8.7 Hz, 2H), 7.91 (m, 3H), 7.70 (t, J = 7.8 Hz, 1H), 7.53 (d, J = 
1.5Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 6.30 (s, 1H), 2.99 (m, 2H), 2.80 (m, 2H), 1.77 (m, 
4H); 13C NMR (CDCl3, 125 MHz): δ = 165.4, 160.6, 146.3, 144.0, 142.2, 136.5, 131.4, 
131.3, 130.6, 130.2, 128.9, 124.4, 123.9, 122.8, 122.2, 118.3, 115.1, 97.6, 52.5, 46.4, 24.4. 
 
O
OH
OMe
 
(Z)-1-(4-methoxybenzylidene)-1,2-dihydronaphtho[2,1-b]furan-2-ol (5a). 1H NMR 
(CDCl3, 500 MHz): δ = 8.27 (d, J = 8.5 Hz, 1H), 7.81 (d, J = 8.0 Hz, 1H), 7.70 (d, J = 8.5 
Hz, 1H), 7.63 (d, J = 8.5 Hz, 2H), 7.54 (t, J = 7.5 Hz, 1H), 7.48 (s, 1H), 7.36 (t, J = 7.5 
Hz, 1H), 7.14 (d, J = 8.5 Hz, 1h), 6.93 (d, J = 7.5 Hz, 2H), 6.35 (s, 1H), 3.82 (s, 3H); 13C 
NMR (CDCl3, 125 MHz): δ = 159.6, 158.5, 136.4, 132.3, 131.8, 130.9, 130.5, 129.9, 
129.4, 127.9, 126.5, 123.8, 122.6, 114.5, 114.4, 112.8, 100.2, 55.6. 
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(E)-1-(3-(4-nitrobenzylidene)-2,3-dihydronaphtho[1,2-b]furan-2-yl)pyrrolidine (5b). 
1H NMR (CDCl3, 500 MHz): δ = 8.21 (d, J = 8.5 Hz, 2H), 8.07 (m, 1H), 7.98 (d, J = 8.5 
Hz, 2H), 7.88 (d, J = 9.0 Hz, 1H), 7.70 (d, J = 9.0 Hz, 1H), 7.53 (m, 2H), 7.47 (d, J = 9.0 
Hz, 1H), 7.21 (d, J = 2.0 Hz, 1H), 6.78 (d, J = 2.0 Hz, 1H), 2.97 (m, 2H), 2.91 (m, 2H), 
1.72 (m, 4H); 13C NMR (CDCl3, 125 MHz): δ (mixture of E and Z isomers) = 159.9, 
146.4, 144.1, 142.8, 136.5, 130.8, 130.6, 129.6, 129.0, 128.1, 127.6, 126.6, 124.0, 123.3, 
123.0, 122.6, 121.5, 121.1, 120.5, 119.6, 119.0, 118.4, 100.0, 99.2, 46.6, 24.9. 
 
O
O
N
NO2
O  
(Z)-3-(4-nitrobenzylidene)-2-(pyrrolidin-1-yl)-2H-furo[3,2-c]chromen-4(3H)-one 
(5c). 1H NMR (CDCl3, 500 MHz): δ = 8.18 (d, J = 8.0 Hz, 2H), 7.81 (d, J = 7.5 Hz, 1H), 
7.69 (d, J = 8.0 Hz, 2H), 7.63 (m, 2H), 7.36 (m, 2H), 6.95 (s, 1H), 3.01 (m, 4H), 1.78 (m, 
4H); 13C NMR (CDCl3, 125 MHz): δ = 169.9, 158.8, 155.2, 146.3, 
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Typical Procedure for the conversion from E-isomer to its Z-isomeric analog using 
secondary amine 
 
To the vial containing 0.1 mmol of E-isomeric α-arylation product, such as (E)-2-
(2-hydroxynaphthalen-1-yl)-3-(4-nitrophenyl)acrylaldehyde, dissolved in 1mL 
chloroform, 0.12 mmol of cyclic secondary amine, such as piperidine, was added in one 
portion. The reaction mixture was stirred at room temperature until the aldehyde was 
totally consumed (determined by TLC analysis). The solvent was evaporated and the 
residue was purified by column chromatography, eluting with a mixture of ethyl acetate 
and hexane. 
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Chapter 4 
Direct Stereoselective α-Arylation of Unmodified Enals with 3-
Bromoindoles via an Organocatalytic Cross-Coupling-Like Strategy 
 
4.1. Introduction 
 Functionalized indoles are important building blocks in organic synthesis and 
privileged structures in drug discovery.1,2 In the realms of organocatalysis, it usually 
serves as a good nucleophile in stereoselective Friedel-Crafts reactions.3 The applications 
of indoles in asymmetric organocatalytic Michael addition towards enals4-7, unsaturated 
ketones8-12 and nitro-olefins13-17, and 1,2-addition towards imines and carbonyl 
compounds18-26 have already been scrutinized in the last decade, and various 
functionalized indoles are received as synthetically useful products for further 
elaborations. 
Compared to benzene, indole is usually considered as an electron-rich hetero-
aromatic system that demonstrates enhanced reactivity in electrophilic aromatic 
substitutions. The most reactive site of indole towards electrophilic substitution is the C3 
position, which is about 1013 times more reactive than benzene.27 The high reactivity of 
indole usually renders a possible access to organic reactions that are unfeasible for 
benzene and similar arenes. As for the methodologies that are already feasible for 
benzene and its derivatives, indole is usually a good alternative substrate after a careful 
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assessment of the reaction conditions as well as additives to suppress undesired poly-
substitution events on the indolyl ring. 
 
4.2. Optimization of Reaction Conditions 
The success of the diphenyl prolinol TMS ether promoted direct α-arylation of 
enals with p-bromophenols as well as bromonaphthols prompts us to explore the ability 
of non-phenolic substrates to serve as aromatic coupling partners.28 We envision that 3-
bromoindoles would be good substrates for the reaction as the integrated indole 
frameworks are electron-rich species and they have already been used in organocatalysed 
enantioselective Friedel-Craft s reactions previously. 
The model reaction between 3-bromoindole 2a and trans-p-nitrocinnamaldehyde 
1a was set up for reaction condition optimization (Table 4.1). The E-isomer was observed 
predominantly as the product, and the structure of compound 3a was determined by X-
ray crystal structural analysis (Figure 4.1).  
At first, various aminocatalysts were screened (Table 4.1). Neither McMillan’s 1st 
(I) nor 2nd (II) generation catalyst provide any stable product, and the reactions were 
sluggish (entries 1 and 2). Babar’s Catalyst (III) gave 27% yield, but the E-to-Z ratio is 
poor (entry 3). Wang’s Catalyst (IV) gave relative good E/Z value, but the yield is low 
(entry 4). When proline (V) and the unprotected diphenylprolinol (VII) were used to 
catalyze the reaction, there was no catalyst turn over at all (entries 5 and 7). 
Diphenylprolinol TMS ether provided best result among all the aminocatalysts, and 
single E-isomer was obtained with 52% yield (entry 6). Since the 3-bromoindole suffered 
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from significant decomposition and polymerization even in solid form at room 
temperature, it should be noticed that two fold equiv. of 3-bromoindole was used to zero 
out the deterioration in reaction solution. 
 
Figure 4.1. Single X-ray crystal structure of 3a at probability ellipsoids of 20% 
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Table 4.1. Screening of catalysts for the cascade reactions using enal 1a and 3-
bromoindole 4aa   
N
H
Br
O
NO2
1a 2a
NH
O
NO2
Cat. 20 mol%
TEA, 1.2 equiv.
CH2Cl2, r.t.
3a
N
N
H
O
N
N
H
N
N
H
O H
N
N
H
S
O
O
N
H
O
OH
N
H OH
Ph
Ph
N
H OTMS
Ph
Ph
N
H
I II III IV
V VI VII VIII
Cat.
N
H
IX X
N
H
 
entry catalyst time (days) yield (%)b E/Zc 
1 I 6 0 ndd 
2 II 6 0 ndd 
3 III 5 27 81:19 
4 IV 5 25 98:2 
5 V 6 6 ndd 
6 VI 3 52 >99:1 
7 VII 6 9 ndd 
8 VIII 5 38 98:2 
9 IX 5 21 98:2 
10 X 8 <5 ndd 
aReaction conditions: unless specified, a mixture of 1a (0.1 mmol), 2a (0.2 mmol),  
designated catalyst (20 mol%, or 0.02 mmol) and triethylamine additive (1.2 equiv.) in 
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dichloromethane (0.5 mL)  was stirred for a specified time period at room temperature. 
bIsolated yields. cDetermined by 1H NMR of crude reaction mixture. dNot determined. 
 
 After the catalyst VI was found as the optimal catalyst, other reaction parameters 
were screened to improve product yield (Table 4.2). As demonstrated, the organic bases, 
such as triethylamine and 2, 6-lutidine, provide lower yield, compared with inorganic 
bases (Table 4.2, entry 1 and entries 2 to 4). Among the three inorganic sodium salts, 
sodium acetate was selected as the best additive (entries 2, 3 and 4). Solvent screen came 
next. Although the methodology could tolerant a large spectrum of solvents, chloroform 
was found to be the optimized solvent (entries 5 to 12). At last, reaction time was 
shortened from 3 days to 7 hours by increasing the temperature from 25° to 60 °C (entry 
13). If the reaction time was prolonged from 7 hours to 24 hours, neither significant yield 
increase nor decomposition of the product was observed (entry 14). Furthermore, E/Z 
ratio did not decrease during the prolonged heating. Additional control reactions 
demonstrated that the sodium acetate base is crucial to the catalyst turn over. When 
sodium acetate was not added, reaction yield is limited to as low as 20% which is about 
the amount of the catalyst used in the reaction system. 
In conclusion, the results of extensive exploratory and optimization studies of the 
model reaction between 3-bromoindole 2a with trans-p-nitrocinnamaldehyde 1a revealed 
that catalyst VI , chloroform as solvent at 60 °C, and sodium acetate, instead of sodium 
carbonate, represent optimal conditions. It is noteworthy that, in contrast to reactions of 
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4-bromophenols, the process can be performed in one pot without the need for gradual 
addition of the 3-bromoindoles. 
 
Table 4.2. Effect of additives and solvents on the synthesis of (E)-α-indolyl-β-
arylacrylaldehyde 3aa 
 
entry solvent additive temp.(°C) time (days) yield (%)b 
1 CH2Cl2 2,6-lutidine 25 5 46 
2 CH2Cl2 NaOAc 25 3 73 
3 CH2Cl2 NaHCO3 25 3 66 
4 CH2Cl2 Na2CO3 25 3 71 
5 CHCl3 NaOAc 25 3 81 
6 MeOH NaOAc 25 3 79 
7 MeCN NaOAc 25 3 52 
8 THF NaOAc 25 3 73 
9 Toluene NaOAc 25 3 78 
10 Et2O NaOAc 25 3 66 
11 DMF NaOAc 25 3 59 
12 Acetone NaOAc 25 3 77 
13 CHCl3 NaOAc 60 0.3 89 
14 CHCl3 NaOAc 60 1 90 
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aReaction conditions: unless specified, a mixture of 1a (0.1 mmol), 2a (0.2 mmol),  
designated catalyst (20 mol%, or 0.02 mmol) and the specific additive (1.2 equiv.) in 
dichloromethane (0.5 mL)  was stirred for a specified time period at the designated 
temperature. bIsolated yields.  
 
4.3. Expansion of Substrate Scopes 
The scope of VI-catalysed direct α-arylation reactions of 3-bromoindoles 2 with 
enals 1 is examined (Table 4.3). The results show that the processes serve as a general 
and efficient method to prepare a variety of (E)-α-indolyl-β-arylacrylaldehyde. Notably, 
high yields (65-100 %) and good to high E-selectivities (9:1 to >30:1) attend these 
processes. Furthermore, the reactions generally proceed faster and with higher yields and 
E-stereoselectivities than those with 4-bromophenols. In addition, as observed with 
reactions of 4-bromophenols, electron-withdrawing (entries 1-6), electron-neutral (entry 7) 
and electron-donating substituents (entries 8-11) or a combination (entry 12) on enals 1 
are found to have limited effects on these processes. Reactions of 3-bromoindoles also 
occur in high yields with other heterocycles (entry 13) and with other conjugated 
aromatic systems (entries 14-15). Again, steric effects are found to influence the 
efficiency of these reactions more than electronic effects. In general, more hindered 
substrates react with diminished E/Z selectivities (entries 4-6, 10-11 and 15).  
A survey of the structural tolerance of 3-bromoidoles indicates that, in all cases, 
good to high yields (65-100%) and high stereoselectivities (16:1 to >30:1) are achieved 
(entries 16-20), regardless of the size and electronic characteristics of substituents. To our 
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dismay, N-Boc protected 3-bromoindole was not active enough to transform to desired 
product, and was left intact after heated at 60 °C for 5 days (data not shown here). 
Surprisingly, although they provide large steric hindrance, 2-substituted 3-bromoindoles 
did react smoothly with enal 1a, and the reactions afforded quantitative yields and good 
E/Z ratios (entries 16 and 17). Interestingly, in case of 5-methoxyindole (entry 20), a 2-
brominated product is unexpectedly obtained. 
 
Table 4.3. Scope of amine-catalysed direct α-arylation reactions of 3-bromoindoles with 
enalsa 
 
entry Ar X time (h) 3 yield (%)b E/Zc
1 4-NO2C6H4 H 22 3a 90 >30:1
2 4-ClC6H4 H 22 3b 79 >30:1
3 4-BrC6H4 H 22 3c >99 >30:1
4 4-CNC6H4 H 22 3d 81 12:1 
5 2-ClC6H4 H 22 3e >99 9:1 
6 2-BrC6H4 H 22 3f >99 9:1 
7 Ph H 22 3g 87 >30:1
8 4-MeOC6H4 H 22 3h 75 >30:1
9 4-MeC6H4 H 22 3i 90 >30:1
10 2-MeOC6H4 H 22 3j 89 13:1 
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11 2-MeC6H4 H 22 3k 97 10:1 
12 4-AcO-3-MeOC6H4 H 22 3l 94 >30:1
13 2-Furanyl H 22 3m 90 16:1 
14 2-Naphthyl H 22 3n 78 >30:1
15 1-Naphthyl H 22 3o 96 10:1 
16 4-NO2C6H4 2-Me 28 3p >99 >30:1
17 4-NO2C6H4 2-Ph 28 3q >99 16:1 
18 4-NO2C6H4 5-NO2 48 3r 65 >30:1
19 4-NO2C6H4 5-Br 22 3s >99 >30:1
20d 4-NO2C6H4 5-MeO 22 3t 87 >30:1
aReaction conditions: unless specified, a mixture of 1a (0.1 mmol), 2a (0.2 mmol),  
designated catalyst (20 mol%, or 0.02 mmol) and sodium acetate additive (1.2 equiv., 0.4 
mmol) in dichloromethane (0.5 mL) was stirred for a specified time period at 60 °C. 
bIsolated yields. cDetermined by 1H NMR of crude reaction mixture. d2-bromonated 
product formed. 
 
4.4. Proposed Reaction Mechanism 
Based on previously studies of the mechanism for the direct α-arylation of enals 
with 4-bromophenols, a plausible mechanism was also proposed for the stereoselective 
organocatalytic synthesis of (E)-α-Indolyl-β-aryl-acrylaldehydes (Figure 4.2). The 
process started from the iminium activation of enal by the aminocatalyst VI. The 3-
bromoindole attacked the iminium species, and the Michael adduct A was formed 
accordingly. Intramolecular alkylation happened in the following step, and the 
intermediate B was produced with the framework of cyclopropane ring. After the opening 
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of the cyclopropane ring, α-indolyl intermediate D was obtained. Noticed that the α-
indolyl moiety was connected with the iminium moiety through a single C-C bond which 
could rotate freely, and the two conjugated moieties were not conjugated. This 
framework was verified by the X-ray structural analysis of compound 3a which possesses 
a dihedral angle between the two planar moieties. The E-conformation was favored due 
to large steric hindrance brought by the diphenylprolinol TMS ether. 
 
Figure 4.2. A proposed reaction mechanism for α-arylation reactions of enals with 3-
bromoindole 
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4.5. Photosynthesis of Furocarbazole  
As a kind of aryl- and heteroaryl-annulated carbazoles (AHACs), [α]-annulated 
carbazoles is an important class of compounds with fascinating biological properties such 
as anti-tumour, anti-microbial and anti-fungal activities.29 Moreover, recently, their 
application has been expanded to the areas of molecular imaging and material 
chemistry.30-31 Generally speaking, there are two major strategies for the synthesis. 
Although photochemical cycliszation method was usually used in the annulations process, 
the substrates submitted for the irradiation were difficult to make, which renders the 
method lacking of generality.32 A newly developed indium-catalyzed annulation 
methodology provides a more general and straightforward strategy for the [α]-annulated 
carbazoles synthesis. Since the method focused on further material application, the 
products generated lack functional groups, and cannot be conveniently diversified 
without further modification in the purpose of biological research.33 
The (E)-α-indolyl-β-arylacrylaldehydes 3 can serve as valuable precursors for the 
efficient synthesis of [α]-annulated carbazoles. As demonstrated, for instance, compound 
3m can be efficiently transformed to furocarbazole 5 through a photoelectronic 
cyclization-photoinduced decarboxylation cascade (Figure 4.3). Although the compound 
3m could be directly transformed to furocarbazole 5 after UV irradiation for 12 hours in 
acetone with catalytic amount of iodine, the yield is as low as 19%. A cascade process 
which combines photoelectronic cyclization with photoinduced decarboxylation could 
improve the yield up to 55% after the substrate’s indole moiety was protected with Boc-
protecting group. It is known that furocarbazole 5 and its analogues are of considerable 
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biological interest. They can be potentially used for the treatment of various infections 
and poisonous snake bites.34,35 
 
Figure 4.3. Synthesis of furocarbazoles 5 via photoelectronic cycliszation-photoinduced 
decarboxylation cascade process 
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4.6. Summary 
As demonstrated above, a general method for the stereoselective synthesis of (E)-
α-indolyl-β-aryl-acrylaldehyde was established. Organocatalyst was used to mediate the 
cross-coupling-like transformation from α, β-unsaturated aldehydes and 3-bromoindoles 
to tri-substituted alkene products stereoselectively in favor of the E-isomer formation. 
Various aromatic enals and brominated indoles could be tolerated in such a direct α-
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arylation cascade process. Furthermore, the (E)-α-indolyl-β-aryl-acrylaldehyde 
framework also served as the crucial template in the concise construction of [α]-
annulated carbazoles via photoelectronic cyclization-photoinduced decarboxylation 
cascade. 
 
4.7. Experimental Section 
General Information: 
All commercially available reagents were used without further purification. The 
progress of the reactions was monitored by analytical thin-layer chromatography (TLC) 
on Whatman silica gel plates with fluorescence F254 indicator. And Merck 60 silica gel 
was used for chromatography. 1H (300 MHz) and 13C (75 MHz) NMR spectra were 
recorded on a Bruker Avance 300. 1H (500 MHz) and 13C (125 MHz) NMR spectra were 
recorded on a Bruker Avance 500. When deuteriorated chloroform (CDCl3) was used to 
dissolve sample, tetramethylsilane (TMS) was used as an internal reference. Data for 1H 
are reported as follows: chemical shift (ppm), and multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet).  Data for 13C NMR are reported as ppm.   
 
Procedure for (E)-α-indolyl-β-aryl-acrylaldehydes (Table 4.3) 
3-Bromoindole (0.2 mmol), α,β-unsaturated aldehyde (0.1 mmol), NaOAc (42 mg, 
0.4 mmol) and catalyst VI (20 mmol %, 7 mg, 0.02 mmol) were dissolved in chloroform 
(0.2 M relative to aldehyde, 0.5 mL) at room temperature, and the reaction mixture were 
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heated to 60 °C. After the aldehyde was totally consumed (determined by TLC analysis), 
the vial was cooled to room temperature. The solvent was evaporated and the residue was 
purified by column chromatography, eluting with a mixture of ethyl acetate and hexane. 
The compound is characterized by 1H and 13C NMR and HRMS with >95 % purity-based 
1H NMR. 
 
 
(E)-2-(1 H -indol-3-yl)-3-(4-nitrophenyl)acrylaldehyde (3a) . The title compound was 
prepared according to the typical procedure as described above in 90% yield. MP 211-
212°C; 1H NMR (acetone-d6 , 500 MHz): δ = 10.82 (br, 1H), 9.93 (s, 1H), 8.04 (d, J = 
9.0 Hz, 2H), 7.69 (s, 1H), 7.62 (m, 3H), 7.48 (d, J = 8.0 Hz, 1H), 7.07 (t, J = 7.5, 1H), 
6.81 (t, J = 7.5, 1H), 6.74 (d, J = 8.0 Hz, 1H); 13 C NMR (acetone-d6 , 125 MHz): δ = 
194.7, 148.3, 144.4, 143.2, 138.3, 137.6, 131.7X2, 128.3, 125.7, 124.1X2, 122.7, 121.0, 
120.4, 112.8, 107.1; HRMS (ESI) calcd. for C17H12N2O3: m/z 315.0746 ([M+Na]+ ), 
found 315.0742. 
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(E)-3-(4-chlorophenyl)-2-(1H-indol-3-yl)acrylaldehyde (3b). The title compound was 
prepared according the typical procedure, as described above in 79% yield. 1H NMR 
(Acetone-d6, 500 MHz): δ = 10.65 (br, 1H), 9.86 (s, 1H), 7.60 (s, 1H), 7.53 (s, 1H), 7.47 
(d, J = 8 Hz, 1H), 7.41 (d, J = 8.5 Hz, 2H), 7.23 (d, J = 8.5 Hz, 2H), 7.08 (t, J = 7.5 Hz, 
1H), 6.90-6.81 (m, 2H); 13C NMR (Acetone-d6, 125 MHz): δ = 194.6, 146.8, 137.4, 136.1, 
135.3, 135.2, 132.4X2, 129.1X2, 127.4, 125.8, 122.3, 120.9, 120.0, 112.5, 107.3; HRMS 
(ESI) calcd. for C17H12ClNO: m/z 304.0505 ([M+Na]+ ), found 304.0503. 
 
 
(E)-3-(4-bromophenyl)-2-(1H-indol-3-yl)acrylaldehyde (3c). The title compound was 
prepared according the typical procedure, as described above in 100% yield. 1H NMR 
(Acetone-d6, 500 MHz): δ = 10.65 (br, 1H), 9.86 (s, 1H), 7.58 (s, 1H), 7.53 (s, 1H), 7.47 
(d, J = 8 Hz, 1H), 7.39-7.33 (m, 4H), 7.08 (t, J = 7.5 Hz, 1H), 6.87-6.82 (m, 2H); 13C 
NMR (Acetone-d6, 125 MHz): δ = 194.6, 146.8, 137.4, 136.1, 135.5, 132.6X2, 132.1X2, 
127.4, 125.8, 123.7, 122.3, 120.9, 120.0, 112.5, 107.3; HRMS (ESI) calcd. for 
C17H12BrNO: m/z 348.0000 ([M+Na]+ ), found 379.9993. 
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(E)-4-(2-(1H-indol-3-yl)-3-oxoprop-1-enyl)benzonitrile (3d). The title compound was 
prepared according the typical procedure, as described above in 81% yield. 1H NMR 
(Acetone-d6, 500 MHz): δ = 10.74 (br, 1H), 9.91 (s, 1H), 7.65 (s, 1H), 7.60-7.55 (m, 5H), 
7.47 (d, J = 8 Hz, 1H), 7.08 (t, J = 7.5 Hz, 1H), 6.83 (t, J = 7.5 Hz, 1H), 6.75 (d, J = 8 Hz, 
1H); 13C NMR (Acetone-d6, 125 MHz): δ = 194.7, 145.2, 141.1, 137.8, 137.5, 132.7X2, 
131.4X2, 128.1, 125.7, 122.6, 120.9, 120.3, 119.1, 112.8, 112.7, 107.1; HRMS (ESI) 
calcd. for C18H12N2O: m/z 295.0847 ([M+Na]+ ), found 295.0841. 
 
N
O
H
Cl
 
(E)-3-(2-chlorophenyl)-2-(1H-indol-3-yl)acrylaldehyde (3e). The title compound was 
prepared according the typical procedure, as described above in 100% yield. 1H NMR 
(CDCl3, 500 MHz): δ = 9.92 (s, 1H), 8.49 (br, 1H), 7.72 (s, 1H), 7.52-7.43 (m, 2H), 7.33 
(d, J = 8 Hz, 1H), 7.15-7.09 (m, 3H), 6.88 (t, J = 7.5 Hz, 1H), 6.82-6.79 (m, 2H); 13C 
NMR (CDCl3, 125 MHz): δ = 194.9, 144.7, 136.3, 136.0, 134.9, 134.0, 130.8, 130.7, 
129.9, 126.8, 126.7, 125.1, 122.5, 120.8, 120.3, 111.5, 107.2; HRMS (ESI) calcd. for 
C17H12ClNO: m/z 304.0505 ([M+Na]+ ), found 304.0503. 
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(E)-3-(2-bromophenyl)-2-(1H-indol-3-yl)acrylaldehyde (3f). The title compound was 
prepared according the typical procedure, as described above in 100% yield. 1H NMR 
(CDCl3, 500 MHz): δ = 9.93 (s, 1H), 8.46 (br, 1H), 7.65 (d, J = 8 Hz, 1H), 7.64 (s, 1H), 
7.44 (s, 1H), 7.33 (d, J = 8 Hz, 1H), 7.11-7.09 (m, 2H), 7.05 (t, J = 7.5, 1H), 6.89-6.80 (m, 
3H), ; 13C NMR (CDCl3, 125 MHz): δ = 194.8, 147.06, 136.3, 135.9, 133.1, 131.0, 130.7, 
127.4, 127.2, 126.6, 125.4, 125.1, 122.5, 120.9, 120.3, 111.5, 107.2; HRMS (ESI) calcd. 
for C17H12BrNO: m/z 348.0000 ([M+Na]+ ), found 379.9996. 
 
 
(E)-2-(1H-indol-3-yl)-3-phenylacrylaldehyde (3g). The title compound was prepared 
according the typical procedure, as described above in 87% yield. 1H NMR (CDCl3, 500 
MHz): δ = 10.15 (s, 1H), 9.86 (br, 1H), 7.53 (s, 1H), 7.40-7.35 (m, 4H), 7.25 (m, 1H), 
7.19-7.13 (m, 3H), 6.94-6.90 (m, 2H); 13C NMR (CDCl3, 125 MHz): δ = 195.1, 149.8, 
136.4, 135.2, 134.6, 130.7X2, 130.1, 128.6X2, 125.9, 125.4, 122.5, 121.0, 120.2, 111.6, 
107.8; HRMS (ESI) calcd. for C17H13NO: m/z 270.0895 ([M+Na]+ ), found 270.0892. 
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(E)-2-(1H-indol-3-yl)-3-(4-methoxyphenyl)acrylaldehyde (3h). The title compound 
was prepared according the typical procedure, as described above in 75% yield. 1H NMR 
(CDCl3, 500 MHz): δ = 9.80 (s, 1H), 8.52 (br, 1H), 7.44 (s, 1H), 7.38 (d, J = 8.0 Hz, 1H), 
7.32 (s, 1H), 7.31 (d, J = 8.5 Hz, 2H), 7.16 (t, J = 7.5 Hz, 1H), 7.00 (d, J = 8.0 Hz, 1H), 
6.95 (t, J = 7.5 Hz, 1H), 6.69 (d, J = 8.5 Hz, 2H), 3.77 (s, 3H); 13C NMR (CDCl3, 125 
MHz): δ = 195.1, 161.3, 150.2, 136.4, 132.8X2, 132.5, 127.9, 125.6X2, 122.4, 121.0, 
121.2, 114.1X2, 111.6, 108.1, 55.5; HRMS (ESI) calcd. for C18H15NO2: m/z 300.1000 
([M+Na]+ ), found 300.0995. 
 
N
O
H  
(E)-2-(1H-indol-3-yl)-3-p-tolylacrylaldehyde (3i). The title compound was prepared 
according the typical procedure, as described above in 90% yield. 1H NMR (CDCl3, 500 
MHz): δ = 9.83 (s, 1H), 8.49 (br, 1H), 7.46 (s, 1H), 7.38 (d, J = 8 Hz, 1H), 7.34 (d, J = 
2.5 Hz, 1H), 7.25 (d, J = 8 Hz, 2H), 7.15 (t, J = 7.5 Hz, 1H), 6.99-6.92 (m, 4H), 2.28 (s, 
3H); 13C NMR (CDCl3, 125 MHz): δ = 195.1, 150.3, 140.7, 136.4, 133.7, 132.4, 130.9X2, 
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129.4X2, 125.7, 125.5, 122.4, 121.1, 120.2, 111.6, 108.0, 21.8; HRMS (ESI) calcd. for 
C18H15NO: m/z 284.1051 ([M+Na]+ ), found 284.1047. 
 
 
(E)-2-(1H-indol-3-yl)-3-(2-methoxyphenyl)acrylaldehyde (3j). The title compound was 
prepared according the typical procedure, as described above in 89% yield. 1H NMR 
(CDCl3, 500 MHz): δ = 9.88 (s, 1H), 8.47 (br, 1H), 7.87 (s, 1H), 7.38 (d, J = 2.5 Hz, 1H), 
7.34 (d, J = 8 Hz, 1H), 7.21 (t, J = 7.8 Hz, 1H), 7.13-7.10 (m, 2H), 6.97-6.88 (m, 3H), 
6.52 (t, J = 7.8 Hz, 1H), 3.94 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 195.4, 158.1, 
144.5, 136.4, 134.2, 131.5, 130.3, 125.9, 125.3, 124.4, 122.3, 121.1, 120.4, 120.0, 111.5, 
110.8, 108.1, 55.9; HRMS (ESI) calcd. for C18H15NO2: m/z 300.1000 ([M+Na]+ ), found 
300.0999. 
 
 
(E)-2-(1H-indol-3-yl)-3-o-tolylacrylaldehyde (3k). The title compound was prepared 
according the typical procedure, as described above in 97% yield. 1H NMR (CDCl3, 500 
MHz): δ = 9.90 (s, 1H), 8.40 (br, 1H), 7.61 (s, 1H), 7.40 (d, J = 2.5 Hz, 1H), 7.33 (d, J = 
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8.5 Hz, 1H), 7.23 (d, J = 7.5 Hz, 1H), 7.14-7.08 (m, 3H), 6.85 (t, J = 7.5 Hz, 1H), 6.80-
6.77 (m, 2H), 2.50 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 195.0, 147.4, 137.6, 136.3, 
135.3, 134.7, 130.6, 129.6, 129.4, 126.3, 125.9, 125.3, 122.3, 121.0, 120.1, 111.4, 107.9, 
20.5; HRMS (ESI) calcd. for C18H15NO: m/z 284.1051 ([M+Na]+ ), found 284.1046. 
 
 
(E)-4-(2-(1H-indol-3-yl)-3-oxoprop-1-enyl)-2-methoxyphenyl acetate (3l). The title 
compound was prepared according the typical procedure, as described above in 94% 
yield. 1H NMR (CDCl3, 500 MHz): δ = 9.85 (s, 1H), 8.57 (br, 1H), 7.44 (s, 1H), 7.36 (d, 
J = 8, 1H), 7.30 (s, 1H), 7.14 (t, J = 7.5 Hz, 1H), 7.06 (d, J = 8Hz, 1H), 7.00-6.95 (m, 3H), 
6.85 (s, 1H), 3.02 (s, 3H), 2.26 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 195.0, 169.0, 
150.8, 148.9, 141.2, 136.3, 134.4, 133.8, 125.8, 125.3, 124.8, 122.8, 122.7, 121.1, 120.4, 
114.1, 111.6, 107.6, 55.2, 20.9; HRMS (ESI) calcd. for C20H17NO4: m/z 358.1055 
([M+Na]+ ), found 358.1053. 
 
N
O
H
O
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(E)-3-(furan-2-yl)-2-(1H-indol-3-yl)acrylaldehyde (3m). The title compound was 
prepared according the typical procedure, as described above in 90% yield. 1H NMR 
(CDCl3, 500 MHz): δ = 9.78 (s, 1H), 8.49 (br, 1H), 7.47 (s, 1H), 7.43 (d, J = 8 Hz, 1H), 
7.40 (s, 1H), 7.36 (d, J = 2.5 Hz, 1H), 7.20 (t, J = 7.5 Hz, 1H), 7.15 (d, J = 8 Hz, 1H), 
7.04 (t, J = 7.5 Hz, 1H), 6.32-6.31 (m, 1H), 6.20 (d, J = 3.5 Hz, 1H); 13C NMR (CDCl3, 
125 MHz): δ = 193.8, 151.4, 145.4, 136.3, 136.0, 131.3, 125.6, 125.5, 122.5, 121.0, 120.2, 
116.8, 113.1, 111.7, 107.9; HRMS (ESI) calcd. for C15H11NO2: m/z 260.0687 ([M+Na]+ ), 
found 260.0684. 
 
N
O
H  
(E)-2-(1H-indol-3-yl)-3-(naphthalen-2-yl)acrylaldehyde (3n). The title compound was 
prepared according the typical procedure, as described above in 78% yield. 1H NMR 
(CDCl3, 500 MHz): δ = 9.91 (s, 1H), 8.49 (br, 1H), 7.94 (s, 1H), 7.71-7.69 (m, 2H), 7.65 
(s, 1H), 7.51-7.40 (m, 5H), 7.35 (d, J = 9 Hz, 1H), 7.14 (t, J = 7.5 Hz, 1H), 6.97 (d, J = 8 
Hz, 1H), 6.87 (t, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ = 195.0, 149.7, 136.4, 
134.6, 134.0, 133.3, 133.0, 132.0, 128.9, 128.0, 127.9, 127.6, 126.8, 126.7, 126.0, 125.7, 
122.6, 121.1, 120.3, 111.6, 108.1. HRMS (ESI) calcd. for C21H15NO: m/z 320.1051 
([M+Na]+ ), found 320.1050. 
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(E)-2-(1H-indol-3-yl)-3-(naphthalen-1-yl)acrylaldehyde (3o). The title compound was 
prepared according the typical procedure, as described above in 96% yield. 1H NMR 
(CDCl3, 500 MHz): δ = 10.04 (s, 1H), 8.38 (br, 1H), 8.27 (d, J = 8.0 Hz, 1H), 8.11 (s, 
1H), 7.89 (d, J = 8.0, 1H), 7.74 (d, J = 8.0, 1H), 7.64 (t, J = 7.5, 1H), 7.57 (t, J = 7.5, 1H), 
7.47 (d, J = 2.5, 1H), 7.35-7.30 (m, 2H), 7.15-7.04 (m, 2H), 6.72-6.65 (m, 2H); 13C NMR 
(CDCl3, 125 MHz): δ = 194.9, 145.9, 136.3, 136.1, 133.8, 132.3, 131.9, 130.1, 129.2, 
128.0, 127.2, 126.7, 126.4, 125.4, 123.9, 122.6, 122.3, 121.1, 120.1, 111.4, 108.0; HRMS 
(ESI) calcd. for C21H15NO: m/z 320.1051 ([M+Na]+ ), found 320.1046. 
 
 
(E)-2-(2-methyl-1H-indol-3-yl)-3-(4-nitrophenyl)acrylaldehyde (3p). The title 
compound was prepared according the typical procedure, as described above in 100% 
yield. 1H NMR (CDCl3, 500 MHz): δ = 9.90 (s, 1H), 8.33 (br, 1H), 8.02 (d, J = 8.5 Hz, 
2H), 7.60 (s, 1H), 7.45 (d, J = 8.5 Hz, 2H), 7.30 (d, J = 8.0 Hz, 1H), 7.13 (t, J = 7.0 Hz, 
1H), 6.99 (m, 2H), 2.11 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 194.4, 147.9, 145.9, 
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141.6, 138.2, 136.1, 134.5, 130.9X2, 126.9, 123.9X2, 122.2, 120.6, 119.4, 111.1, 104.9, 
13.2; HRMS (ESI) calcd. for C21H15NO: m/z 329.0902 ([M+Na]+ ), found 329.0900. 
 
 
(E)-3-(4-nitrophenyl)-2-(2-phenyl-1H-indol-3-yl)acrylaldehyde (3q). The title 
compound was prepared according the typical procedure, as described above in 100% 
yield. 1H NMR (CDCl3, 500 MHz): δ = 9.76 (s, 1H), 8.68 (br, 1H), 7.94 (d, J = 8.5, 2H), 
7.66 (s, 1H), 7.42-7.34 (m, 5H), 7.27-7.25 (m, 3H), 7.20 (t, J = 7.5 Hz, 1H), 7.06-7.02 (m, 
2H); 13C NMR (CDCl3, 125 MHz): δ = 194.0, 147.9, 145.0, 141.4, 138.1, 137.1, 136.7, 
132.3, 130.8X2, 129.3X2, 128.6, 127.3X2, 127.3, 123.8X2, 123.5, 121.1, 120.0, 111.8, 
105.4; HRMS (ESI) calcd. for C21H15NO: m/z 391.1059 ([M+Na]+ ), found 391.1052. 
 
 
(E)-2-(5-nitro-1H-indol-3-yl)-3-(4-nitrophenyl)acrylaldehyde (3r). The title 
compound was prepared according the typical procedure, as described above in 65% 
yield. 1H NMR (CDCl3, 500 MHz): δ = 9.93 (s, 1H), 9.09 (br, 1H), 8.08-8.04 (m, 3H), 
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7.80 (d, J = 1.5 Hz, 1H), 7.61 (s, 1H), 7.59 (d, J = 2.5 Hz, 1H), 7.48 (d, J = 9.0 Hz, 2H), 
7.45 (d, J = 9 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ = 193.6, 148.2, 146.7, 142.5, 
141.0, 139.3, 136.2, 130.9X2, 129.6, 124.6, 124.0X2, 118.6, 117.5, 112.1, 109.2; HRMS 
(ESI) calcd. for C17H11N3O5: m/z 360.0596 ([M+Na]+ ), found 360.0592. 
 
 
(E)-2-(5-bromo-1H-indol-3-yl)-3-(4-nitrophenyl)acrylaldehyde (3s). The title 
compound was prepared according the typical procedure, as described above in 100% 
yield. 1H NMR (Acetone-d6, 500 MHz): δ = 10.90 (br, 1H), 9.93 (s, 1H), 8.09 (d, J = 8.0 
Hz, 2H), 7.75 (s, 1H), 7.64 (s, 1H), 7.63 (d, J = 8.0 Hz, 2H), 7.45 (d, J = 8.5 Hz, 1H), 
7.19 (d, J = 8.5 Hz, 1H), 6.90 (s, 1H); 13C NMR (Acetone-d6, 125 MHz): δ = 194.5, 
148.4, 145.4, 143.0, 137.8, 136.2, 131.7X2, 129.7, 127.6, 125.3, 124.2X2, 123.4, 114.5, 
113.2, 106.7; HRMS (ESI) calcd. for C17H11BrN2O3: m/z 392.9851 ([M+Na]+ ), found 
392.9847. 
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(E)-2-(2-bromo-5-methoxy-1H-indol-3-yl)-3-(4-nitrophenyl)acrylaldehyde (3t). The 
title compound was prepared according the typical procedure, as described above in 87% 
yield. 1H NMR (CDCl3, 500 MHz): δ = 9.89 (s, 1H), 8.65 (br, 1H), 8.05 (d, J = 8.5 Hz, 
2H), 7.70 (s, 1H), 7.45 ((d, J = 8.5 Hz, 2H), 7.21 (d, J = 9.0 Hz, 1H), 6.83 (dd, J = 9.0, 
2.0 Hz, 1H), 6.47 (d, J = 2.0 Hz, 1H), 3.66 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 
193.1, 155.2, 148.2, 146.9, 141.1, 136.4, 131.8, 131.0X2, 127.3, 124.0X2, 113.6, 112.2, 
110.2, 108.5, 101.2, 55.9; HRMS (M = C18H13BrN2O4, for Br-79 isotope): [M+Na]+ = 
422.9956 (cal. = 422.9956). 
 
Typical Procedure for the photoelectronic cyclization 
A solution of (E)-3-(furan-2-yl)-2-(1H-indol-3-yl)acrylaldehyde (0.2 mmol) 
dissolved in acetone (7 mL) in the presence of a catalytic amount of I2 was irradiated for 
11 h in a reactor with an HPK-125W Philips high-pressure mercury vapor UV lamp in a 
water-jacketed immersion well. The solvent was evaporated and the residue was purified 
by chromatography on silica gel. 
 
 
10H-furo[3,2-a]carbazole-5-carbaldehyde (5). The title compound was prepared 
according the typical procedure, as described above in 55% yield. 1H NMR (Acetone-d6, 
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500 MHz): δ = 11.29 (br, 1H), 10.50 (s, 1H), 9.13 (d, J = 8.5 Hz, 1H), 8.17 (s, 1H), 8.09 
(s, 1H), 7.62 (d, J = 8.0 Hz, 1H), 7.45 (t, J = 7.5 Hz, 1H), 7.38 (s, 1H), 7.26 (t, J = 7.5 Hz, 
1H), ; 13C NMR (Acetone-d6, 125 MHz): δ = 193.1, 154.2, 149.2, 141.1, 134.6, 130.0, 
126.4, 126.1, 123.8, 120.3, 118.6, 116.1, 112.6, 111.8, 105.6; HRMS (ESI) calcd. for 
C15H9NO2: m/z 258.0531 ([M+Na]+ ), found 258.0528. 
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Chapter 5 
Organocatalytic Regio- and Chemo-selective “One-pot” Access to 
Polysubstituted Arenes from Simple Enals via a Michael-Aldol 
Condensation-Aromatization Cascade 
 
5.1. Introduction 
The ‘privileged’ status of ubiquitous arenes is underscored by their broad 
applications in organic synthesis, pharmaceuticals, perfumes and cosmetics, 
agrochemicals and materials.1-4 Accordingly, synthesis of functionalized arenes has long-
standing interest to chemists. Classic synthetic methods include electrophilic aromatic 
substitution, such as the Friedel-Crafts reaction, and directed ortho metalation in 
construction of substituted arenes.5-8 Since they introduce specific substitute groups to 
pre-existed arenes, the scopes of the reactions is restricted by electronic nature of 
substrates. Moreover, the rigorous reaction conditions and poor regioselectivity render 
the methodologies less demanded by organic chemists. Recently transition metal 
catalyzed direct C-H functionalization of arenes has open new doors for synthesis of 
functionalized arenes.9-11 However, generally directing groups and relatively harsh 
reaction conditions are needed in order to achieve respective high regioselectivity and 
reactivity.12-14 
Direct construction of aromatic rings from linear precursors is an important 
alternative. Transition-metal-catalyzed cycloaddition and ring-closing-metathesis are the 
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two well developed strategies in the past two decades.15-21 Although these methodologies 
provide straightforward assembling routes, the use of less appealing transition metal 
complexes as catalysts, the poor selective orientation of substituents on aromatic rings 
and arduously accessible starting materials are the major drawbacks. 
In addition to organometallic catalysis, the development of organocatalyzed 
processes in construction of polysubstituted arenes may be an attractive alternative, but 
remains elusive. To our knowledge, no such study has been reported. Only a study of L-
proline catalyzed [3+3] and [4+2] cycloadditions to give 6- membered ring products from 
enals has been reported by Hong and co-workers.22,23 However, the products are not 
arenes; an additional DDQ oxidation is required to generate them. Furthermore, poor 
regioselectivity resulting from competing [3+3] and [4+2] cycloaddition reactions and 
high catalyst loading (as high as 50%) render the methodology lack of practical 
generality. 
 
5.2. Initial Discoveries 
Recently we have developed an organocatalytic stereoselective cross-coupling-
like α-arylation reaction of aromatic α, β-unsaturated aldehydes with 4-bromophenols  
(Scheme 5.1, equation 1).39 However, when an aliphatic crotonaldehyde was subjected to 
the reaction, an unexpected 4-methyl benzaldehyde was obtained (equation 2). This 
serendipitous discovery prompted us to investigate this interesting “side reaction”. 
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Scheme 5.1. An unexpected formation of 4-methyl benzaldehyde from the study of cross-
coupling-like α-arylation process 
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5.3. Optimization of Reaction Conditions 
Initial studies were carried out by examining a simple self-dimerization (homo-
coupling) of hexenal as sole reactant at r.t. in chloroform in the presence of a secondary 
amine (Table 5.1). Instead of p-bromophenol, unsubstituted phenol was used as mediator 
to zero out the influence of electronic effect. McMillan’s catalysts I and II did not 
produce any product, and starting materials were left intact (entries 1 and 2). With L-
proline (III), a catalyst used in Hong’s study, the reactant was completely consumed after 
3 days, but the desired aromatic product 3a was obtained in only 6% yield and several 
byproducts were observed (entry 3). Diphenyl prolinol V also displayed low catalytic 
activity. Only reactant was recovered for 5 d reaction (entry 4). An encouraging result 
came from diphenyl prolinol TMS ether IV, which gave rise to 2a in 35% (entry 5). 
 127 
Other amines, such as pyrrolidine VI or piperidine VII could also drive the reaction to 
completion, but in much lower yield due to a complicated reaction (entries 6 and 7). 
 
Table 5.1. Optimization of reaction conditionsa 
 
entry cat. promoter (x equiv.) time (d) yield (%)b 
1 I PhOH (1.0) 5 0 
2 II PhOH (1.0) 5 0 
3 III PhOH (1.0) 3 6 
4 IV PhOH (1.0) 3 35 
5 V PhOH (1.0) 5 0 
6 VI PhOH (1.0) 3 10 
7 VII PhOH (1.0) 5 <5 
8 IV TEA (1.0) 3 0 
9 IV PhCOOH (1.0) 5 11 
10 IV PhCOOH (0.5) 5 20 
11 IV PhCOOH (0.2) 5 7 
12 IV 4-MeO-PhOH (1.0) 3 54 
13 IV 4-Me-PhOH (1.0) 3 56 
 128 
14 IV 4-Br-PhOH (1.0) 2 70 
15 IV 4-I-PhOH (1.0) 2 77 
16 IV 4-NO2-PhOH (1.0) 2 99 
17 IV 4-NO2-PhOH (0.5) 2 47 
18 IV 4-NO2-PhOH (0.2) 2 52 
aReaction conditions: enal 1a (0.4 mmol) dissolved in chloroform (2.0 mL) was followed 
by addition of a specified amount of promoter and catalyst (0.02 mmol). The reaction 
mixture was stirred at r.t. for specified time in a loosely capped vial. bIsolated yields. 
 
Catalyst IV was selected for further studies accordingly. We examined the effect 
of promoters on the reaction. Acidic reaction environment was crucial for the process, 
since basic additive, such as triethylamine (TEA), produce no transformation (entry 8). 
Interestingly, benzoic acid, which possesses stronger acidity than phenol, could also serve 
as a promoter, but the efficiency was relatively low (entries 9-11). Survey of substituted 
phenols revealed that a correlation between the acidity derived from electronic property 
of substituents and the reaction efficiency (e.g., product yield) was observed (entries 4 
and 12-16). The acidity of phenol was proportional to the yield. Notably, p-nitrophenol 
gave an almost quantitative yield (entry 16). Further reduction of the amount of p-
nitrophenol resulted in decreased yields (entries 17 and 18). Chloroform was identified as 
the choice of reaction medium after screening various solvents. It is worthy of note that 
no additional oxidant was necessary in our case while required in Hong’s protocol. 
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5.4. Expansion of Substrate Scope 
With the optimized reaction conditions in hand, we turned our attention to the 
scope of the efficient “one-pot” synthesis of arenes with catalyst IV. As shown in Table 
5.2, the self-dimerized homo-coupling processes with single aliphatic enals proceeded 
efficiently and regioselectively to give 3,4-substitued benzylaldehydes 2 under the mild 
reaction conditions. The majority of products were obtained in almost quantitative yields 
(entries 1 and 3-7). It is noteworthy that crotonaldehyde bearing a benzyloxy 
functionality in terminal can provide a 3-BnO substituted product in high yield (92%, 
entry 7). 
 
Table 5.2. Substrate scope of self-dimerizationa 
 
entry R 2 time (d) yield (%)b
1 C2H5 2a 3 99 
2 H 2b 2 76 
3 CH3 2c 2 94 
4 n-C3H7 2d 3 99 
5 n-C4H9 2e 3 99 
6 n-C8H17 2f 3 99 
7 OBn 2g 3 92 
aReaction conditions: unless specified, see footnote a in Table 5.1. bIsolated yields. 
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It has been demonstrated that single aliphatic enals can efficiently participate in 
the arene formation highly regioselectively. However, the employment of two different 
enals for the process presents a significant challenge because in addition to 
regioselectivity, chemoselectivity could be an issue and multiple products could be 
formed. We envisioned that an aliphatic enal as a donor while an aromatic coupling 
partner as an acceptor might minimize the problem. 
 
Table 5.3. Substrate scope of cross-over dimerizationa 
 
entry R1 R2 2 time (d) yield (%)b 
1 H 4-NO2-Ph 2h 3 87 
2 CH3 4-NO2-Ph 2i 3 93 
3 C2H5 4-NO2-Ph 2j 3 99 
4 C3H7 4-NO2-Ph 2k 3 99 
5 C4H9 4-NO2-Ph 2l 4 99 
6 C2H5 2-NO2-Ph 2m 3 99 
7 C2H5 4-CN-Ph 2n 3 99 
8 C2H5 2-naphthalenyl 2o 4 91 
9 C2H5 2-furyl 2p 4 87 
10 C2H5 4-CF3-Ph 2q 3 92 
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11 C2H5 4-Cl-Ph 2r 3 99 
12 C2H5 2-Cl-Ph 2s 3 96 
13 C2H5 4-MeO-Ph 2t 4 84 
14 C2H5 2-MeO-Ph 2u 4 80 
15 C2H5 COOEt 2v 4 95 
aReaction conditions: unless specified, to a solution of a donor enal 1 (0.2 mmol) and an 
acceptor enal 3 (0.2 mmol) in chloroform (2.0 mL) was added p-nitrophenol (0.2 mmol) 
and catalyst V (0.02 mmol, 20% mol). The reaction mixture was stirred at r.t. room for a 
specified time, and the vial was loosely capped. bIsolated yields. 
 
With the concern in mind, we probed a reaction between less hindered 
crotonaldehyde as a donor and highly active p-nitrocinnamaldehyde as an acceptor under 
the same reaction conditions used in the homo-couplings (Table 5.3, entry 1). To our 
delight, the process proceeded smoothly. Only a single product was formed chemo- and 
regioselectively in high yield (87%). Encouraged by the outcome, we attempted to extend 
to more hindered aliphatic substrates with longer chains (entries 2-5). It appeared that the 
steric effect was limited. Remarkably, even higher yields of products were achieved (93-
99% yields). Furthermore, significantly the substrate scope extended to steric demanding 
(entries 6, 10, 12 and 13) and less reactive acceptors of aromatic enals (entries 7-12). 
Besides the aromatic ring carrying electron-withdrawing substitutes (entries 7-10), even 
electron-donating ones (entries 11 and 12) worked nicely. We were particularly pleased 
to find that fused aromatic (entry 13), heteroaryl (entry 14) and ester (entry 15) enals 
could be tolerated to give valuable substituent diversified arenes. 
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5.5. Investigation of Mechanism  
While a mechanism for this transformation is unknown, we propose an amine 
catalyzed Michael-aldol condensation-aromatization cascade sequence (Scheme 5.2). 
Catalyst IV promoted formation of a dienamine species from a corresponding enal serves 
as a Michael donor for a conjugate addition reaction with an iminium ion derived from an 
enal as an acceptor.40-44 The resulting Michael adduct 6 in the presence of p-nitrophenol 
initiates an intramolecular aldol condensation reaction to give intermediate 10 (steps 3-6). 
Finally, aromatization of the compound is achieved in the presence of the catalyst to 
furnish the target 2. In these transformations several features are deserved to be pointed 
out. Similar to the reaction pathway proposed by Hong and coworkers in their [3+3]/[4+2] 
processes,40-44 the amine activates both substrates for the initial Michael reaction, while 
an aldol condensation reaction, promoted by acidic p-nitrophenol, is proposed for the first 
time in the cascade sequence. Finally, the subsequent aromatization of the aldol 
condensation products 10 to final targets 2 occurs efficiently without requiring an 
additional oxidant. It seems that the catalyst IV plays critical and unique roles in these 
conversions involving multiple reversible iminium ion and enamine transformations. 
In order to verify the proposed reaction mechanism, we conducted a preliminary 
mechanistic investigation. In the proposed reaction pathway, two key intermediates 6 and 
8 are involved (Scheme 5.2). Therefore two derivatives 13 and 14 were synthesized 
(Scheme 5.3). When compound 13 was submitted to the same reaction conditions in the 
presence of IV and p-nitrophenol, the expected aromatic product benzaldehyde was 
obtained in quantitative yield (eq. 1). However, a control experiment in the absence of p-
nitrophenol could not produce the aromatic product, and reactant 13 was recovered (eq. 
 133 
2). We concluded that p-nitrophenol participated in the aldol condensation reaction as a 
co-catalyst. However, compound 14 in the presence of catalyst IV with or without p-
nitrophenol gave the anticipated product in full conversion (eq. 3). Moreover, without IV, 
almost no reaction occurred. These studies implied that catalyst IV was essential for the 
aromatization through iminium ion and enamine transformations. When the 
transformation was carried out in argon instead of in air, less than 15% conversion was 
observed (eq. 4). As a result, oxygen in the air was believed as the oxidant for the 
aromatization process. 
 
Scheme 5.2. A proposed reaction mechanism 
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Scheme 5.3. Transformation of two key intermediate analogues 13 and 14 to aromatic 
compounds in the proposed reaction mechanism involving aldol condensation and 
aromatization processes 
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5.6. Summary 
In conclusion, we have successfully transformed a “side reaction” discovered in 
our early study of the cross-coupling-like α-arylation process into a new valuable method 
for the facile construction of polysubstituted arenes from easily accessible enals. Notably, 
the cascade process can proceed via two different fashions of self-dimerization of the 
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same aliphatic enals and hetero-dimerization with two distinct enals regio- and 
chemoselectively. Polysubstituted arenes bearing a broad spectrum of functionalities are 
generated in “one-pot” with high yields under mild reaction conditions. Furthermore, an 
unprecedented highly efficient organocatalyzed Michael-aldol condensation-
aromatization process was proposed and verified by preliminary mechanistic studies. The 
further exploration of the interesting chemistry for new organic transformation and 
understanding of the reaction mechanism are currently being pursued in our laboratory. 
 
5.7. Experimental Section 
General Information: 
All commercially available reagents were used without further purification. The 
progress of the reactions was monitored by analytical thin-layer chromatography (TLC) 
on Whatman silica gel plates with fluorescence F254 indicator. And Merck 60 silica gel 
was used for chromatography. 1H (300 MHz) and 13C (75 MHz) NMR spectra were 
recorded on a Bruker Avance 300. 1H (500 MHz) and 13C (125 MHz) NMR spectra were 
recorded on a Bruker Avance 500. When deuteriorated chloroform (CDCl3) was used to 
dissolve sample, tetramethylsilane (TMS) was used as an internal reference. Data for 1H 
are reported as follows: chemical shift (ppm), and multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet).  Data for 13C NMR are reported as ppm.   
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Procedure for synthesis of arenes 2 
0.1 mmol of enal donor, 0.1 mmol of enal acceptor are dissolved in 2mL of 
chloroform, following with the addition of 0.2 mmol of p-nitrophenol and 0.04 mmol 
catalyst (20 % mol relative to the sum of enals). If donor enal and acceptor enal are the 
same, total amount of 0.2 mmol of the enal is used, and catalyst is 20 % mol relative to 
the same enal. The reaction mixture is stirred as room temperature, and the seal cap for 
the vial is loosely attached. After the enal was totally consumed (determined by TLC 
analysis), solvent was evaporated and the residue was purified by column 
chromatography, eluting with a mixture of ethyl acetate and hexane. 
 
 
3-Ethyl-4-propylbenzaldehyde (2a, Table 5.2, entry 1). 1H NMR (CDCl3, 300 MHz): δ 
= 9.95 (s, 1H), 7.69 (s, 1H), 7.63 (d, J = 7.5 Hz, 1H), 7.29 (d, J = 7.5 Hz, 1H), 2.70 (m, 
4H), 1.64 (m, 2H), 1.26 (t, J = 12.5 Hz, 3H), 1.00 (t, J = 12.5 Hz, 3H); 13C NMR (CDCl3, 
125 MHz): δ = 192.6, 148.1, 143.0, 134.9, 130.0, 129.7, 127.7, 35.2, 25.6, 24.1, 15.2, 
14.4. 
 
O
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4-Methylbenzaldehyde (2b, Table 5.2, entry 2). 1H NMR (CDCl3, 300 MHz): δ = 9.96 
(s, 1H), 7.78 (d, J = 8 Hz, 2H), 7.33 (d, J = 8 Hz, 2H), 2.44 (s, 3H); 13C NMR (CDCl3, 
125 MHz): δ = 192.3, 145.8, 134.5, 130.1, 130.0, 22.2. 
 
 
4-Ethyl-3-methylbenzaldehyde (2c, Table 5.2, entry 3). 1H NMR (CDCl3, 300 MHz): δ 
= 9.94 (s, 1H), 7.65 (m, 2H), 7.32 (d, J = 8Hz, 2H), 2.70 (q, J = 7.5 Hz, 2H), 2.38 (s, 3H), 
1.24 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 192.6, 150.2, 137.1, 134.7, 
131.4, 128.8, 128.2, 26.8, 19.4, 14.2. 
 
 
4-Butyl-3-propylbenzaldehyde (2d, Table 5.2, entry 4). 1H NMR (CDCl3, 300 MHz): δ 
= 9.94 (s, 1H), 7.66 (s, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.30 (d, J = 7.8 Hz, 1H), 2.67 (m, 
4H), 1.64 (m, 4H), 1.43 (m, 2H), 0.96 (m, 6H); 13C NMR (CDCl3, 125 MHz): δ =192.7, 
148.6, 141.5, 134.7, 130.7, 130.1, 127.7, 34.8, 33.3, 33.0, 24.3, 23.1, 14.4, 14.2. 
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3-Butyl-4-pentylbenzaldehyde (2e, Table 5.2, entry 5). 1H NMR (CDCl3, 300 MHz): δ 
= 9.94 (s, 1H), 7.66 (s, 1H), 7.62 (d, J = 7.5 Hz, 1H), 7.29 (d, J = 7.5 Hz, 1H), 2.67 (m, 
4H), 1.60 (m, 4H), 1.37 (m, 6H), 0.95 (m, 6H); 13C NMR (CDCl3, 125 MHz): δ = 192.6, 
148.6, 141.8, 134.7, 130.6, 130.0, 127.7, 33.4, 33.2, 32.4, 32.1, 30.9, 23.0, 22.8, 14.2. 
 
 
4-Nonyl-3-octylbenzaldehyde (2f, Table 5.2, entry 6). 1H NMR (CDCl3, 300 MHz): δ = 
9.94 (s, 1H), 7.66 (s, 1H), 7.62 (d, J = 7.5 Hz, 1H), 7.29 (d, J = 7.5 Hz, 1H), 2.66 (m, 4H), 
1.59 (m, 4H), 1.28 (m, 22H), 0.88 (m, 6H); 13C NMR (CDCl3, 125 MHz): δ = 192.6, 
148.6, 141.8, 134.7, 130.6, 130.0, 127.7, 33.3, 32.8, 32.2, 31.3, 31.2, 30.0, 29.8, 29.6, 
29.5, 22.9, 14.4. 
 
 
3-(Benzyloxy)-4-(benzyloxymethyl)benzaldehyde (2g, Table 5.2, entry 7). 1H NMR 
(CDCl3, 300 MHz): δ = 9.95 (s, 1H), 7.70 (d, J = 7.8 Hz, 1H), 7.49 (d, J = 7.8 Hz, 1H), 
 139 
7.39 (m, 11H), 5.14 (s, 2H), 4.72 (s, 2H), 4.65 (s, 2H); 13C NMR (CDCl3, 125 MHz): δ = 
192.3, 156.6, 138.4, 137.0, 136.6, 135.2, 128.9, 128.7, 128.4, 128.0, 127.6, 125.1, 109.7, 
73.3, 70.4, 67.2. 
 
 
4'-Nitrobiphenyl-4-carbaldehyde (2h, Table 5.3, entry 1). 1H NMR (CDCl3, 300 MHz): 
δ = 10.10 (s, 1H), 8.35 (d, J = 8.0 Hz, 2H), 8.02 (d, J = 8.0 Hz, 2H), 7.79 (d, J = 8.0 Hz, 
4H); 13C NMR (CDCl3, 125 MHz): δ =191.7, 147.8, 146.0, 144.5, 136.3, 130.5, 128.2, 
128.1, 124.3. 
 
 
2-Methyl-4'-nitrobiphenyl-4-carbaldehyde (2i, Table 5.3, entry 2). 1H NMR (CDCl3, 
300 MHz): δ = 10.06 (s, 1H), 8.32 (m, 2H), 7.84 (s, 1H), 7.81 (d, J = 7.8 Hz, 1H), 7.53 
(m, 2H), 7.41 (d, J = 7.8 Hz, 1H), 2.36 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 192.1, 
147.6, 145.8, 136.6, 136.4, 132.0, 130.4, 130.1, 127.7, 123.9, 20.5. 
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2-Ethyl-4'-nitrobiphenyl-4-carbaldehyde (2j, Table 5.3, entry 3). 1H NMR (CDCl3, 
500 MHz): δ = 10.07 (s, 1H), 8.32 (m, 2H), 7.88 (m, 1H), 7.80 (m, 1H), 7.50 (m, 2H), 
7.36 (d, J = 7.5 Hz, 1H), 2.64 (q, J = 7.5 Hz, 2H), 1.15 (t, J = 7.5 Hz, 3H); 13C NMR 
(CDCl3, 125 MHz): δ = 192.3, 147.7, 145.6, 142.8, 136.8, 130.6, 130.4, 130.1, 127.6, 
123.9, 26.3, 15.6. 
 
 
4'-Nitro-2-propylbiphenyl-4-carbaldehyde (2k, Table 5.3, entry 4). 1H NMR (CDCl3, 
300 MHz): δ = 10.07 (s, 1H), 8.32 (m, 2H), 7.86 (s, 1H), 7.79 (d, J = 7.8 Hz, 1H), 7.50 
(m, 2H), 7.36 (d, J = 7.8 Hz, 1H), 2.60 (q, J = 7.5 Hz, 2H), 1.53 (m, 2H), 0.84 (t, J = 7.5 
Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 192.3, 147.8, 147.6, 145.8, 141.3, 136.6, 
131.0, 130.6, 130.1, 127.5, 123.8, 35.1, 24.4, 14.1. 
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2-Butyl-4'-nitrobiphenyl-4-carbaldehyde (2l, Table 5.3, entry 5). 1H NMR (CDCl3, 
300 MHz): δ = 10.07 (s, 1H), 8.32 (m, 2H), 7.86 (s, 1H), 7.78 (d, J = 7.8 Hz, 1H), 7.50 
(m, 2H), 7.36 (d, J = 7.8 Hz, 1H)2.63 (m, 2H), 1.49 (m, 2H), 1.24 (m, 2H), 0.81 (t, J = 
7.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 192.3, 147.8, 147.6, 145.7, 141.6, 136.6, 
131.0, 130.6, 130.1, 127.5, 123.8, 33.5, 32.8, 22.6, 14.0. 
 
 
2-Ethyl-2'-nitrobiphenyl-4-carbaldehyde (2m, Table 5.3, entry 6). 1H NMR (CDCl3, 
300 MHz): δ = 10.05 (s, 1H), 8.10 (d, J = 8.0 Hz, 2H), 7.86 (s, 1H), 7.72 (m, 2H), 7.59 (t, 
J = 7.8 Hz, 1H), 7.33 (d, J = 7.8 Hz, 1H), 7.26 (d, J = 7.8 Hz, 1H), 2.47 (m, 2H), 1.12 (t, 
J = 7.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 192.4, 148.6, 143.9, 142.8, 136.5, 
135.7, 133.2, 132.0, 129.6, 129.5, 129.3, 127.5, 124.8, 26.3, 14.7. 
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2'-Ethyl-4'-formylbiphenyl-4-carbonitrile (2n, Table 5.3, entry 7). 1H NMR (CDCl3, 
300 MHz): δ = 10.06 (s, 1H), 7.87 (s, 1H), 7.77 (m, 3H), 7.45 (d, J = 7.8 Hz, 2H), 7.34 (d, 
J = 7.8 Hz, 1H), 2.63 (q, J = 7.5 Hz, 2H), 1.15 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 125 
MHz): δ = 192.3, 146.0, 145.7, 142.7, 136.6, 132.4, 130.6, 130.3, 129.9, 127.8, 118.9, 
111.9, 26.2, 15.5. 
 
O
CF3  
2-Ethyl-4'-(trifluoromethyl)biphenyl-4-carbaldehyde (2o, Table 5.3, entry 8). 1H 
NMR (CDCl3, 300 MHz): δ = 10.06 (s, 1H), 7.87 (s, 1H), 7.77 (d, J = 7.8 Hz, 1H), 7.71 
(d, J = 7.8 Hz, 2H), 7.44 (d, J = 7.8 Hz, 1H), 7.35 (d, J = 7.8 Hz, 2H), 2.64 (q, J = 7.5 Hz, 
2H), 1.15 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 192.4, 146.6, 144.6, 
142.9, 136.4, 130.8, 130.2, 129.5, 127.5, 125.6, 125.5, 26.3, 15.5. 
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4'-Chloro-2-ethylbiphenyl-4-carbaldehyde (2p, Table 5.3, entry 9). 1H NMR (CDCl3, 
300 MHz): δ = 10.04 (s, 1H), 7.83 (s, 1H), 7.73 (m, 1H), 7.40 (m, 2H), 7.32 (d, J = 8.0 
Hz, 1H), 7.24 (m, 2H), 2.64 (q, J = 8.5 Hz, 2H), 1.14 (t, J = 8.5 Hz, 3H); 13C NMR 
(CDCl3, 125 MHz): δ = 192.4, 146.9, 143.0, 139.4, 136.2, 134.0, 130.9, 130.2, 128.8, 
127.5, 26.3, 15.5. 
 
 
2'-Chloro-2-ethylbiphenyl-4-carbaldehyde (2q, Table 5.3, entry 10). 1H NMR (CDCl3, 
300 MHz): δ = 10.06 (s, 1H), 7.85 (s, 1H), 7.76 (m, 1H), 7.49 (m, 1H), 7.30 (m, 3H), 7.22 
(m, 1H), 2.50 (m, 2H), 1.12 (t, J = 8.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 192.5, 
145.4, 143.7, 139.5, 136.5, 133.2, 130.9, 129.9, 129.6, 129.5, 127.4, 126.9, 26.3, 14.9. 
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2-Ethyl-4'-methoxybiphenyl-4-carbaldehyde (2r, Table 5.3, entry 11). 1H NMR 
(CDCl3, 300 MHz): δ = 10.0 (s, 1H), 7.83 (s, 1H), 7.72 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 
8.0 Hz, 1H), 7.24 (d, J = 8.5 Hz, 2H), 6.97 (d, J = 8.5 Hz, 2H), 3.87 (s, 3H), 2.69 (q, J 
=7.5 Hz, 2H), 1.15 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 192.6, 159.4, 
148.0, 143.1, 135.7, 133.3, 131.2, 130.2, 130.1, 127.4, 114.0, 55.6, 26.3, 15.6. 
 
 
2-Ethyl-2'-methoxybiphenyl-4-carbaldehyde (2s, Table 5.3, entry 12). 1H NMR 
(CDCl3, 300 MHz): δ = 10.04 (s, 1H), 7.83 (s, 1H), 7.73 (d, J = 7.5 Hz, 1H), 7.33 (m, 2H), 
7.12 (d, J = 7.5 Hz, 1H), 7.00 (m, 2H), 3.74 (s, 3H), 2.53 (m, 2H), 1.10 (t, J = 8.5 Hz, 
3H); 13C NMR (CDCl3, 125 MHz): δ = 192.7, 156.6, 145.2, 144.2, 136.0, 131.3, 130.8, 
129.8, 129.5, 129.3, 127.3, 120.8, 111.0, 55.7, 26.2, 14.9. 
 
 
3-Ethyl-4-(naphthalen-2-yl)benzaldehyde (2t, Table 5.3, entry 13). 1H NMR (CDCl3, 
300 MHz): δ = 10.07 (s, 1H), 7.88 (m, 4H), 7.78 (m, 2H), 7.53 (m, 2H), 7.45 (m, 2H), 
2.71 (q, J = 7.5 Hz, 2H), 1.15 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 125 MHz): δ = 192.6, 
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148.2, 143.2, 138.5, 136.0, 133.4, 132.8, 131.3, 130.2, 128.4, 128.0, 127.9, 1275, 127.2, 
126.8, 126.6, 26.4, 15.6. 
 
 
3-Ethyl-4-(furan-2-yl)benzaldehyde (2u, Table 5.3, entry 14). 1H NMR (CDCl3, 300 
MHz): δ = 10.00 (s, 1H), 7.79 (m, 3H), 7.58 (s, 1H), 6.71 (d, J = 3.0 Hz, 1H), 6.55 (d, J = 
3.0 Hz, 1H), 2.94 (q, J = 7.5 Hz, 2H), 1.30 (t, J = 7.5 Hz, 3H); 13C NMR (CDCl3, 125 
MHz): δ = 192.3, 152.5, 143.3, 141.6, 135.5, 131.0, 128.3, 127.6, 112.1, 110.9, 27.5, 14.8. 
 
 
Ethyl 2-ethyl-4-formylbenzoate (2v, Table 5.3, entry 15). 1H NMR (CDCl3, 300 MHz): 
δ = 10.06 (s, 1H), 7.95 (d, J = 7.8 Hz, 1H), 7.79 (s, 1H), 7.75 (d, J = 7.8 Hz, 1H), 4.40 (q, 
J = 7.5 Hz, 2H), 3.03 (q, J = 7.5 Hz, 2H), 1.42 (t, J = 7.5 Hz, 3H), 1.28 (t, J = 7.5 Hz, 3H); 
13C NMR (CDCl3, 125 MHz): δ = 192.2, 167.4, 146.5, 138.5, 135.7, 131.4, 131.1, 126.9, 
61.7, 27.6, 15.9, 14.5. 
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Chapter 6 
Aminocatalytic Diels-Alder-retro-Diels-Alder Cascade Reaction of 
Alkynals and 2-Pyrones for the One-Pot Construction of 
Polysubstituted Salicylaldehyde Frameworks 
 
6.1. Introduction to Polysubstituted Salicylaldehydes 
Polysubstituted salicylaldehydes are key structural motifs for the construction of 
synthetically important Salen-ligands1, 2 and pharmacologically essential natural 
products,3-5 such as coumarins, flavones, and mycotoxins. The Reimer-Tiemann reaction, 
the direct electrophilic ortho-formylation of a suitable phenol derivative, is a traditional 
synthetic approach towards functionalized salicylaldehydes.6 However, due to the 
electronic nature of phenolic substrates, when the ortho- and para-positions with respects 
to the hydroxyl functionality are not properly blocked, the electrophilic substitution 
process will furnish poor regioselectivity and chemoselectivity, and thus is restricted 
from practical application and less demanded by synthetic chemists.1  
Moreover, the molecular framework of biphenyls is a privileged structure 
ubiquitously found in pharmaceuticals.7 Analysis shows that 4.3% of all known drugs 
consist of the substructure.7, 8 Due to the versatility in binding interactions of the aromatic 
moieties with biomolecules, not only do the compounds containing biphenyl framework 
have various distinct therapeutic properties, such as antiamebic, antifungal, 
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antihyperchloesteremic, analgesic and uricosuric, they are also known to possess 
promising potentials as antitumor, antihypertensive, and antiatherosclerotic agents.7-12  
Recently, Tejedor and coworkers have discovered a microwave-assisted domino 
rearrangement process in preparation of polysubstituted biphenyl salicylaldehydes.13 
Nevertheless, since a series of pre-arranged complicated substrates is used to foster the 
intramolecular cycloaddition process under harsh reaction conditions with only moderate 
yields of desired products, the methodology suffers from the drawback of lack of 
generality. Herein, we would demonstrate an alternative organocatalytic Diels-Alder-
retro-Diels-Alder cascade approach for the direct synthesis of polysubstituted 
salicylaldehydes containing biphenyl framework. 
 
6.2. Diels-Alder-retro-Diels-Alder process 
As for the construction of functionalized six-membered cyclic frameworks, the 
Diels-Alder reaction is one of the most powerful cycloaddition reactions. Although the 
synthetic application of Diels-Alder or retro-Diels-Alder reaction have already been 
respectively documented and reviewed, the strategy of Diels-Alder-retro-Diels-Alder 
tandem process is seldom systematically summarized or extensively elaborated.  
Not only is the cascade methodology widely used in the construction of 
functionalized synthetic building blocks, such as pyridazines,14 diaza-polycycles,15 
bipyridine thiamacrocycles,16 naphtha[2,3-c]furan-4(9H)-ones17 and trifluoromethylated 
olefins,18 it has already been integrated in the total synthetic route towards nature 
products including Cycloproparadicicol,19 Stemoamide,20, 21 Furanosteroids,22 etc. 
 152 
Furthermore, the Diels-Alder-retro-Diels-Alder sequence is also a crucial activation mode 
in asymmetric catalysis, and it has already been employed in the enantioselective 
synthesis of chiral lactams,23, 24 chiral allylic alcohols25 and axially chiral bi-aryl 
compounds.26 
 
6.3. Substrate Design 
Recently, we have developed several novel asymmetric oxo-Michael tandemed 
reactions involving an unprecedented chiral iminium-allenamine cascade using alkynal 
substrates.27, 28 Although alkynals were initially designed as a new class of easy-
functionalizable oxo-philic Michael acceptor, its potency in direct multiple C-C bonds 
formation via cycloaddition protocol is attractive and still left uncharted. By employing 
LUMO-lowering strategy based on iminium activation of alkynals, a suitable diene with 
matched HOMO energy should be discovered via extensive screens.  
After tremendous efforts, the dienes bearing the skeleton of 3-hydroxy-2-pyrone 
is unprecedentedly found to be readily reactive with various alkynals under the activation 
of aminocatalysts. 2-Pyrones are usually known as a kind of electron-deficient diene with 
weak aromatic property, which is relatively inert to participate in Diels-Alder reaction. 
Although the development of cycloaddition reaction with 2-pyrones as dienes is 
challenging, the distinct usefulness and synthetic importance of the bicyclic Diels-Alder 
adduct render the methodology worthy of further exploration.  
Actually, Deng and coworkers have already discovered asymmetric Diels-Alder 
reactions of various functionalized alkenes with 2-pyrones.29, 30 It has been demonstrated 
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that various cinchona alkaloid-based bifunctional organic ctatlysts are highly effective for 
enantioselective and diasteroselective catalysis for the cycloaddition process. 
Additionally, Cho and coworkers have focused on polycarbocycle natural product 
synthesis via tandem Diels-Alder strategies using modified 2-pyrones.31-36 Novel efficient 
synthetic route to galanthamine, aspidosperma alkaloid, pancratistatin, crinine-type 
alkaloids, and tetracyclolactones have been elaborated by using the tandem Diels-Alder 
cascade of various modified 2-pyrones as key strategies. 
 
6.4. Optimization of Reaction Conditions 
To demonstrate the feasibility of the proposed organocatalytic Diels-Alder 
reaction, we set up a model reaction between 3-hydroxy-2-pyrone 2a and alkynal 1a in 
the presence of 20 mol% secondary amines in chloroform at room temperature (Table 
6.1). Although the [4+2] adduct 3a was not observed, an aromatized salicylaldehyde 
derivative was received as final product. The structurally labile bicyclic [4+2] adduct 
could easily undergo retro-Diels-Alder process by losing a molecule of carbon dioxide. 
The releasing of ring string of the bridged bicyclic Diels-Alder adduct as well as the 
aromatization process provided a driving force for the cascade sequence. 
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Table 6.1. Optimization of secondary amine catalyzed Diels-Alder-retro-Diels-Alder 
cascade processa 
 
entry cat. x (mol%) solvent additive time (h) yield (%)b 
1 I 20 CHCl3 - 42 0 
2 II 20 CHCl3 - 42 33 
3 III 20 CHCl3 - 42 39 
4 IV 20 CHCl3 - 42 41 
5 V 20 CHCl3 - 42 16 
6 VI 20 CHCl3 - 42 58 
7 VI 20 CHCl3 NaOAc 72 52 
8 VI 20 CHCl3 PhCOOH 72 <5 
9 VI 20 CHCl3 TEA 8 93 
10 VI 20 CHCl3 TEA 12 99 
11 VI 10 CHCl3 TEA 12 99 
12 VI 5 CHCl3 TEA 12 96 
13 VI 2 CHCl3 TEA 60 51 
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aUnless state otherwise, the reaction was carried out with alkynal (0.2 mmol), 3-hydroxy-
2-pyrone (0.22 mmol), additive (0.22 mmol), and corresponding amount of catalyst in 2 
mL of chloroform for a specified time. bIsolated yield. 
 
McMillan’s 2nd generation catalyst provided no effect of catalysis (Table 6.1, 
entry 1). Both Barbas’ catalyst and L-proline could drive the reaction to completion but 
with moderate yield (entries 2 and 3). While unprotected diphenylprolinol only produce 
16% yield (entry 4), diphenylprolinol TMS ether give 41% yield (entry 5). The simple 
aminocatalyst, pyrrolidine, was found as an optimal catalyst, which provided 58% yield 
(entry 6). Solvent screening had provided the information that chloroform was the 
optimal one (data not shown here). When inorganic basic salt, such as sodium acetate, 
was added to reaction mixture, there was no significant change of yield (entry 7). If 
organic base was used, a large boost of yield was observed (entry 9). With the presence 
of triethyl amine as additive, the catalyst loading could be decreased to as low as 5% 
without significant interference of final yield.  
 
6.5. Expansion of Substrate Scopes 
After the optimal reaction conditions have been established, we further extend the 
substrate scope of the Diels-Alder-retro-Diels-Alder cascade reactions (Table 6.2). As 
demonstrated, a wide range of alkynals are suitable for the transformation. As for the 
aromatic alkynals, electronic donating groups would generate a slightly lower yield than 
alkynals with electronic withdrawing groups on phenyl ring (entries 2-6 v.s. entries 7-13). 
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The lower electronic density on the alkyne moiety would lower the LUMO energy of the 
dienophile and thus render a more efficient Diels-Alder transformation. Furthermore, 
aliphatic alkynals could also produce products in decent yields (entries 15 and 16). 
 
Table 6.2. Substrates scope expansion of the Diels-Alder-retro-Diels-Alder cascade 
reactionsa 
 
entry R1 R2 3 yield (%)b 
1 Ph H 3a 99 
2 4-Me-Ph H 3b 82 
3 3-Me-Ph H 3c 80 
4 4-MeO-Ph H 3d 86 
5 3-MeO-Ph H 3e 84 
6 2-MeO-Ph H 3f 89 
7 4-Br-Ph H 3g 91 
8 4-Cl-Ph H 3h 99 
9 3-Cl-Ph H 3i 98 
10 2-Cl-Ph H 3j 98 
11 4-F-Ph H 3k 95 
12 4-NO2-Ph H 3l 99 
13 4-CN-Ph H 3m 83 
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14 2-thiophenyl H 3n 83 
15 C5H11 H 3o 85 
16 THPO-CH2- H 3p 97 
17 Ph Allyl 3q 94 
18 4-Cl-Ph Allyl 3r 92 
19 4-NO2-Ph Allyl 3s 90 
20 Ph Cl 3t 74 
21 Ph Br 3u 64 
aUnless stated otherwise, the reaction was carried out with alkynal (0.2 mmol), 2-pyrone 
(0.22 mmol), TEA (0.22 mmol), and catalyst VI (0.02 mmol) in 2mL chloroform for 24 
hours. bIsolated yield. 
 
The electronic property of diene could be fine tuned via attaching different 
substituent group on 3-hydroxy-2-pyrone. An electronic donating group, such as allyl 
group, could raise the HOMO energy of the diene. As a result, 4-allyl-3-hydroxy-2-
pyrone could undergo Diels-Alder process smoothly with various alkynals (Table 6.2, 
entries 17, 18 and 19). On the contrary, an electronic withdrawing group, such as halide, 
would decrease the reactivity of the diene via lowering the HOMO energy (entries 20 and 
21).  
In such circumstances, the Diels-Alder process pathway was interfered, and the 
O-Michael addition reaction became a major competitive side reaction (Scheme 6.1). 
Since the simple cyclic secondary amine, pyrrolidine, could not provide large steric 
hindrance than other bulkier secondary amines, poor E/Z ratio was observed in O-
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Michael adducts. Additionally, if both 4- and 6- position of the 3-hydroxy-2-pyrone were 
substituted, the O-Michael addition process would overwhelmingly dominate over the 
Diels-Alder process, and the O-Michael adduct was obtained as the only products 
(equation c). 
 
Scheme 6.1. The competition between Diels-Alder reaction and O-Michael addition 
reaction when electronic deficient dienes used 
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6.6. Summary 
In conclusion, herein we present the first organocatalyzed [4+2] cycloaddition 
reaction of alkynals with modified 2-pyrones via Diels-Alder-retro-Diels-Alder cascade 
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process. By releasing carbon dioxide, the bicyclic Diels-Alder adduct was spontaneously 
collapsed to a class of polysubstituted salicylaldehydes which was difficult to construct 
using traditional synthetic methods. The operationally friendly one port reaction 
conditions and high efficiency for overall transformations render the process extremely 
attractive in the realm of organic synthesis and medicinal chemistry.  
 
6.7. Experimental Section 
General Information: 
All commercially available reagents were used without further purification. The 
progress of the reactions was monitored by analytical thin-layer chromatography (TLC) 
on Whatman silica gel plates with fluorescence F254 indicator. And Merck 60 silica gel 
was used for chromatography. 1H (300 MHz) and 13C (75 MHz) NMR spectra were 
recorded on a Bruker Avance 300. 1H (500 MHz) and 13C (125 MHz) NMR spectra were 
recorded on a Bruker Avance 500. When deuteriorated chloroform (CDCl3) was used to 
dissolve sample, tetramethylsilane (TMS) was used as an internal reference. Data for 1H 
are reported as follows: chemical shift (ppm), and multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet).  Data for 13C NMR are reported as ppm.   
 
Typical procedure for the synthesis of salicylaldehyde derivatives 
Alkynal (0.2 mmol,1 equiv.) and 0.24 mmol of diene (1.2 equiv.) were dissolved 
in 2 mL of chloroform. 0.22 mmol of triethylamine (1.1 equiv.) and 0.02 mmol of 
 160 
pyrrolidine (10 mol%) were added to the reaction mixture at room temperature. After the 
alkynal was totally consumed (determined by TLC analysis), the solvent was evaporated 
and the residue was purified by column chromatography, eluting with a mixture of ethyl 
acetate and hexane. 
 
 
3-Hydroxybiphenyl-2-carbaldehyde (3a). 1H NMR (CDCl3, 500 MHz): δ = 11.90 (s, 
1H), 9.84 (s, 1H), 7.53 (t, J = 8.0 Hz, 1H), 7.45 (m, 3H), 7.38 (m, 2H), 7.00 (d, J = 8.0 
Hz, 1H), 6.89 (d, J = 8.0 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ = 197.4, 163.1, 147.8, 
137.8, 136.9, 130.4, 128.7, 128.6, 121.8, 118.4, 117.3. 
 
OH
CHO
 
3-Hydroxy-4'-methylbiphenyl-2-carbaldehyde (3b). 1H NMR (CDCl3, 500 MHz): δ = 
11.90 (s, 1H), 9.85 (s, 1H), 7.52 (t, J = 8.0 Hz, 1H), 7.27 (s, 4H), 6.97 (d, J = 8.0 Hz, 1H), 
6.88 (d, J = 8.0 Hz, 1H), 2.43 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 197.6, 163.1, 
147.9, 138.6, 136.9, 134.8, 130.3, 129.4, 121.8, 118.4, 117.0, 21.5. 
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OH
CHO
 
3-Hydroxy-3'-methylbiphenyl-2-carbaldehyde (3c). 1H NMR (CDCl3, 500 MHz): δ = 
11.90 (s, 1H), 9.84 (s, 1H), 7.52 (t, J = 8.3 Hz, 1H), 7.35 (t, J = 7.3 Hz, 1H), 7.25 (m, 1H), 
7.17 (m, 2H), 6.98 (d, J = 8.0 Hz, 1H), 6.89 (d, J = 7.5 Hz, 1H), 2.42 (s, 3H); 13C NMR 
(CDCl3, 125 MHz): δ = 197.6, 163.0, 148.0, 138.5, 137.7, 136.9, 131.1, 129.3, 128.6, 
127.5, 121.7, 118.3, 117.1, 21.7. 
 
 
3-Hydroxy-4'-methoxybiphenyl-2-carbaldehyde(3d). 1H NMR (CDCl3, 500 MHz): δ = 
11.90 (s, 1H), 9.86 (s, 1H), 7.51 (t, J = 7.5 Hz), 7.29 (d, J = 8.5 Hz, 2H), 6.99 (d, J = 8.5 
Hz, 2H), 6.95 (d, J = 7.5 Hz, 1H), 6.87 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 MHz): 
δ = 197.6, 163.2, 160.1, 147.6, 136.9, 131.6, 130.0, 121.8, 118.5, 116.8, 114.3, 55.7. 
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3-Hydroxy-3'-methoxybiphenyl-2-carbaldehyde (3e). 1H NMR (CDCl3, 500 MHz): δ 
= 11.90 (s, 1H), 9.85 (s, 1H), 7.52 (t, J = 8.0 Hz, 1H), 7.37 (t, J = 8.0 Hz, 1H), 6.88-7.02 
(m, 5H), 3.85 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 197.5, 163.0, 159.8, 147.6, 
139.1, 136.8, 129.7, 122.9, 121.6, 118.3, 117.3, 116.0, 114.0, 55.7. 
 
 
3-Hydroxy-2'-methoxybiphenyl-2-carbaldehyde (3f). 1H NMR (CDCl3, 500 MHz): δ = 
11.74 (s, 1H), 9.63 (s, 1H), 7.52 (t, J = 8.0 Hz, 1H), 7.41 (td, J = 8.0, 1.5 Hz, 1H), 7.26 
(dd, J = 7.5, 1.5 Hz, 1H), 7.07 (t, J = 7.5 Hz, 1H), 6.97 (dd, J = 8.0, 2.5 Hz, 2H), 6.80 (d, 
J = 7.5 Hz, 1H), 3.75 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 198.0, 162.4, 156.7, 
143.8, 136.9, 131.7, 130.4, 126.7, 122.2, 121.3, 118.3, 117.4, 111.0, 55.8. 
 
 
4'-Bromo-3-hydroxybiphenyl-2-carbaldehyde (3g). 1H NMR (CDCl3, 300 MHz): δ = 
11.89 (s, 1H), 9.82 (s, 1H), 7.61 (d, J = 8.0 Hz, 2H), 7.54 (t, J = 7.5 Hz, 1H), 7.25 (d, J = 
8.0 Hz, 2H), 6.99 (d, J = 7.5 Hz, 1H), 6.85 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 
MHz): δ = 196.9, 163.2, 146.3, 137.0, 136.6, 132.0, 131.8, 123.1, 121.7, 118.1, 117.7. 
 163 
 
OH
CHO
Cl
 
4'-Chloro-3-hydroxybiphenyl-2-carbaldehyde (3h). 1H NMR (CDCl3, 300 MHz): δ = 
11.88 (s, 1H), 9.79 (s, 1H), 8.34 (d, J = 8.0 Hz, 2H), 7.57 (m, 3H), 7.08 (d, J = 7.5 Hz, 
1H), 6.88 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ = 196.0, 163.4, 148.1, 
144.9, 144.4, 137.2, 131.2, 123.9, 121.6, 118.8, 118.0. 
 
 
3'-Chloro-3-hydroxybiphenyl-2-carbaldehyde (3i). 1H NMR (CDCl3, 500 MHz): δ = 
11.89 (s, 1H), 9.82 (s, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.41 (m, 3H), 7.25 (d, J = 7.5 Hz, 
1H), 7.02 (d, J = 7.5 Hz, 1H), 6.86 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ = 
196.9, 163.2, 146.0, 139.5, 137.0, 134.8, 130.2, 129.9, 128.8, 128.6, 121.7, 118.1, 117.9. 
 
OH
CHO
Cl
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2'-Chloro-3-hydroxybiphenyl-2-carbaldehyde (3j). 1H NMR (CDCl3, 300 MHz): δ = 
11.79 (s, 1H), 9.60 (s, 1H), 7.55 (t, J = 7.5 Hz, 1H), 7.48 (m, 1H), 7.37 (m, 3H), 7.04 (d, 
J = 7.5 Hz, 1H), 6.79 (d, J = 7.5 Hz, 1H) ; 13C NMR (CDCl3, 125 MHz): δ = 196.8, 162.7, 
144.2, 136.9, 136.6, 133.9, 131.9, 130.1, 129.9, 127.2, 121.9, 118.2. 
 
OH
CHO
F
 
4'-Fluoro-3-hydroxybiphenyl-2-carbaldehyde (3k). 1H NMR (CDCl3, 300 MHz): δ = 
11.90 (s, 1H), 9.82 (s, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.35 (m, 2H), 7.16 (m, 2H), 7.00 (d, 
J = 7.5 Hz, 1H), 6.85 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 MHz): δ = 197.1, 163.2, 
146.6, 136.9, 131.9, 131.8, 121.8, 118.4, 117.5, 115.9, 115.7. 
 
OH
CHO
NO2
 
3-Hydroxy-4'-nitrobiphenyl-2-carbaldehyde (3l). 1H NMR (CDCl3,300 MHz): δ = 
11.89 (s, 1H), 9.82 (s, 1H), 7.53 (t, J = 7.5 Hz, 1H), 7.44 (d, J = 8.5 Hz, 2H), 7.32 (d, J = 
8.5 Hz, 2H), 7.00 (d, J = 7.5 Hz, 1H), 6.85 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 
MHz): δ = 196.9, 163.2, 146.3, 136.9, 136.1, 134.9, 131.5, 128.9, 121.7, 118.2, 117.7. 
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2'-Formyl-3'-hydroxybiphenyl-4-carbonitrile (3m). 1H NMR (CDCl3, 300 MHz): δ = 
11.88 (s, 1H), 9.78 (s, 1H), 7.78 (d, J = 8.0 Hz, 2H), 7.58 (t, J = 7.5 Hz, 1H), 7.51 (d, J = 
8.0 Hz, 2H), 7.02 (d, J = 7.5 Hz, 1H), 6.86 (d, J = 7.5 Hz, 1H); 13C NMR (CDCl3, 125 
MHz): δ = 196.1, 163.4, 145.3, 142.5, 137.1, 132.5, 131.0, 121.6, 118.6, 117.9, 112.7. 
 
OH
CHO
S
 
2-Hydroxy-6-(thiophen-2-yl)benzaldehyde (3n). 1H NMR (CDCl3, 300 MHz): δ = 
11.92 (s, 1H), 10.07 (s, 1H), 7.48 (m, 2H), 7.14 (m, 1H), 7.09 (m, 1H), 7.01 (m, 2H), ; 
13C NMR (CDCl3, 125 MHz): δ = 197.2, 163.3, 139.7, 136.9, 129.8, 127.9, 127.7, 122.6, 
118.6, 117.8. 
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2-Hydroxy-6-pentylbenzaldehyde (3o). 1H NMR (CDCl3, 500 MHz): δ = 11.89 (s, 1H), 
10.31 (s, 1H), 7.40 (t, J = 8.0 Hz, 1H), 6.81 (d, J = 8.0 Hz, 1H), 6.72 (d, J = 8.0 Hz, 1H), 
2.91 (m, 2H), 1.64 (m, 2H), 1.36 (m, 4H), 0.90 (m, 3H); 13C NMR (CDCl3, 125 MHz): δ 
= 195.5, 163.7, 147.8, 137.7, 121.4, 118.1, 116.2, 33.2, 32.1, 31.9, 22.7, 14.2. 
 
 
2-Hydroxy-6-((tetrahydro-2H-pyran-2-yloxy)methyl)benzaldehyde (3p). 1H NMR 
(CDCl3, 500 MHz): δ = 11.94 (s, 1H), 10.39 (s, 1H), 7.45 (t, J = 7.8 Hz, 1H), 6.95 (d, J = 
8.0 Hz, 1H), 6.91 (d, J = 7.5 Hz, 1H), 5.07 (d, J = 12.0 Hz, 1H), 4.70 (m, 2H), 3.86 (m, 
1H), 3.56 (m, 1H), 1.82 (m, 1H), 1.72 (m, 1H), 1.58 (m, 4H); 13C NMR (CDCl3, 125 
MHz): δ = 196.6, 163.7, 141.6, 137.1, 121.3, 118.8, 118.5, 98.4, 66.4, 62.9, 30.8, 25.6, 
19.6. 
 
OH
CHO
 
4-Allyl-3-hydroxybiphenyl-2-carbaldehyde (3q). 1H NMR (CDCl3, 300 MHz): δ = 
9.82 (s, 1H), 7.43 (m, 4H), 7.33 (m, 2H), 6.84 (d, J = 7.5 Hz, 1H), 6.03 (m, 1H), 5.12 (m 
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2H), 3.47 (d, J = 7.0 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ = 197.6, 160.9, 145.8, 
137.8, 136.9, 130.4, 128.7, 128.4, 128.3, 121.4, 117.8, 116.6, 33.4. 
 
 
4-Allyl-4'-chloro-3-hydroxybiphenyl-2-carbaldehyde (3r). 1H NMR (CDCl3, 300 
MHz): δ = 9.81 (s, 1H), 7.42 (m, 3H), 7.28 (m, 2H), 6.80 (d, J = 7.5 Hz, 1H), 6.01 (m, 
1H), 5.13 (m, 2H), 3.47 (d, J = 7.0 Hz, 2H); 13C NMR (CDCl3, 125 MHz): δ = 197.1, 
161.1, 144.4, 137.0, 136.3, 136.0, 134.8, 131.6, 128.9, 128.8, 121.3, 117.7, 116.7, 33.4. 
 
 
4-Allyl-3-hydroxy-4'-nitrobiphenyl-2-carbaldehyde (3s). 1H NMR (CDCl3, 300 MHz): 
δ = 9.79 (s, 1H), 8.33 (m, 2H), 7.56 (m, 2H), 7.47 (d, J = 7.5 Hz, 1H), 6.84 (d, J = 7.5 Hz, 
1H), 6.03 (m, 1H), 5.17 (m, 2H), 3.50 (d, J = 7.0 Hz, 2H); 13C NMR (CDCl3, 125 MHz): 
δ = 196.2, 161.3, 148.0, 144.6, 142.9, 137.1, 135.7, 131.2, 130.2, 123.9, 121.3, 117.4, 
117.0, 33.5. 
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4-Chloro-3-hydroxybiphenyl-2-carbaldehyde (3t). 1H NMR (CDCl3, 300 MHz): δ = 
9.82 (s, 1H), 7.63 (d, J = 8.0 Hz, 1H), 7.47 (m, 3H), 7.36 (m, 2H), 6.88 (d, J = 8.0 Hz, 
1H); 13C NMR (CDCl3, 125 MHz): δ = 119.9, 81.3, 69.1, 59.4, 56.3, 53.0, 51.6, 44.7, 
44.3, 41.6. 
 
OH
CHOBr
 
4-Bromo-3-hydroxybiphenyl-2-carbaldehyde (3u). 1H NMR (CDCl3, 300 MHz): δ = 
9.80 (s, 1H), 7.80 (d, J = 8.0 Hz, 1H), 7.49 (m, 3H), 7.38 (m, 2H), 6.84 (d, J = 8.0 Hz, 
1H); 13C NMR (CDCl3, 125 MHz): δ = 197.1, 159.4, 147.2, 139.8, 136.8, 130.2, 129.0, 
128.9, 122.6, 118.8, 110.6. 
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Chapter 7 
Enantioselective Diels-Alder Reaction of Alkynals and 3-Hydroxy-2-
Pyridones with a C2 Symmetric Organocatalyst 
 
7.1. Introduction 
Although Diels-Alder reaction has been extensively scrutinized and broadly 
applied in organic synthesis, few examples of alkynes as dienophiles in the cycloaddition 
methodology were documented.1 The first enantioselective catalytic Diels-Alder reaction 
of dienes and acetylenic aldehydes had been discovered by Yamamoto and coworkers in 
1997.2 Corey and coworker also brought up the similar strategy in the same year.3 In both 
methods, chiral boron catalysts activated the acetylenic aldehydes and provide the 
asymmetric recognition of the carbonyl face of the acetylenic dienophiles. Hilt and 
coworkers also developed a regio-selective Diels-Alder reaction of both non-activated 
and silicon-functionalized alkynes.4, 5 Cobalt centered metal complexes are also used as 
efficient catalysts to produce dihydro-aromatic Diels-Alder adducts in good chemo-
selectivity. After MacMillan and coworkers had discovered the first enantioselective 
organocatalytic Diels-Alder reaction as early as in 1999,6 the same research group has 
successfully integrated the Diels-Alder reaction of propynal in an enantioselective 
catalytic cascade sequence to assemble the core structure of (+)-Minfiensine.7 As a result, 
a more general methodology of enantioselective organocatalytic Diels-Alder reaction of 
acetylenic aldehydes is still in urgent need for the further development of modern organic 
chemistry. 
 173 
7.2. Substrate Design 
 Previously, we have discovered an amine catalyzed Diels-Alder-retro-Diels-Alder 
cascade process of alkynals and 3-hydroxy-2-pyrone (Scheme 7.1, equation a). The [2, 2, 
2] bicyclic Diels-Alder adduct was not stable enough to be isolated, and the bicyclic rings 
could break down and produce the final aromatic salicylaldehydes by releasing a carbon 
dioxide. In order to strengthen the bicyclic ring system and prevent it from collapsing, the 
oxygen atom in the ring should be substituted by a protected nitrogen atom (equation b). 
As a result, the diene designated for the Diels-Alder process should be changed from 3-
hydroxy-2-pyrone to N-protected 3-hydroxy-2-pyridone accordingly. 
 
Scheme 7.1. Diels-Alder process of acetylenic aldehydes 
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7.3. Optimization of Reaction Conditions 
 In order to optimize reaction conditions, a model reaction of alkynal 1a and N-
protected 3-hydroxy-2-pyridone 2a was set up for further exploration (Table 7.1). 
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Various aminocatalysts were screened at first (entries 1-9). McMillan’s 2nd generation 
catalyst I could not activate alkynal for any transformation, and both reactants were left 
untouched after two days (entry 1). The expected Diels-Alder adduct 3a was received 
when Barbars’ catalyst II was used, but the catalyst provided no stereoselectivity (entry 
2). A series of diphenyl prolinol silyl ethers could drive the Diels-Alder reaction to 
completion with moderate to good yields and medium enantioselectivities (entries 3-5). 
Interestingly, increasing the steric hindrance by using larger silane protecting groups, 
such as from TMS to TES or TBS, decreased the effect of stereo-control of the chiral 
aminocatalyst, and the enantiomeric excess of the product 3a decreased from 80% (entry 
3) to 78% (entry 4) and 66% (entry 5). To our delight, when a C2 symmetric 
aminocatalyst VI was chose to mediate the Diels-Alder transformation, excellent 
stereoselectivity was obtained (entry 6). However, a different class of C2 symmetric 
aminocatalyst could not provide similar ability of stereo-control (entries 7-9). Various N-
protecting groups were also screened, and the toluenesulfonic (Ts) was selected as an 
optimal one (data not shown here). 
 After chiral C2 symmetric 2, 5-diphenylpyrroildine VI was selected as optimal 
organocatalyst, solvents were screened (entries 10-16). When dichloroethane was used, 
the Diels-Alder adduct could be obtained with 65% yield and 98% enantiomeric excess 
(entry 11). Addition of triethylamine could increase the efficiency of the overall 
transformation (entry 17). And the decrease of the reaction temperature to -20 °C could 
result in an excellent yield of as high as 95% with the retention of enantioselectivity 
(entry 18). 
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Table 7.1. Reaction Condition Optimization of Enantioselective Diels-Alder reaction of 
Alkynal 1aa 
 
entry cat. solvent time (h) yield (%)b ee (%)c 
1 I CHCl3 48 0 ndd 
2 II CHCl3 12 47 0 
3 III CHCl3 12 73 80 
4 IV CHCl3 12 56 78 
5 V CHCl3 12 61 66 
6 VI CHCl3 12 54 94 
7 VII CHCl3 12 41 16 
8 VIII CHCl3 12 <5 ndd 
9 IX CHCl3 12 29 28 
10 VI CH2Cl2 12 48 95 
11 VI DCE 12 65 98 
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12 VI Toluene 12 51 83 
13 VI THF 12 53 94 
14 VI Et2O 12 7 94 
15 VI MeOH 12 13 96 
16 VI DMF 12 34 90 
17e VI DCE 6 66 98 
18e, f VI DCE 48 95 97 
aUnless state otherwise, the reaction was carried out with alkynal 1a (0.2 mmol), 3-
hydroxy-2-pyridone 2a (0.22 mmol), and catalyst (0.04 mmol, 20 mol%) in 2mL solvent 
for a specified time. bIsolated yield. cEnantioselective excess determined by chiral HPLC. 
dNot determined. eTriethyl amine (0.22 mmol) was added to the reaction mixture before 
catalyst was added. fReaction mixture was cooled to -20 °C before catalyst was added. 
 
7.4. Expansion of Substrate Scopes 
 After the optimal reaction conditions were determined, further expansion of 
substrate scope was carried out (Table 7.2). Alkynals with neutral aromatic substituents 
could provide desired Diels-Alder adducts with almost quantitative yields and excellent 
enantioselectivities (entries 1 and 2). Similarly, aromatic alkynals with electronic 
donating groups on phenyl ring could also generate the bicyclic products with decent 
results (entries 3-7). And the positions of the substituents, such as para- (entries 3 and 6), 
meta- (entries 4 and 7) or ortho- (entry 5), did not interfere with the activation and stereo-
control of substrates. Meanwhile, the Diels-Alder reaction of alkynal substrates with poor 
electronic withdrawing groups could also proceed smoothly (entries 8 and 9). The 
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absolute configuration of the bicyclic Diels-Alder adduct 3h was determined by X-ray 
crystal structural analysis (Figure 7.1).  
 
Table 7.2. Substrate Scope Expansion of Enantioselective Diels-Alder reaction of 
Alkynal 1a 
 
entry R time (day) 3 yield (%)b ee (%)c 
1 Ph 2 3a 95 97 
2 2-Thiophenyl 2 3b 99 99 
3 4-MeO-Ph 3 3c 92 98 
4 3-MeO-Ph 3 3d 89 98 
5 2-MeO-Ph 3 3e 87 98 
6 4-Me-Ph 3 3f 93 98 
7 3-Me-Ph 3 3g 94 99 
8 4-Br-Ph 2 3h 90 99 
9 4-Cl-Ph 2 3i 90 99 
aUnless state otherwise, the reaction was carried out with alkynal 1 (0.2 mmol), 3-
hydroxy-2-pyridone 2a (0.22 mmol), triethylamine (0.22 mmol), and catalyst (0.04 mmol, 
20 mol%) in 2mL solvent at -20 °C for a specified time. bIsolated yield. cEnantioselective 
excess determined by chiral HPLC. 
 178 
Figure 7.1. Single X-ray crystal structure of 3h at probability ellipsoids of 20% 
 
 
 
Furthermore, when a strong electronic withdrawing group, such as nitro group, 
was attached on the phenyl ring of aromatic alkynal, a side reaction of oxo-Michael 
addition would take place (Scheme 7.2). The oxo-Michael addition reaction of 3-
hydroxy-2-pyridone to alkynal 1j could proceed even without the activation of 
aminocatalyst, and the additive of triethylamine could mediate the background reaction 
with the yield of 27% of Michael adduct 4j (Scheme 7.2, equation a). When the C2 
symmetric catalyst VI was used, both the desired Diels-Alder reaction and the 
background oxo-Michael addition occurred at the same time (equation b). Moreover, 
when the 3-hydroxy-2-pyridone diene was substituted, the oxo-Michael addition reaction 
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would dominate over the Diels-Alder reaction, and only oxo-Michael adduct was 
received (data not shown here). 
 
Scheme 7.2. The competition between the oxo-Michael addition pathway and the Diels-
Alder pathway using alkynal 1j 
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7.5. Summary 
 The enantioselective Diels-Alder reaction of various alkynals with a C2 symmetric 
organocatalyst was established. Compared with the cascade process developed in Chapter 
6, the decomposition of the bicyclic Diels-Alder adduct via the route of retro-Diels-Alder 
mechanism was prevented by switch the diene from 3-hydroxy-2-pyrone to N-protected 
3-hydroxy-2-pyridine. The chiral organocatalyst VI with C2 symmetry was identified as 
an effective aminocatalyst for acetylenic aldehyde substrates. Additionally, when 
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alkynals containing strong electronic withdrawing substituent groups were used as 
dienophiles, the side reaction of oxo-Michael addition could compete with the Diels-
Alder reaction. 
 
7.6. Experimental Section 
General Information: 
All commercially available reagents were used without further purification. The 
progress of the reactions was monitored by analytical thin-layer chromatography (TLC) 
on Whatman silica gel plates with fluorescence F254 indicator. And Merck 60 silica gel 
was used for chromatography. 1H (300 MHz) and 13C (75 MHz) NMR spectra were 
recorded on a Bruker Avance 300. 1H (500 MHz) and 13C (125 MHz) NMR spectra were 
recorded on a Bruker Avance 500. When deuteriorated chloroform (CDCl3) was used to 
dissolve sample, tetramethylsilane (TMS) was used as an internal reference. Data for 1H 
are reported as follows: chemical shift (ppm), and multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, m = multiplet).  Data for 13C NMR are reported as ppm.). 
Enantiomeric excess was determined by HPLC with a Chiralpak column, compared with 
racemic isomer. 
 
Typical procedure for the synthesis of  
0.2 mmol of alkynal (1 equiv.) and 0.24 mmol of diene (1.1 equiv.) were 
dissolved in 2 mL of DCE (dichloroethane) and were cooled to -200C. Following with 
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0.22 mmol of triethylamine (1.1 equiv.), 0.02 mmol of catalyst VI (20% mol) was added 
to the reaction mixture at -20 0C. After the alkynal was totally consumed (determined by 
TLC analysis), the solvent was evaporated and the residue was purified by column 
chromatography eluting with a mixture of diethyl ether and dichloromethane within 20 
min at room temperature. The product solution was carefully evaporated at -20 0C within 
60 min. 
 
N
O
Ts
HO CHO  
(1R,4R)-4-hydroxy-3-oxo-7-phenyl-2-p-tolyl-2-azabicyclo[2.2.2]octa-5,7-diene-8-
carbaldehyde (3a). 1H NMR (CDCl3, 500 MHz): δ = 9.67 (s, 1H), 7.81 (d, J = 8.0 Hz, 
2H), 7.56 (m, 5H), 7.28 (d, J = 8.0 Hz, 2H), 6.79 (dd, J = 7.0 1.5 Hz, 1H), 6.64 (t, J = 6.5 
Hz, 1H), 6.31 (s, 1H), 6.24 (d, J = 6.0 Hz, 1H), 2.42 (s, 3H); 13C NMR (CDCl3, 125 
MHz): δ = 183.4, 161.2, 154.7, 138.5, 136.4, 127.4, 124.6, 124.5, 122.6, 122.2, 122.1, 
121.1, 120.9, 78.5, 52.2, 22.6; HPLC (Chiralpack AS-H, i-PrOH/Hexane = 40/60, flow 
rate = 0.6 mL/min, λ = 254 nm): tmajor = 38.13 min, tminor = 55.59 min, ee = 97%. 
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(1R,4R)-4-hydroxy-3-oxo-7-(thiophen-2-yl)-2-tosyl-2-azabicyclo[2.2.2]octa-5,7-
diene-8-carbaldehyde (3b). 1H NMR (CDCl3, 500 MHz): δ = 10.03 (s, 1H), 7.75 (m, 
4H), 7.26 (m, 3H), 6.80 (dd, J = 6.5 1.5 Hz, 1H), 6.67 (t, J = 6.5 Hz, 1H), 6.38 (dd, J = 
6.5 1.5 Hz, 1H), 6.14 (s, 1H), 2.40 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 189.8, 
168.6, 152.2, 145.9, 143.7, 134.5, 134.4, 133.4, 132.9, 129.9, 129.3, 128.3, 85.4, 59.5, 
21.9; HPLC (Chiralpack AS-H, i-PrOH/Hexane = 40/60, flow rate = 0.6 mL/min, λ = 254 
nm): tmajor = 60.39 min, tminor = 70.30 min, ee = 99%. 
 
 
(1R,4R)-4-hydroxy-7-(4-methoxyphenyl)-3-oxo-2-tosyl-2-azabicyclo[2.2.2]octa-5,7-
diene-8-carbaldehyde (3c). 1H NMR (CDCl3, 500 MHz): δ = 9.63 (s, 1H), 7.80 (d, J = 
8.0 Hz, 2H), 7.53 (d, J = 8.0 Hz, 2H), 7.26 (d, J = 8.0 Hz, 2H), 7.04 (d, J = 8.0 Hz, 2H), 
6.76 (d, J = 6.5 Hz, 1H), 6.62 (t, J = 6.5 Hz, 1H), 6.53 (s, 1H), 6.24 (d, J = 6.5 Hz, 1H), 
3.90 (s, 3H), 2.41 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 190.9, 168.6, 162.9, 162.2, 
145.8, 143.7, 134.7, 133.9, 131.6, 129.9, 129.3, 128.2, 124.2, 115.1, 85.8, 59.2, 55.9, 21.9; 
HPLC (Chiralpack AS-H, i-PrOH/Hexane = 40/60, flow rate = 0.6 mL/min, λ = 254 nm): 
tmajor = 41.41 min, tminor = 61.13 min, ee = 98%. 
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(1R,4R)-4-hydroxy-7-(3-methoxyphenyl)-3-oxo-2-tosyl-2-azabicyclo[2.2.2]octa-5,7-
diene-8-carbaldehyde (3d). 1H NMR (CDCl3, 500 MHz): δ = 9.69 (s, 1H), 7.81 (d, J = 
8.0 Hz, 2H), 7.42 (t, J = 8.0 Hz, 1H), 7.28 (d, J = 8.0 Hz, 2H), 7.09 (d, J = 9.0 Hz, 3H), 
6.78 (d, J = 6.0 Hz, 1H), 6.63 (t, J = 6.0 Hz, 1H), 6.37 (s, 1H), 6.22 (d, J = 6.0 Hz, 1H), 
3.88 (s, 3H), 2.42 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 190.9, 168.5, 161.9, 160.3, 
145.9, 143.7, 136.4, 134.7, 133.2, 130.6, 129.5, 128.2, 121.9, 117.7, 114.5, 85.9, 59.5, 
55.6, 21.9; HPLC (Chiralpack AS-H, i-PrOH/Hexane = 40/60, flow rate = 0.6 mL/min, λ 
= 254 nm): tmajor = 34.65 min, tminor = 50.34 min, ee = 98%. 
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(1R,4R)-4-hydroxy-7-(2-methoxyphenyl)-3-oxo-2-tosyl-2-azabicyclo[2.2.2]octa-5,7-
diene-8-carbaldehyde (3e). 1H NMR (CDCl3, 500 MHz): δ = 9.54 (s, 1H), 7.75 (d, J = 
8.0 Hz, 2H), 7.51 (m, 1H), 7.24 (d, J = 8.0 Hz, 2H), 6.99 (m, 3H), 6.74 (m, 1H), 6.70 (m, 
1H), 6.27 (s, 1H), 6.21 (m, 1H), 3.95 (s, 3H), 2.42 (s, 3H); 13C NMR (CDCl3, 125 MHz): 
δ = 190.8, 168.9, 161.9, 158.0, 145.6, 142.9, 137.5, 135.1, 133.1, 132.1 130.7, 129.8, 
128.4, 120.9, 120.7, 111.7, 85.5, 59.3, 55.9, 21.9; HPLC (Chiralpack AS-H, i-
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PrOH/Hexane = 40/60, flow rate = 0.6 mL/min, λ = 254 nm): tmajor = 31.86 min, tminor = 
44.55 min, ee = 98%. 
 
 
(1R,4R)-4-hydroxy-3-oxo-7-p-tolyl-2-tosyl-2-azabicyclo[2.2.2]octa-5,7-diene-8-
carbaldehyde (3f). 1H NMR (CDCl3, 500 MHz): δ = 9.65 (s, 1H), 7.80 (d, J = 8.0 Hz, 
2H), 7.42 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 6.77 (dd, 
J = 6.5 1.5 Hz, 1H), 6.63 (t, J = 6.5 Hz, 1H), 6.43 (s, 1H), 6.23 (dd, J = 6.5 1.5 Hz, 1H), 
2.45 (s, 3H), 2.41 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 190.9, 168.6, 162.4, 145.8, 
143.7, 142.8, 135.3, 134.7, 130.3, 129.9, 129.6, 129.4, 129.0, 128.2, 85.8, 76.9, 59.4, 21.9, 
21.8; HPLC (Chiralpack AS-H, i-PrOH/Hexane = 40/60, flow rate = 0.6 mL/min, λ = 254 
nm): tmajor = 34.57 min, tminor = 49.45 min, ee = 98%. 
 
 
(1R,4R)-4-hydroxy-3-oxo-7-m-tolyl-2-tosyl-2-azabicyclo[2.2.2]octa-5,7-diene-8-
carbaldehyde (3g). 1H NMR (CDCl3, 500 MHz): δ = 9.65 (s, 1H), 7.82 (d, J = 8.5 Hz, 
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2H), 7.39 (m, 2H), 7.28 (m, 4H), 6.77 (dd, J = 6.5 1.5 Hz, 1H), 6.63 (t, J = 6.5 Hz, 1H), 
6.38 (s, 1H), 6.22 (dd, J = 6.5 1.5 Hz, 1H), 2.44 (s, 3H), 2.42 (s, 3H); 13C NMR (CDCl3, 
125 MHz): δ = 191.0, 168.6, 162.4, 145.9, 143.6, 139.5, 136.0, 134.8, 132.7, 131.9, 130.0, 
129.9, 129.5, 129.4, 128.2, 126.7, 85.9, 76.9, 59.5, 21.9, 21.6; HPLC (Chiralpack AS-H, 
i-PrOH/Hexane = 40/60, flow rate = 0.6 mL/min, λ = 254 nm): tmajor = 27.81 min, tminor = 
43.72 min, ee = 99%. 
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(1R,4R)-7-(4-bromophenyl)-4-hydroxy-3-oxo-2-tosyl-2-azabicyclo[2.2.2]octa-5,7-
diene-8-carbaldehyde (3h). 1H NMR (CDCl3, 500 MHz): δ = 9.66 (s, 1H), 7.80 (d, J = 
8.0 Hz, 2H), 7.67 (d, J = 8.0 Hz, 2H), 7.40 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 
6.78 (d, J = 6.0 Hz, 1H), 6.63 (t, J = 6.0 Hz, 1H), 6.18 (m, 2H), 2.43 (s, 3H); 13C NMR 
(CDCl3, 125 MHz): δ = 190.2, 168.4, 160.3, 146.1, 143.7, 136.9, 134.6, 132.9, 130.9, 
130.1, 129.4, 128.2, 126.7, 85.9, 59.3, 53.7, 21.9; HPLC (Chiralpack AS-H, i-
PrOH/Hexane = 40/60, flow rate = 0.6 mL/min, λ = 254 nm): tmajor = 35.35 min, tminor = 
44.73 min, ee = 98%. 
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(1R,4R)-7-(4-chlorophenyl)-4-hydroxy-3-oxo-2-tosyl-2-azabicyclo[2.2.2]octa-5,7-
diene-8-carbaldehyde (3i). 1H NMR (CDCl3, 500 MHz): δ = 9.67 (s, 1H), 7.81 (d, J = 
8.0 Hz, 2H), 7.50 (d, J = 8.0 Hz, 2H), 7.46 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 
6.78 (d, J = 6.0 Hz, 1H), 6.63 (t, J = 6.0 Hz, 1H), 6.16 (d, J = 6.0 Hz, 1H), 6.12 (s, 1H), 
2.42 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 190.1, 168.4, 160.1, 146.1, 143.8, 138.4, 
137.0, 134.7, 130.7, 130.5, 130.1, 129.9, 129.4, 128.3, 85.9, 59.5, 21.9; HPLC 
(Chiralpack AS-H, i-PrOH/Hexane = 40/60, flow rate = 0.6 mL/min, λ = 254 nm): tmajor = 
32.09 min, tminor = 38.36 min, ee = 99%. 
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(E)-3-(4-nitrophenyl)-3-(2-oxo-1-tosyl-1,2-dihydropyridin-3-yloxy)acrylaldehyde (4j). 
1H NMR (CDCl3, 500 MHz): δ = 9.39 (d, J = 7.8 Hz, 1H), 8.25 (d, J = 8.0 Hz, 2H), 8.10 
(dd, J = 7.5 1.8 Hz, 1H), 7.97 (d, J = 8.0 Hz, 2H), 7.85 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 
8.0 Hz, 2H), 7.27 (dd, J = 7.5 1.8 Hz, 1H), 6.33 (t, J = 7.5 Hz, 1H), 5.48 (d, J = 7.5 Hz, 
1H), 2.47 (s, 3H); 13C NMR (CDCl3, 125 MHz): δ = 190.8, 171.7, 155.0, 149.6, 147.3, 
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144.3, 137.7, 132.9, 131.7, 130.9, 130.2, 130.1, 130.0, 129.8, 128.5, 126.7, 124.0, 123.7, 
110.9, 104.8, 22.1. 
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